>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 1; Drug: Control Apo 0.5 然
bLhbRhbRhRsRsmmbRibRgbLhbRhbRcbRibRgRsmbRiRsmbRgbRhbRcbRiRsmbRjRsmbLjb
RibRibRcLsRsbRibRiRsmbRibLebRcbRibRsRsmbRsbRsRsmbRgRsmbRsbRgbRgbRsLsbR
sbRsbRsRsmbRsbLjbLibRgbRjbRhbRsbRibLgRsbRsRsmbRgbRsRsmbRgbRsbRgRsmbRsb
RsbRsRsmbRgbRibRsbRgbRgbRsbRgbRsRsmbRgbRgbRgRsRsRgLsmmbRgbRgbRgbRsRsRs
mmbRgbRgRsmbRgbRibRiRsmbRgRsmbRgbLgbRcbRibLcbLibRcbReLobRiRsLsmbRibRgb
LibLcbLcLsmbRsbLibRibRiRsmbRiRsmbRcbRhbRibLhRsbRhbRibLoRsbLiRsbRiRsmbR
iLsbRhbRcbRcRsmbRibRibLibLibRjbRibRjbRjRsmbLobLcbRjbRibLhbLebLibLcbLib
RibRibLgbRibRibRiRsmbLibRibRibRiRsmbRibRibRgbRibRhbLjbRiRsmbRjbRibRibL
cbLcbRibRjbLcbRiRsmbLcbRhbRibLjbLjbRibRjbLcbLjbLcbLjbLiRsbLgbRibRibRcR
smbRhLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 2; Drug: Control Apo 0.5 然
bLgbLgbRoLsLsmbRibRgbLebRsbLiLsbRsRsmbLjbLcbLgbLibLhbRebLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 3; Drug: Control Apo 0.5 然
bRgbRgbLgbLgbLibLiLsbLsbLjbRjbRibLibLsLibRcbLsRjRsmbRjbLcbRhRsmbLjbRcb
LgbRibRhbRibRiRsmbRibLsbsbLsbRgbRgbRgbRhbRibRgbLibRgbRibRgbRhbLcbLjbRj
bRhbLcRsbLjbRibLibRibRjbLcbRebRgbLibRebLebLsbRsbRsbRhbLsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 4; Drug: Control Apo 0.5 然
bLsbLjbLgbRcLsbLibLgLsbRhbLjbLsbLibLjbLgbLgbLgbLgLsbLgbRsbRsLsbLsLsmbL
gbLsbLgRsbRsbLgbLsLsmbLgLsbLsbLsLibRgbLgbRsbRgbRsbLibLgbLsbLgbLsbLsbLi
bLsbLiLsbLsLsmbLgbRhLsbLibRgbRgLsbLsbLgbRsRsRsmmbLgbLgbLjRsbLiLsbLgbLi
LsbRjbLhbLgbLhbRgbLgbLgbRibLgbRiLsbLibLgbRibLjbRcbLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 5; Drug: Control Apo 0.5 然
bLgbRsbLibRsbRsLsbRsbLibLsLsmbLgbLgbRgbRgbLibLibLgbLgbRibRsbLgbRgbLjbL
gbLgbLgbLgbRsLsbRjbRjbRjLsLsmbRibLibLjLsRsmbRibRjbLhbRibRhbRgbLgbRsbLs
RsbRjbLibRjbReRsRiRsmmbRgbLsbLcbLiRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 6; Drug: Control Apo 0.5 然
bLsbRcbRibRibLsbRjbRgbRsbRsbRjLsbRcbRjbRibRgbRsLsbRsRsmbRsLsRsbLjbRjRj
bRobLcbRsbRgbRgbsbRjbRjLsbRibRsbRsRsmbRgbRgbRjbRibLibLjbLgLgbRgbRsRhLs
bLcbLgbLsbRgbLcRsLgRsRsmbRibLibLibLibLcLsmbRoLsbLcRcRsmbLgLsbRcbLsbRcb
RcbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLibRibRjbLibLjbLjbLjbRjbRhLsbRibRibRcbRhbLcbRsbRjbLgbLjbLjbRsbRsbLsbL
jbRobLcbLebLjbLjbLobLibLjbRebRsbRcbLhbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bLobLgbLjbLibRhbLsbRibLobLibRjbLcbRhbRsRcbLhbLsbLcbLibRibLibRibRjbLjbR
jbLhbRibLhbRhRsmbLcbLcbRjbRjbRibLjLibRjbRibLcbRibRhbLibLcbLibRcbRjbLjR
sbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bLhbLibLibLsbLhbLibLgbLgbLgbLcbLiRsbLgbLibLsbLgbRgbLgbLsbRibLjbLibLgRs
bLcbLibLibLibLgRsRsmbLibLiRsbRibRjbLibLiRsbLgbLibLgbLgRsbLsRsbLgbLibLi
bLjbRgbLjbLibLcbLcbLibRibLcRsbRhbRibLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bRibRiLsLsmbRiRsmbLibRgbLgLsbLibRhbLjbRoLsbLibsbLjbLhbRobLjbLebLibLsbL
gbLibLibLgbLebLgbLibLibLibLsRsbLgbLgbLcbLobLhbRhLsbLsbLgbLobLibLgbRcbR
oLsLsLsmmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bLobRcbRhbRobRhbLgbLibLjbLgbRjbRobRcbRhbLiLsbLgbRibLsLgbRsbRjbRhbLebLi
bRjbRhbRiLsbLjbRhbRibRjLsbRcRsmbRsRibLibRcbRhbLjbLgbLiRsbRcbLgbLobLcRs
bRhbLsRcLsbRsbRgbRcbRhbRiRsmbLsbRsbRgbLcbLibLibLgRsbRgbLiLsbRcbRobRcbR
ibLjLsmbRcbLcLsmbRcbRgbRjRsmbRobLgbLgLsbLibLiLsbLgbLgLsbLhbRibLsbRobLc
bRcbRhbLhbLhbLeLgbLobLhbRgbLsbRibRjRsmbLcbLibLgRsbRhbRibRibRobRibRibRg
bRibRibRibLcbLgbRjbRcbRibRoLsbRibRgbRibLjbLobRcbRcbLibLibRjbLibRcbLhbL
sbLgbLsRsbRcbRibLjbLjbLibRcbLcbRibLibLibLibLsLsmbLobLgbLibRjbRcbLjbLcb
RiRsmbLibLhbRgbLibLgRsbLgbLgbRsbLiLsRsbRsbLgbLibLgbLhbRibLgbRgLsbLgbLi
bLibRgbRhbRibRibRgbLgbRibRibLgbLcbLibRgbLgbLgLsbLhbLibLibLgbLgbRjbRibL
ebLibLsbLsLsmbLgLsbLhLsbLobLjRsbRsLsbLebLgLsLgLsbLsbLcbRgbLgbRgLsbLsbL
ibLgbLsbLgbRgbLgbLhbLcbRjRsmbLibRgbRibRgbRgbRgbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bRgbLgbLsbLsbRgbLcLsmbLibLgRsLsbLsbRgbRgRsmbLgbLjbRgbLsLsmbRgbLjbsbLcb
LgbLhbLcbLhbRjbLcbLcbRibLsbLjbRgbLhbRibLcbLcbLhRsbLobLsRsbRgRsmbRibRcb
Lib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bRibLsbLsbLsbRgbRjbLjbLiLsbLsLsLsmmbLcbRsbRsRsmbLhbRoRsmbRoLsbLoRsbRcb
RcbRjbRobLhbLiRsbLibRcRsmbLgbRsbLgbLgRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bRjbRibRgLsbRjRsmbRjbRgbRibRibLsbRgbRsRsmbLibLhRsbLgbLsLsLsmmbLsbLibLc
bLiRsbLiRsbLcbLgbLsbLjLsmbLcbLibLgbLcRsbLjbLjbLjbLiRsbLhbLcRsbLibRibLs
bRgLsbLsbLibLiRsbLhRsbLhbLgRsbsbLgbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bRgbLsbRsbRibRsbRgbRsbRsRsmbRsbRjLsbLgbRgbRsRsmbRgRsRsmmbLsbRsbRsbRgbR
sbRsbLcbLcbLiLsbRibLibRibLgRsbRgbLiRsbLibRcbRcbLjbLsLobRcbLjbLjbRcbLsL
smbLcLsmbRcbLcbRjbRobRcLsbLcbLhbLibLgbLgLsbLibRsbLsbLsLsRsmbsbLgbLibRg
bRsbLsLsmbLgbLsbLgbLsbLsbLibLiRsbRiRsLsmbRsbLibRsbRsbLibLiLsbLcLsmbRsR
smbLcbLsbLibLibRgbRsLgbLgbLcbLsLiRsbLobLibLibLcbRibLibRsbRsbRcbRcbRsbR
sbRsbRsbRsRiRsmbLsRsbRibLsRsbLibLoRsbLobLcbLsbLibLcbRjbRcbRhbLobLcLsmb
RjbRobLcbLcbRhbRcbLjbRibRsbRsRsmbLcbLibLgbLcbRcbRcbLibLsbLiLsbRsRsmbRs
bRsbLsbLcbRiLsbLsbLgbLcbLibsbLsbRsbRgbRiRsmbRiRsmbRibRibRibRsbRsbLibRj
bLhbRjbRcbRibLcbLjRsbLibLsbsbRjbRsbLgbRjbRcbRjRsmbLcbRcbLgbRgbRgRsmbRo
bRibLiLsbRsbLgbRobRiRsmbLgRsbRcbRobRoLsbRcbLhbLobRobRibLhbRiRsmbLjLibR
jbLcbRobLobRcbRobLcbLcbRiLsbRjRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLsbLhbLibLgRsbRsbLibLobRgbRhbLgbLibLibLcbLhLsbLcbLiRsbRcbLiLsbRgbLibL
hbRcbLhbLcbRibLhbRibLjbLobLibLibRhbLjbRcbLjbLibLibLibRhbRcbLibLjbLobLh
LsbLibLibLibLobLobRjbLhbLibRcbLjLsmbLobsbLjbLhbLjRsbLcbLcRsbLibLibLibR
cbLibRoRsmbLjbLibLhbRhbLjbLcbRibLcbRobLibRcbLiLsbRhbLgbRgbLhbRcbLibRcL
sbLhbRcbLibLjLsmbRebLcbRebLibRibLjbLjLsRsmbRobRjbLhRsbLjbRibRibLibLjbR
cbLjRsbRjbLjbLibRcLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bRsbRibLgbLsbLibRibLgbLibLsLoRsbLhbRibLsbLhbRibLebRhbRcbLibRsbLsbLgbLs
RsbLhbLibLibLibRgbRgbRsbLgbRsbRibRgbLcbLsbLsbLibLibLgbRsbRsbRgbRjRsmbL
obRsbRsbLibLiRsbRsRsmbLiLsbRsbRsbLgbLsbLiLsbLgbLibLgbRgbRsbLibLgbRebLo
bsbRgbLibLibLgbRibLgbLsbRgRsmbLjbRhbLjbLcbLcbRibRsbLhbRgbLgLsbRoLsbLob
RsLsbRcRsmbRcbLibLsLsmbRibRsbRgbRsRsRsmmbLcbLcbLibLiRsbRgbRsbLgbLibLiR
sbRgbLhbLibRiLsbRgbLibLhbLibLcbLgbRsbRibLgRsbRgbLgbLgbRobLjbRibLibLibR
cbRjbLjbLibRobLsbLjbRibLhbLjbRcLsbRjLsbLcbLobLhLsbLibLibLgbRjLsbLcbRib
LcbRcbRcbRcbRcbRibRsbLibLibRcbRgbLjbLibLjbLsLsmbLibLgbRgbRjbLibLibRgLs
bLobRiRsmbRgbLibLibLgbRsbLibRgRsmbRsbRgbLcbLjbLibRibRgbLcbRibRcbLjbLjb
RjbLcbRjbLibRsLhbLibRgbRgbRsRsmbLcbRsbRibRsbLcbLgLsbLibLcbRibRhbLibRib
RgbLibRgbLcbRjbLcbRibRcbLjbLcbRcbLcbRjbLcbLgbLsbLgbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bRsRsmbRsbRibLgLsbRgbRiLsbLjbRibLsbRgbRgbRgbRsbRoLsbLcbLibLsbLjbRsbLsb
LgbLibLhbLsbRgbLsbRgLsbLcbLobLibLibLjLsmbLsbRgbRebLebLcbLhRsbLcbLjbRgb
LsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bRsRgbLgbLgbRsbLsbLgbLgbLoLcbRcRsmbRibRobRgbRibLibRgbRjbRgRsmbLobRjbLi
bLsRsbLibLobRibLcLsmbLhRsbLibRgRsmbRsbLgRsbRjbRgbRibLcbRsRsmbRiRsmbRib
LibRjbLjbLebRgbRcbLibLcbRcbRebLibLgbRgbLibLibLcbLobRibRgRsmbLjbLcbLhbR
hbLibLibRebRsLibLcbLgbLhbLcRsbLebRebLebLcbLibLiRsbRibLsLibLcbLjbLebLib
LibLhbLhbLcbLibLgbLibLeRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bLgRsbLsbLgLsbRgbLgbLsbReLsbLhbLibLgbLiRsRsmbRgbRibLcbRjbLibRgbLgbLibR
gbLgbLgLsbLsbLgRsbLgbLsbRsbRebLcLsmbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bLibLcLsLsmmbRgbLgbLsbLcRsbLgbLsbLsbLgbLsLsmbLsbLcRsLsbRgbLsbLgbLhLsbL
gbLhbLgbLsbLsbLsbLgLsbLgbLsbRsbLibLsbLsbLsbLsLsRsmbLibLsbLsbRsRsmbRobR
hbRiLsbRgbRsbLhbRhbRsRsmbLcbLcbLsLobLibRsbLhbRoLsbLeLsbRobRobRobLgbLib
LibLgLsbLgbLgLsbsbRoLsbRgbLobLobLcbRcbRsbLsbLcbLobRoRsmbLcbLsbLsRsbLjb
RcLsbRcbLobRibLibLibLsbLsbLgbLgbRobRcbLcbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bLhRsbLibRsRsmbLiRsbRsLsbLgbLgbLgLsbLgbRibRgbLcbLsbRebLcbRcRsmbLcbRiRs
mbRgbRgRsmbLsLsmbLcRsbRgbLcbLgbLsLsmbLsLsmbLgRsbLibRibLiLsLsmbLgbRhbLc
bLgbLhbLoLsmbReRsmbRebLgbRjRsmbLsbLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bLiLsbLgbLgbLgbLgbLsbLgbRsbsbRjbRibRibRibRgLsbLjbRibLsbRibLjbRjbLcbLjb
LebRcbRhbLjbRhbRibLibRgbLsbLsLsmbRjbRsbRsbLgbLsbLgbRsbLsLsmbRjbLcbLibR
sbLcbRjbLcbRjbLgbLiLsbLhbRjbLobRhbRibLobRebLhbRjbLjbRjbLgbRjbLibRjbLsb
LibLsLsmbLibRjbLobRibRjbLibRjbLibLsbLgbLgLsbLsLsmbLsbLsbRsbRibRcbRcbLc
bRiLsbLsLsmbLsbRsbRibRgRsmbLobLibRgbRjbLibRcbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bLibLgLsbLsbLsbRsbLjbRjbLjbLibLgbLgLsbLsLsmbLgbLobLibLsbRsbRgbRgbLgbRg
LsbRsbLsbRebRibLsbLsbRsbLsRhbRibRgRsmbRgbRgbLgRsbRcbLgbRsbRgbRobLgRsbR
cbLgbLsRsbRcLsLsmbLgbRhbLsbRsbRsbLsbLsbLsRgbRsRsmbRgbLsbLcRsbLibLibLsb
sbLoRsLsbRjbLobLsLsmbLsbRcRsmbLsRhbRibRsbRsLsbRsbLibLgbLsLsmbLgbLsbLgb
LsbLsbRsbLsLsmbLgLsbLsLsmbLgbLsLsLsmmbLsbLgbLsbLgLsbRobRgbRgLsbRgLsbRg
bLsLsmbLsbRgbRgbLgbLibLgLsbLgbsbLgbLsbLibRjbRobRibRgbLgbRgbRsbRgbRsbRs
bsbLsbRcRsmbRebLobLjbLiLsbRjbRcbLsbLjbRhbRhbRgbLgLsbLgbLibRcbRibRgbRgb
RsbRgbRgbRsbRgbRsbRibLibRsbRobRjbLgbLiRsbLgbLsbLsbLsbRsbRoRsmbRjRsmbLs
bLsbRgbRgbsbRgbLgRsbLjbLgbLsLsmbLibLsbRsbLibLsbLgbLjbLgbLgbLgLsLsLsmmb
RsbLgbLsbsbsbLsbLsbLcbRibLcbLibRsRebRsLsbRgbLsbRsbLsbLsRsLsbLsbLsbLsLs
mbRsbLsRsbRsbLsbLsbLsbLsRsbRsbRjbRebLsbLsbLibRsbLgbLgbLsbLoLsLsmmbLgRs
bLhbRhRsmbRgbRsbLjbLibLsbLibRibRhRsmbLebLgRsbRjbLibRjLsbRgbLjbsbRebLcb
RcbRcbRibRsbRiRsmbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 25; Drug: Control Apo 0.5 然
bRiLsbRibRiLsbRibRibRibRibLcbRgbLsbRsbLcLsmbRibLiLsbLobLibRjbLcbLjbLcb
RgbLgbLjbRjbRgbLibRcbLcbRjbLcbLgbLobLcLsmbRibLibLsbLcbRjbLobRjbRibLcbR
cbLcbRcbLcbRjbLobRobRoLsbRibLibRsbLsLsmbRgbRcbLcbRcbsbLibRhbRobLgbLcbR
hbLcbRibLibLsLsmbRsbRjbLibRibLgbRcbRsbRcbRcbRcbLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 26; Drug: Control Apo 0.5 然
bLeRsbRjRsmbRibRsbRsbRsbRgbRgbRsbRjLsbLhbLhLsbLcbLcbLcbRobLibLgbRgbRsR
sRgRsRsLsmmmbRsbLsbLibLibLibLjbRjbRcbRebRcbRcRsmbRibLcbRibRibLgbRobLjb
LjbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 27; Drug: Control Apo 0.5 然
bLobLgbRgbLibRiRsmbRsLgRsbRjbRcbRiRsmbRjbRibRhbRgbLhbRibRgbLgbRsRjbRcb
RibRiRibRibLcbLjbLiRsbRhbLjbRgbRsbRhbLjbRcbRsRsmbRgbLjbLibLcbRibReLsbR
hbRgbRhbRobLsbRsbRsbRibLgbLgbRiRsmbRibLgbLgbLobRgbRibLcbLcbLibRgbLcbRh
bRiLsbRsbRjbLebLiRsbRobRgbLibLsbRgbLsbLsbLsbRsbRibRjRsmbRcbRjbRibRibLj
bLibLhLsbRgbLeLsbLcLsmbLsbLjbRibLgbRcbRibRibLibRsbRsbRjbRcbRibRsRibLjb
RibLibRsbLiLsbLcbRsbRsbRcbRhRsmbRgbRgbLsLsmbRsLsbLsbRibRcbRcbRhbRgLsbR
ibLgbLsbLsbLsbRsbRsbLjRsbLhbLibRgbRgbLsbLcbLcbLibLiLsbLjbLhbRibRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 28; Drug: Control Apo 0.5 然
bRsbLobLobLjbLobRcbLjbLobRebRobLobRobRobRobLcbLcbRjbRsbLebLjbRcbRebRob
LobLsbRebRobLebRcbRcbLjbLebRsbLobLcbLobLobLjbLobRobLobRcbLjbLobLobRebR
ebRcbLobLobLjbRjbLcbLebRjbRjbRobLobLobLobRobLebLsbLebRobLebRobLobRobRe
bLebRobRebLobLjbRobLobRebRobLebRebRcbRobRobRjbLcbRebRsbRebLebRebLjbLeb
LobRsbRebLcbRcbRobLjbLjbRjbLsbLcbRebRsbLebRebRobLsbLebRsbRebLcbRebRobR
obRsbLebRebRebLsbRobRcbLebRobLobLebRebLjbLebRobLsbLebRjbRjbRebRebRobLo
bRjbLcbLcbLobLsbRcbRebLsbRebLobRebRcbLcbLobRsbLcbLcbLobRcbLjbLcbLjbLeb
RebLcbLsbRobRcbLobRobRebLobRjbRebLebRjbRsbRobRobRcbLebRsbRebLebLsbRcbL
cbRebRobLobRobLebLsbLebLobRebLebRobRebLebRjbLobRebRobRobLobLebLobRebLs
bRobRebRebRcbLsbLsbRobRebRjbLcbRobRjbLobRjbRjbRsbLebLobRjbRobRebRobLsb
RjbRobRsbRcbRsbRobRcbRjbLobLsbLjbLcbRcbLobRjbRebLjbRsbRcbRebLcbRjbLobL
ebLobRobRobLsbRjbRjbLebRobRcbRobLsbLobRebRcbRsbLsbLjbRjbRcbLebRobLcbRo
bLjbLebRebRobLobRobLobRcbRebLobRobLobLsbRobRjbRobLebRsbRobRobRobLjbRcb
LobRebLsbLjbRcbLobLobRsbLobLebLebRobRebRcbLobLjbLjbLjbLobRebRebLobRebL
obRobRsbLobLobLebRobLobRcbLobRebRsbLobLebLebRsbRcbRebLobRjbLsbRobRobRo
bRebLobLsbLsbRebRebRebRjbLobRjbLobRjbRcbRcbLsbLobLcbRobLcbLjbLebLjbLjb
RobLobLjbLsbLobLobLebLsbRebLobRobRebRobLebRobRjbLcbRobRobLjbRobLcbLjbL
cbLjbRsbRcbRjbRsbRebLebLjbLobLsbLebRobRcbRebRcbLcbRebLobRebRobLebLjbLo
bLobRobLsbLjbLjbRcbLobLebLobRobRobRjbRsbRjbRobRebRebLsbLobRcbRsbRhbLob
LobRebRobLcbRjbLebRibLobRebRobRjbLebRsbRobLobRebRobLobRebLebLibRibRobL
ebRcbLobRebLcbLobRcbRebLsbLhbLobLebRgbRcbRebRgbRcbRcbRibLgbLebRebLebLo
bLobLebLobRobLobLobLcbRibRgbLebRebLobLebLobLcbLcbRobRobLcbRobRsbRebRsb
LebLcbLobRcbRebLebRobRcbRobLcbRcbLobRobRgbRgbRcbLebLobRcbLcbRobLjbRebL
ebLobRebRjbRgbRebLgbLobRobLjbLgbRgbLcbLcbLebLobLobLebLsbRobLgbRobLsbLo
bRcbLcbRebLobLebLcbRibRsbLebRsbLjbRobRjbRobRobLobRebLebLobLjbRsbRgbLeb
RobLebRebLobRobRgbLobLsbLobRobLobRobRgbRobLobRobRcbLcbLcbRebLobRgbRebR
obLsbLobLobLobRgbLgbLjbLgbLcbRobLobRobLobLobRobLebLebRebLgbRebLobRobLg
bRebLsbRobRebLcbLobRebRobLsbRobRobRobLsbLebRsbRebLjbRsbRebRebRcbRebRgb
LobLobRebLibRobLjbLcbRobRsbRobLobRebLobLsbLgbRjbLcbLcbLobLebLobRobRebR
obRobLibLcbRibLebRobRsbRebLebRobLebLjbLsbRhbRcbLobLsbRsbRhbRobRebRgbRo
bRibLebRsbRobLobLcbRcbRebRobLobRebLobLobRobLebLebRobLobLobRobRhbRobLob
RobLebLobRcbLsbLobLebLobLgbRebRobRebLgbRsbRobRobLibRebLebRobRsbRhbLebL
gbRobLgbRobRibRebLcbRibRobRgbLibLibLobLebLobLebRobRcbLebRobRobLcbRebLo
bRobLobRebRobLebLobLebLibRobRebLcbRibRcbLobRobRsbLobLobRobLobRcbRebRob
LebLobRobLobLgbRibLobLibRobLobLobLcbRobRobRobLobRcbLsbRebLebRobRobRebR
obLgbLcbLebRobLcbLgbLsbLhbLobLibRebRgbRebLebLgbRobLobRobLobRgbRebRobRg
bRobLebRobRobLebLsbRgbLobLobRcbLebRebRsbRgbRobLebLcbRgbRobLobLobLobRib
RcbLobRobLobLobLobLobLebLgbRobRsbRcbLobRobLebLgbLebLebRobRibRebRcbLcbR
obLobLebRobRebRgbLobRibRgbRgbLobLebLcbLsbRibRebLobLgbRobLebRebLcbLobLi
bLobLobLgbLcbRcbLcbLsbLibLsbRcbLobLgbLobRgbLobRcbRgbRobLsbLebLebLebRib
RobLebRobLcbRgbLobLebLebRobRebLhbLibLcbRobRobRjbLobLsbRebLgbLebRobLobR
obLibRebLobRsbRobLobRobLobRobLobRobRobRobRobLebLebRobLobLobLibRibLobRe
bRobLebLobLobRcbLjbRobRcbRobRsbRobRobRsbLobLebRebRebLobRobRebLcbLebReb
RobLobRebRobRsbLobRibLjbLobRobLgbRgbLobRobLsbLebRebRobLobRobLebRebRhbL
obRgbRcbLebRebRobRebRobRobLobRobLobLebLebLobLebRsbRobLobRcbLsbRebLebRo
bLgbLcbRobRebLobRibRobRobRebLebLibLobRobLobRebLgbLgbLobLibLebLobRobRsb
LobLebLobRobLebLobRibRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbRsbRsbLjbLhbLibRgbRsLsbRibRibLobLsbRobRiLsbLibRhbRobRibRibRhbLcbRc
bRcbRcbRgLsbLebRoRsmbRiLsbRibRhbRcbLjbLcbRcbRcbRobRcbLcbRcbRcbRhbRcbRi
bRibLcbRobRjbRibRibRibRibRsbLcbLoRsbRibLsLsmbRibRibRibLibLcbRobLibRcLs
bRcbRjbLibLibLcbRibRgbLcbLhbRjbRcbRcbLcbRibRcbRcRsmbLjbLcbLibLcbLibLsb
LgbLcbLgbRebLcbRcbLcbLcbLjbLjbLcRsbLcRsbRsbRcbRcbLhbLibLjbRjLsbRcbRibR
eLsbRhbRibRjRsmbLjbRcbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 30; Drug: Control Apo 0.5 然
bLsbRsRsmbLjLsmbLobRhbRibRsbRjRgRsmbRgbRgbRjRsRimbLcbLibLibLsLsLsLsmmm
bRgbLibLcbLibLsbLgbLibRibRcbLhbLgbRcbLhbRjbRibRibRebRibRibLiLsbRcbRhbL
obRjbRibLibRcbLjbLcbRoRsmbRiLsbLgbRjbLjbLcbLibRibRhbLhbLcbRcbRjRsmbLjb
LcbLcRsRsmbLsRsbLibLgbRhbLcbLobRhbRcbLcbLcRsbRsRhbLjbLhbLibLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bRibRcbRgbRjbLibRcbRiRsmbRibLobRhbRhbRcbLsbRcbRsbRibLobLibRjbRcbRgbRoL
sbRoLsbRcbRebLgbRibLibLgbLgbLibLgbRibLgbLibLoLsmbLhbRibLjbLobLcbLobLib
LsRsbRgbRibRobRhLsbRjbRcbRobRgbLobRebLjbLgbLgbLsLsLsmmbLebLcbLcbLibLsb
LsbLjLsmbRobRhbLcbLibLibRcbRobRoLsbLsbLgLsbLgbLibRgbLsRsbLhRsbLcbRsbLc
bLobLibLsbLhbRgbRsRsmbLsbRgbLcbLibRcbLibLoRsbLoLsmbLjbLoRsbLobLibRjbRc
bRhbRgbLsbLoRsbRhbRgbLibLcRsbLhRsbLibLibLhLsRsbLsLsmbLcbLsbLhLsbLoRsbL
ibRgbRsbLsbLcbRjbRsRsmbRsbLhbLcRsbLcbLobLcbRjbRcbRcLsbLhbLcbRgbLcbLcRs
bRibLibRgbLibLsbLiRsbLhbLibLgbLsbLibLsLjbLcbRibLibLsbRibRibRgbRcbRibRi
bLibRcbRhbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bLcbLcRsbLibRgbRsLsbRsbRsbRsLsbRgbLjbLjbRgbRjbLgbLjbRcbLibLibLebLgbRcb
RgbLsbRibLcbLibLgbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bRsbRgRsmbRsRsmbRsbLibRibLgbLgLsbLgbRibLgbRebLgbLiLsbRibLsbRgRsmbLobRs
bRsbRsbRibLsbLiRsbRibLibLibLibLgbLgbLgRsbLhLsbLibLiRsbLgbLgbLgbLsbLgbL
gbLsLsmbLgbLgRsbRibLiLsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bRiRsmbLgLsbLsbLiRsbRibRibLhLsbLhbLcbLibLibRhbRiRsmbRibLgRsbRibRgbLcbR
ibLgbRibRsbRgbRgLsbRgbLgLsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bLgbRjbRgbRgbLjbLcbRgLsbRcRsmbRgbRjbLcbLiRsLsbLoRsbRibLhbLgbLibRiRsmbR
gRsRsmmbLiLsbLibRibRiLsbLgbRgbRibLjLsmbLgbLibRcbRgbRgbLobRgLsbRgbLobLc
bLcbRibRgbLibLgbLoRibLgbRcRsmbRgbRsbRcbRibRcLsbRcRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bRcbRibLoLsmbLoRsbRhbRsRsRsmmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLibLcbLibLibRgbLibLsbLibLcbLibLibLibLibRjbLibRcbLjbLibLcbRibRobRibLgb
RibLibRiRsmbLcbRcbRsbLobLibLibRcbLibLibRcbLgbLobLcbLhbLgbLcbLjbRhbLhbL
gbLcLsmbLibRebRcLsbRjRsmbLcbLjLcbReb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLibLgbRjbLjbRcbRgbLsbRsLjbRhbLjbLibRhbRibLibLibRibRsbRibLcbLgLsbRiRsm
bRibRsbRgbRgRsmbRgbRsbRsLsbRgbLjLjbLibRibRhbLibLcbLibLibRgbRgbLgbRsbLi
bLjbLgbLcRsbLibLibLibLibLsbLhbRcbLibRjbRhbLibLibLsbLhbLgbLsLibLobLgbLi
RsbLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLcbRjbRibLcbLibRibLibLsbLgbLobLsbLgbLcbLibRgLsbLsLsmbLgbLsbLgbLsbLibL
cbLgbLgbLcbRcbLhbRjbLibRcLsbLcbRhbRsbRibLhbRibLebLsbRgRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bRoRsmbRsbRgLsbRsLsbLebLgbLsbLgbRjbLsbLgLsbRobLebLibRsbLibLgbLsbLsbLgb
RsbLibRibLibRibRjbLsbRgbRsRsmbRgLsbRobLjbLsbLcbLibRebLjbRcbRgbLsbRsbRg
bRibLjbRhbLobLobLsbLibLibRgbRgbRibLebLhbRgbLgbRcbRgbLsLsmbRgbLgbLoLsmb
RoRsmbLgbRgRsmbRibLjbRibRiLsbRgbLjRsLsbRibLjbLgbRhbLjbRsRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bRcbLjbRibRibRibLjLsmbLcbRcbRjRiLsbLjbLcbLgbRibRgbRibRcbRcbRcbRibRibLj
bRgbRgbRibRcbLiLsbLsbLsbLsLsmbLgbLgbLibRsbLgbLsbLgLsbRgbLibLsbRibRibRi
LsbLhbLjbRibRibLcbLcbRgbRibRhbRibLcbLcbRcbRhbRcbRcRibRhbRgbRibLjbLcRsb
RjbRcbLjbRiLsbLjbRibLjbLcbRgbLcbLcbRibRibLjLsmbRgbLsLsmbRgbLsLsmbLgbLg
LsbRsLsbLgbLsbLibLsLsmbLsbLgbLsbLgLsbLobLcbLcbRibLcbLjbRibLibLgbLgLsLs
mbLgLsbLsbRhbRibLcbRibLcbRhbRiRsmbLcbLobLibLgbRgbRgbLsbRgLsbLsRsLsbLgb
RgbRsbRcbRjbRjRsmbRcbRgRsmbLcbLibLgLsbLsLsmbLsbLsbLiLsbRjbLjLsmbRibLhL
sbLibRiLsbRgbRjbLibRiLsbLgbRibLobRcbLibLjbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bRsRsmbRsbLsbRsLsbRgbLgbRgbRjLsbRgbRjLgbRgbRsbRgbRsbRsRsmbRsbRgbRsbRib
RgbLgbRsRsRsmmbRgRsmbRsbRgbLsbRsRsmbRsbLjbLcbLibLgbLgbLsLsmbLgbLgbLgbR
gRsmbRsRsmbRgbRsbRsbRsbRsbLsbRjRsmbLsbLsbRgbRgbLsLsmbLsLsLsmmbLsbLsbLg
bLgRsbLsLsmbLgRsbRobRoLsRsLsbRibRgbLiLsbLsLsmbsbRsbRgbLsbLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bRhbRibRgbLsbRibRoLsLsLsLsRsmmmbRsbRgbRgbLsbRcbRcRsmbLgbRobRibRibRgbRs
bRgbRgbRgbLsbRsbRgbRcbLjLsmbRobLiRsbLsbLsbLgbLsbLgbLgbRsbLgbRsbLcbRsbR
ibRcbRobRgbRgbRsbRsbLsLsmbRgRsmbRibLsbRcbRgbRgbRjbRcRsmbRhbLsRsbLsbRhb
RsRsmbRibRibRgbLobRgbRsbRgbRibRoRsmbLsRsbLsLgbRoRsLsmbRibLsbRgbRobRcbR
ibLibRjRcbRcbRobRgbRebRcbRobRcbRobLgbRoLsRsbRibRiRsmbRjbRobRsbRibLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bLjbLgbLibRgbLgbRjRiLsbLiRsbRgRsmbLgbRsRsRsmmbRgbRgbRhbLibRoLsbRgbRsRs
RsmmbLibLsbRcbRgbLgbRgbLsbLsbRibRgbRibLgbLgbRibsbRobRgRsmbRgbRgbLibLgb
RsbRiRsRsmmbLcbLiLsbRibRgbRjbLibRibLhbRibLjbLobLobLcbLhLsbLibRobLcbLjb
LcbRibLgRsbRobRgbRgbLebLjbLcbLiRsbRsbRibLjbLibLibReb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bLcbRjbRiLsbLibRsbLibLibLsbLsbLibLgbLebLhLsbRgbRgbRgbLgbLoLsmbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bLgbRsbLsbLibRibRiRsmbRgLsbRsbLgbRgbRoLsLsmbLcbLibLjbRiLsbLgbLsbLjRsbL
eLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRcbLobRcRsmbLobRcbRjRsLsmbLobRcbLjbRiRsmbRsbLobLiRsbLgbLcbRjbRcbLobRj
bRgbRsbLjLsmbRjbLibRjRsmbLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 174431; End: 174931;
Recording: 1-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bRsbRibRiLsbLgbLgbLsbRsbRjRhbRcbLibLsbRibLibLsbRibRsbRsbRibRibRhbLibRo
bLibRobLcbRjbRhbRgbRjbRcbLibRcbRcbLibRsRjRsmbRgbLjbRobLcbLobRibRgbRibR
jRsmbRgbRgbRsbLibRibLsbLjbRgbLcbRjbRobLcbRgbLsbLsbLsbLibRiRsmbLibRgbRg
bLibLgbLsLsmbLcbLibLcbRcbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 1; Drug: Control Apo 0.5 然
bLjbLibRibRiLsbRjbLobRhbRibRcbLgbRibRhbRibRjLsLsmbLgbLibRibRibRjLsbLcb
RebLjbLobLgRsbRhbRiRsmbRibRhbLcbRibLcbLgbRsbLibLsLibLibLjLsmbLibLiRsbL
ibRjbRhbRjLsbLjbRibRsbRgRsmbRsbRgRsRsmmbRiRsmbLsbLjbLibLcbLibRcbRibLcb
RibLsRsbRgbLcbLhbRgbRibLcbLcbLcbRgbLibLibLsbLiLsLgRsLsLiLgbLeLgbLgbRcb
RebRhbRgRsmbLiRsbRgbRibRibLhbLibLibLgbLjbLcRsbRcbRcbLgbRcbLgbRcbRiLsbL
sRsbLjbLgbRjbRhbRgbRcRsmbRcbRibLjbRibRgbRgLsbRgbRsbRsbRgbRgbRsRsmbRgbL
cbLcbRsRsRsmmbLcbLibRsbRjRsmbRcRsmbLgbLjbRcbLsRobRibLcLsmbRgRsmbLhbRgb
LhbLhbLgbRgbLibLgbLgbLibLibLibLgbRgbRgRsmbLsbLhbLhbRgRsmbLgLsbLsLgbLib
RsbLhbLhbLgbLsbLibRjbRhbRcbRiRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 2; Drug: Control Apo 0.5 然
bLsbRgRsmbLibLibLgbLebLsbsbRobLsRsbLebLibRoRsmbRcLsbRjbRobLcbLcRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 3; Drug: Control Apo 0.5 然
bRgbRgbRgbRgbRcRsmbLibRiLsbLhbRibLebLgbRgbRgbLibLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 4; Drug: Control Apo 0.5 然
bLgbLjbLgbLgbLibLgbLibLgbLibLgbRcbRgbRgbRgbLgbRgbRsbRgbLjbRiLsbRgbLgbL
oLsmbRjbRjbLibLhbsbRobLjbLibLjRsbLsbLsLibLibRsbLgbLgbLibLgbLsbRiRsmbLg
bRgLsbLgbRcRsmbRgbRibRsbLibRsbLgbLgbLgLsbsbLgbRobRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 5; Drug: Control Apo 0.5 然
bRobRobLgbLsbRobRibRiRsmbLoRsbRgLsbRobRcbLibRibRiRsmbRibLobRgLsbRcRsmb
LibLhbRhbRcbRibRcRsmbRsbRhbRhLsbRibLobRiLsbLsbRgbLsRsbRsbRoRsmbRjbRibR
ibLsbLjbRobRcbRibRibRibRibLibRjbRhRsmbRcbRgbRgbRsbRhLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 6; Drug: Control Apo 0.5 然
bLcRsRsmbRcbRoRibLcbLcLsmbRibRjbRobRcbLibRcLiRsbLgbLgbLibLobLcbRiLsRsb
LcRsbRibRobLcLiRsbLobLgbLobRgbLsRibLcLsmbRebRgbLibRobRibRibLibRoLsbLob
RibRsbRjRsmbLoRsbRiLsbRhbRjRsmbLcLsmbLibRcbLcLsmbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bRsbRiRsmbRiRsmbLsbLgLsbLibLibRsbRsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bLiLsbRcbRjbRcbLiLsbLibRjbRibLobRebRibLjbRibLjbLsLcbRjbRgbRibLjbRibLhb
RjRsRsmmbLiRsbLgbRobRobLjbLcbRibRjbRobRibRcbRjbLcbRcbRcbRcLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bRobLsbRsbLsbLsLsRsRsmmbRsbReLsLsmbLsLsLsReRsRsmmmmbLsRsbRsbRsbRsbRsbR
sRsmbRsbRsbRsbRsbLsbRsLsbRsbRsbLebLebLobRebRcbLoRsbRoLsbLobRsLebLsbReR
smbLebLsLebReLsbLebRsbRobLobRebRcbLsbRobLsbRiLobRobLsbRsbRsbLoRebLeLsb
LsLobRobLcbRsRebRsbRcbLobLebLobRobRcbRcbLebRobLobRobRibLebRebLobRobLsb
LsbLsbLobRobRobRebRoLebLobRobRsbRcbLhbRobRobLobLsbRobLsbLoLsLsmmbLobLe
bRebRcbRobLsbRobRobRebLsbLgLsLsRjmbLjbLobLobLsbLibLobRobLsbLobRsbRcbLe
bRobLjbLobRebRobRebLobRebRcLebLobLobRebLobRebLibRobRibRibLobRebLobRebL
obLcbRebRobRcbLobRebLobRcbRsbRobLibRcbRebLsbLobRobRobRobLcbRgbRobLebLo
bLobRobRebRebRebRobRsbLebRobLebRobLibRcbLebLcbRobRobLobRgbLcbLebLsbRob
RgbRobLibRebRcbRobRebRebLhbRibRsbRobLobRibLgbRebRcbLebRebRobLebRebRobR
ebRobRobLobRobLgbRibLobLhbLsbRgbLebRobLobLebRjbRcbRobRobRebRcbLibRibRo
bRjbLhbRobLobRsbRobLobLobRobLobLobRibRjbRobRobLgbRgbRobLobRobLcbRobReb
LhbRobLibRebLobRjbLebRebRebLobLcbLebRibLobLebLobLobLhbRgbLobLcbLebLobL
cbLebRobRcbLobLebRebRgbRobLobLibRcbLgbLobRebRobLobRcbLibRibLobRsbRobLc
bRcbLsbLibLibRebLobLcbRobRobRgbRobLobLobRebLcbLebRsbRobLebRobRcbLibRcb
LcbLibRebRobRcbRobRobRibRobRobLcbLobRcbRebLibLgbRgbRobRobRebLsbLobLsbR
ebRebRcbLobRcbLobLgbRobRsbRebLgbRobLebRsbRobLobLobRebRcbLobRebRcbLcbRe
bLebLobLobLobRibRobRcbLobRebRobRgbLgbLobLobRebRobLebRgbLobLobRobLcbRob
RobLobRobRhbLobLcbLobRobRobLhbLobRebLgbLebRjbLcbLobLebRcbLebRebLjbRibL
ebLebLebLobLobRibRcbRgbRibLsbLebLebRsbLcbLibRgbLobRibRobLobLibRgbLobLc
bRobLcbRebRobLobLobRobRsbLsbLebLobRjbRobRobRcbRobLibRebRibLobLibRsbRcb
LobLobRobLsbLobLobLobRobRcbRibLebLobRsbLebLobLebRcbRobRobLobRobLcbRobL
obRebLibRobLebRebRsbLobRgbLebLcbLobLebLobRebLobRobLgbRgbLobLobRjbRsbRe
bRsbLobRobRibLobRobRgbLobLhbRobRcbRgbRibLgbRobRobRcbRgbLobLobRebLobLcb
RebRobLobRobLobLcbRcbRsbLebRsbLebLgbRebLobLebRhbRsbLibLcbRibRobLgbLebL
obLebRobRebRcbRebRobRibLebRebLobLgbRobRgbRobLhbRobRebLebLebRebRcbLebRs
bLcbRsbRobLebRibRobRobRobRebRgbRcbRobRebLobRobRsbRobLgbRobLobLebLobRob
RgbRjbRcbRobRobRsbRobLebLebRobRobLobRcbRobRcbRobLebRobRebRebRobLgbLebR
obLebRobLebRobRebRebRcbLobLobRobRcbRcbLobRcbLcbLebRebRebRgbRobRebRobLo
bRobLcbLibLebRebLebRebRgbRobLebLcbRibLsbLobRcbLebLsbRobRcbRebLibLobReb
RobRebRebRebLibLcbRcbRibLcbRobLobLsbRcbRobRcbLebRsbLebRsbRgbRobRobLobR
ebLgbLobRobLjbLobLobRcbRgbRibLobRibRobLsbRebLobLebLebLibRebLcbRjbLebLg
bRibRcbLgbLibRobLebRobLgbLobLobLgbRebRjbLobLebLgbLobLibLobLsbLobRebRsb
LebRobRcbRebRsbRobLjbRebLobRibRgbLsbLcbLebLobLobLcbLobRjbLebRgbRjbLobR
cbRobLobLobLgbLebRobLobLjbRibLsbRhbLebRebLjbRebLebRebLobRobRebLebLsbRe
bLebRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bRebRibRsbRobLgbRibRsbLsbRcLsbRjbLiLsbRobLcbLcbLcbLsbLsRsbLcbLjbLoRsbR
gbRjbLhbLsbLcRsbLibLjbLcbRsbLobLibLobRsbRobRsbLhbRobLgbLsbRcLsbRoLsLsm
b

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bRjbLcbLgLsbLgbLsLgbRjbLiLsbLibLibLgbLsbLgbRibRgbRibRoLsbRcLsbRgbLsbRg
bRjbLjbRibLjbRibLjbLjbRjbRhLsbRhbLibLibRiLsbLgbLjbLibRsbLibLsbLgbRjbLi
bRcbRibLjbLibRsRcbRibLcbLgbRibLcbRjbLiLsbRibLibLjbRjbRcbLcbLsLhbRcbRib
LibRcbLgbLebRcbRjbRcbLhbRjbRoLsbLhbRcLsbRibRcRsmbLibLcbRcbRcbRjbRcLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bLibRebRhbLsbLiRsbLiRsbLibLhbLjLhLsbRsbRibRiRsmbRsbLiLsbRcbLibRjbLgbLi
bRibLiLsbRsRsmbLcbLobRjbRebRcRibRsbRibRgbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bLibLgbLsbLsRsbLsbLsbLsbLsbRsLsbsbRsbLsRsbsbLsRsbLsbRsbsbRsRsmbLsbLsbs
bLsbLsbLcRsbLobLibLsbLiRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bRgbRobRebLobRebRjbRcRsmbRcbRcbRhRsmbLcbRibLcbLobLobLjbLhbLebRiLsbRsbL
cbLibLobLiRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bRcbLsbLiLsbRjbRcbRhbRcbRibRiLsbLcbRobLjLjbRcbRsLibLobRjbRcbLiRsbRcbLi
bRiLsbRsbLcRsbLibRhbLibRsbRjbLibRobLjbRcbRjbRcbRcbLibRobLjbRhbRsbLcbLi
bRhbRjbRibLjbLjbRhbLjbRcbRsbLebLsLgbLibRobLhbRsRhbRibLibLjbRobLhbLhbRi
bRcbLobLcbRjbRjbRcbRibLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLgbLibLiLsbLhbLhbLjRsbLcbRoRsmbLgbRiRsmbLsRsbLhbLibLibLiRsbRobLibRjbL
ibLgbRobLibLiRsbLgbRibLibRoRsmbLsbLibLibRhLsbLibLibRibLhbLhbLoLsmbLgbL
ibRsbRiLsbLibLsRsbLjbLsLcbLibLibRgbLibLibRgRsmbLiLsbRcbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bRcbRibLibLcbRobLhbRibLibRgbLgbRsbLiLsbRcbLjbLobLoRsbRjbRjbLobRgbLsbLj
bLjbRsbRibRgbLcbRsRsRsmmbLgbRgLsbLgbLsbRhbRcbLjbRgbLcbRhbRobRcbRhbLibR
ibLibRsbLsRsbLjbRhLsbLgbLcbRhbRhbRgbLoRsbLibRjbRebRjbLcbRibRjbRjbRhbRo
LsbRjRsmbLjLsmbLsbRibRgbLjLsmbRgLsbRjbRhbLebRibLjbRibRhbRhbLibLcbRgbRi
bRhbLgbLgbLibRgLoRsbLgbLgbLcbRcbRobLibLeLsbLjbRjRsmbLjbLsbRsbLjLsmbRob
RibRibRibLibLcbRibLhbReLsbRobRhbRibRibRiRsmbLhLsbRjbLcbLibLcbLjbLibLgb
RsRsmbRsRsmbLcbLibRgbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLcbLcLsmbLibLibLibRgbLsbRsbRgbLgbLsLsmbLgRsbRsbRgbRgbLsRsbRsbRobRgbRg
bLsbRsbRsbLcLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bsbLgbLgRsRsmbLgbLgbLsbRsbLgLsbLgbLgbRsbRebRebRob

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bRcbLjbLcbRhbRibLibLcbRcLsbLibRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bLgRsbRsbRcbRcbLibRsbLgbLiRsbLiRsbRiLibRhLsLsmbLsbLjbRhRsmbLiRsbRibLjb
LsbRibsbLibLgLsbRibLsbLsbLsbRcbLhbLcLsmbLsbLsRsbRsbLsbLjbRebLobLebRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bLibRibRibLcbRsbRibLjbRcbLibLsbRsbLebLhLsbRsbLjbLibRsLcbLsbLoLsRsmbRib
RobRcLsbRcbLibLiLsbRhbsbsbLjbRibLiLsbRjbLhbLibLobRhbRgbRibRibRibRibLjb
RcbLcbRjbRibLcbRjbRjbLhbRjbLibRjbRibLobRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bLibLgbLgbRsbLgbLsbLsbLgLsbRsbRsbLsbRcLsbRcLsbRhLsbLibLsbRgbLobRjbLibL
gbLgLsbsbsbsbsbsbLgbRsbLgbLsbRgRsmbRjbRobRhbRsRjbLibLibLgbRcbLiRsbLibR
cbRcbLgbLsbLjLsmbLiLsbLgbLgbRsLsbRcbRiRsmbLgRsbLgbRibLsbLcbLibRgRsmbLs
bLibLhbRcbLibRgbRgbRibRhbRobLobRebLgbLgbRcbRcbLhbLhbLobLobRsLsbRobRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 25; Drug: Control Apo 0.5 然
bRcLsbLobRgbLibLibRcbLgbLibLibRgLsbLobLsbRjbLhbRcbLhbRebRgbLibRebLjbRc
LsbLobLibLebRcbRsbLjbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 26; Drug: Control Apo 0.5 然
bLcbRibLgbLibRcbLibLibRcbLgbLcbLgbLcbLgbLhbLgbLibRibLibRibLibRibRsLsRs
bLebLoRsbRsbLjbRjbLsbRobRoLsbRibRibRcbLobLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbLibRhbLcbRgbLgbLgbRsRcbLsbRgRsmbLgbRcbRiRsmbRsbRsbLhbRgbRibRiLsbLi
bRjbRgLsbRcbLibLjbRebRcbRcLsbRcbLcbRjbRhbLsbRibLjbLcbRsLsbLgbLsbRsbReb
RsbRgbLsbRsbRsRsmbRsbRgbRsbLsbRsLgbRibLgbRsbRibLgbRsbRiLsbLsbRgbRgbRgb
RsbRsbRibRibRhbLhbLsbRibLgbRsbRgbLgbLgbRjbRcbRcbLibLgRsbRsbRsbLibRhbLj
bRjbLhLsbLsbLjRsbRibRjbRsRibLjbLjbLiRsbLcbLgbRjbLibLsbLgbRsbLiLsbLibRe
bLibLgbRcbRhbLcbRjbRebRibRhbLibLjbRiRsmbRibRcbRibLjbRibLhLsbLcbLsbLgbL
gbsbLebLcbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 28; Drug: Control Apo 0.5 然
bRcbRebRcbRcbLgbRebLobLobRobLibLebLebRjbLobRebLebRsbRebRcbRcbRsbLibLib
RcbRebRebRobLcbLebRebLobLobLobLebLgbRobLcbLcbLgbLibRcbRcbRcbLcbRobRobR
ebLebLobRobLebRcbRcbLebLcbLobLobLobRobRobRobLobLhbLgbLebLebLobLebRebLo
bRebLobRibRobLibRebRcbLobRobLobRobLcbLobRgbRobLobRobLibLebRobLcbLibRob
RgbLibRcbRobRobRobLibRebRibLcbRsbRhbLibLibLcbLobLcbRobRgbRobRobLhbRebL
ebLebRobRebLebRjbRhbLcbLebLcbRobRobRgbLobRcbLgbRibRcbRobRobRobLobRgbRe
bLobLgbRobRebRebRcbRcbLobLebLobRsbLcbRebLcbLobLobRsbRebRebLcbLobRhbLgb
RobLebRebRcbRobRobRebLebRobRobLobRobLcbLobLebRobLcbRibLobRobRebRcbLcbL
obRcbRcbLobRobRcbRcbRobLsbLebLobLsbRobRcbRobLobRgbRebLobRcbRobLgbRobRo
bRobRgbRcbLgbLhbLobRobRcbRgbRebRcbLobLobLcbLobRebLobLcbRcbLibLebLebRcb
RgbRgbRebRsbRebRcbRibRobLobRobRobLobLobLsbLobRcbRebRsbRobRobRobRobLobR
obRebLobLgbLobRhbRebLebLhbLibRibRsbRcbRhbLibRgbLcbRebRgbRobLebLebRcbRo
bRcbLcbRcbLobLebRobLobRebRebRobLebRobLobRobLgbRobLebLobLobRgbRibLebLgb
LgbRobRobRebLsbRhbLcbLsbLcbLobRjbRhbLsbLebLsbLsbLobRobLibRobRebLobLobL
obLsbLebLobRobRobRibRsbLobRebLsbRcbRcbLibLebRobRebRebRcbLobRcbRobLcbLo
bLobRcbLebLobRobLsbLobRgbLcbLobLobRobLcbLcbLobRjbLcbRcbLobRebRebRibReb
RgbLibLebRsbLsbRebRcbRobRebLibLobRebRibRcbLobLebLobRgbRcbLgbLobRobLobL
cbRebRcbRebLgbRsbRebRobLebLgbLebRobRobLobLibLsbLobRcbLgbRcbRcbRebLobLc
bRebRobLebLebRebRobRsbLibLobRobLobLcbRobRgbLobRebRcbRobLcbLobRebRebLeb
LhbRobRobRebRobRobRobRibRobLebRsbLebRgbRebRibRobRebRebLebLcbLobRcbRobL
ebRobLcbRebRebRsbRibRcbLebRobLobRobLsbLgbRebLsbRobLebRebRobLgbLobLsbRi
bRobLebLebLobRebRobLobLobLgbRebLobRobRjbLibLebLcbLebLebRobRebRobRobLsb
RgbLibRobLebRibRcbRsbRsbRebLebLobRcbRobLobRobLobRobRebLcbLobLobLgbRhbR
obLebRobLobRebRebLobRebRebRebLcbRobLobLebLjbLobLobLsbLsbRobRobLobLobRo
bLsbLebRobLobLobRgbLebLobLcbLobRobLobRobLebLebLcbRibLcbRobLcbLobRobLeb
RsbRobRcbRobLibRobRobLgbLgbLebRcbLobRobLobRebLobLebRcbLebRobLebRobRobL
ibRcbLebRebLgbLgbLcbRobLobRebRgbLobLobRebLebRebRebLobRcbRobLobRebRobRs
bRobLcbLobRgbLobLobLebRobLjbLobLebLcbRobLsbLcbLobRibRobRibRobLebLobRsb
LebRobLobLsbRhbLebRobLobLobLgbLcbLobLebRcbRcbRobLibRobLibLebLebLebRobL
obLebRobRcbLobRobRobLebLobRibLebLobLcbRobRobRobRobRgbLcbLhbRebRobRcbLs
bLobRgbRebLgbRcbLebLobRibRobRebLsbRibRobLobRcbRobLcbRobLebRobLobLcbRob
RobLebLgbRebLebLobLobLobLsbRobRobRobRobLsbLhbLebLobLjbRobRebRcbRcbRebL
hbLebLibRobLebRobRcbRobRebLobRcbLebRobLibRobRobLebLcbRobRobRobLcbLhbLe
bRebRebRebRobLobRobRobRobRcbLobRebLcbRibLobRsbRobRobRebLobLibLebLobLsb
LobRibLebRsbRcbRobRibRobRobRebRsbRcbRobLobLsbRobLcbRgbRebLebRcbRhbRgbR
cbRhbRobRobRebLobLibLcbRebRobRsbRgbLobLcbLobRobRobLobLsbLobRibLgbRgbLc
bRobRebRebLobLobRebLobLgbRsbLobLibRcbRebRibLobLcbLebLobLcbLobLobRgbLob
LobRobRobLebLsbLsbLobLhbLgbRobLjbRibRobRebLobRgbRgbLobRobLgbLobLobLobR
ebRcbLcbLobRsbRobRebRcbLgbLebLobRobRcbRibLobLobRebRobRibLobRobLebRobLi
bRibLobRobLobRebLebLebRobRcbRobRebLhbLcbLebLgbLobLebRebRobLebRebLcbLsb
LobLobRobRgbLobLcbLobRobLebLobLobLgbLobLebLebRobRobLebRsbRobRebRsbRebL
ebRobRebRebRebLgbRobLobRebLobRebRcbRcbLebLebLebRgbRibLobRcbRebRebLgbRo
bRobRobRebLgbLibRebLgbRibRobLobRobRgbLebLebLsbRobLgbRebLibRebLebLsbRob
RobLobRcbRebRebLsbLgbRibRcbRebLcbRobRebRobRob

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 29; Drug: Control Apo 0.5 然
bsbsbLjRsbLgRsbLibRiLsbLcbLjbRjbRhbRcbRcbLcbLibRhbLobRibRjbRibLjbLcbRc
bLhbRcbLibLgbRgbLibLgbRibLibLcbLgLsbLgbLibLhbRcbRibLibLiLsbLcbLcbLjLsm
bLgbLibLibRcbLibLgbLcbRcbRjbLjbLhbLjbLibLgbLhbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 30; Drug: Control Apo 0.5 然
bLcbLibLcbLgbLgbLibRjRsmbLhLsbRgRsmbLibRibLibRgbsbLibLoRsbRjbRcbLebLsR
cbRjbRcbRsbLibLgbLebRiLsbLsbLcRsbLjLsmbRsbRjRibLsbRsbLgRsbLjbRibRjbRob
LibLgLsbRibLibLgLsbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bRobLibRhbLibLsbRiRsmbRgbLsLsmbLsLsmbRjbLcbRjbRcbLcRsbRjRsLsmbRebRoLsb
RcbLcbRebLcbRibRhLsbLhbLibRgbRibLcbLcLsmbRebRgbRgLsbLcbRiRsmbLsLsmbRgb
RjbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bLsbRoLsRsbLobsbLgbLgbLsbLgbRjLsbLgbLgbRjbLiRsbRjbLgbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bLsbLsbLsbRebRgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bRibsbRcbRgRsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bRcbRgbRgbRobLgbLebLsRsLsbRsRsmbRcRsmbRibLoRsbLgbRobRgbLhbRgbRsbRibLiR
sbRjbLgbRsbLibLobRibRsbLsbRsbLcbLgbRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bRobRobLibRjbLjbRiRsmbRibRibRcRsmbLobRhbRibRgbLobRhbRcbRibRjbRibRibRjb
RobRibRoLsbRsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bRibRgbRhbLsbLibRcbLiRsbRsbRgbLgbRebLgbLsbLibLibLoRsbLibRibRjbReLsbRsL
gLsbRsbLsbLibLibLgbRebRebRcbLgbLobLiLsbLhRsLsbLobLobLhbRsLsbLcbRhRsmbL
gb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLobLhbRobLcbLibLibLgbLjLsmbLjLibLhbLcbLibLobLiLsbRsbRsbLgRsbLibLjbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLibRjbRgbRibLibLibRebRobLgbLhbLiRsbLgbLobLibRcbRcbLibRhbRgbLcbRcbRcbR
ibRoRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLcbRgRsLsmbLiLsbRcbRibLgbRsbRiRsmbRibRibRsbLsbLgbLibLibRibLibRjbLhbLg
bRoLsbLgRsbLibRcbRsbRsbLcbLgbRibLiRsbLgbLsbRcLsbRgbRsbRgLsbRgbRgRsmbRi
bRibLgbLobRobRhbRhbsbRgbRhbRibRiLsbRjLsbLsbRgbRgbLjbLgbRoLsbRsbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bRcbRibRibRgbRibRgbLibRjbRjbLjLsmbLebLcbRjbLcbRgbLcbRibLcbLibLcLsmbRjb
RhbRibLsbRibLebRgRgbRibLcbLcbRjbRcbRibLjbRibRgbLgbRgRsmbRgbRgLsbRgbRgb
RgbsbRibLsbRgRsmbRsbRsbRhbRibLsbLjbLibRgbRibLhbsbRcbLcbLobRgbRibLsbRib
RibRgRsmbLibRgbRjRsmbLjbLcbRibRjbRhbLjbLjLsmbRibLobRebRibRjbLibLgbLjbR
jbLcbRhbLibsbRjRibLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bLgbLsbLsbRsbLgbRjbRoLsbsbRiLsbRcLsRsbLibLibRgbLgbLjbLobRsRsmbsbsbsbsb
sbRsbsbsbsbRjbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bRobRcbRibRiLsbRibRiRsLsmbRiRsmbLoRsbRsbRsbRibRiRsmbRhbRgbRobRsbRgRsmb
RgbRgbRsbRibRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bRhbLcbRgbRgbLcbRsRobRjbLobLibRibLhbLiRsbLcLsmbLobLibLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bLcbLibLobRsbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bLgRsbLhbRgbLibRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bLsbRsRsmbLhRsbRgRsmbLgbLibLibRgLsbLsbLibLcRsbRsbRhbLgbRsbRsbRibLhbRcb
LcbLibRcbLhbLjbRcbLobLobRibLjbRcbLibLgbLgbRsbRjbLibLobLobRjRsmbRebRibL
gRsbRsbLjLjbRcbLibRsbRibLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 174933; End: 175433;
Recording: 2-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bLibRgbLcbRgbRgbRsbRgbRibsbLobLobRobRibRsbRsbLibRibLcRsbLhbRjLsbRcbLgb
LsbRcbRibRcbRobRebLgbRhbLsbLibLcRsbRgbRhbRibLsbLjbLsLibRob

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 1; Drug: Control Apo 0.5 然
bRgbLgbRjbRiRsmbRjbRsbRsbLjbLiLsbLgbRsLsbRjbRgbLsbRgbRsbRgbRgRsmbRgRsm
bLsbRgRsRsmmbRsRsmbRsbRsbRgbRsRsmbRsRsmbLsbRgbLsbRgbRgbLsRsbLibLibLgbR
jbLcLsmbLobLiRsbRjbRibRcbLgbLgbLjbRjbRjbRhLsbLgbLhbRgbLibLcRsbLhbLibRi
LsRsbRsRsmbLjbLiLsbRgbLcRsbRibLcRsbRibLgbLiLibLsLhRsbLgRsbRsRsmbRobLoR
sbLibLibLiRsbLgbLgbLhRsbRgbRhbRibRibLsbLgbLgbLcbRgbLobRgbRibLibRibLgbR
ibRgbRsRsmbRibLsRsRsRsmmbRgRsmbRsbRgRsmbRgbLsRsbRgbLsRsbLcbLgbRjbRoRsL
smbLgbLibRibRcbRibLcbLibLibLibRjbLgbLgLsbLsLsmbLgLsLsmbLsbLsbLsbLgbLgb
LgbRsbLgbLgbRjbRcbRsRiLsbLgbLjbLibLhbRjbRhbRcbLcbLsbLjbLcbRgbRjbRibLsb
LsbRjbRcRsmbRsbLibLsLhbRgbLcbLibRgbRsbRiRsmbLsbRjbRsbRobRibRgbLgbRgbRi
bRhbLgRsLsbRibRibRibRgbRsbLibLsbRjbRjRsmbLjbLibRjbRiRsmbRjbRcbLgbRgbRi
bRibRgbLhbLibRjbRibRsbLjbLjbLibLgRsbLsbRhbLibLcbRgRsmbLobRgbLcbLgbLgbL
gbLibRjbLjbLcbRcbRibRsbRibRobRhbRibLjbLibRjbRibLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 2; Drug: Control Apo 0.5 然
bRsbRcbsbRsRsmbLsRsbRgRsmbRoLsLsmbLgbLjbLhbLcbLgLsbLibLcbLiRsLsbLgbLsb
LobLcbLgbLobLobRobLibLgbLgbLoRsbRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 3; Drug: Control Apo 0.5 然
bLjLsmbLibRsbLhRsbRgbLgbLsbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 4; Drug: Control Apo 0.5 然
bRgRsmbLsbLgbLgbLibRobRgRsmbRoLsbLgbRhbLgbLibLcbLgbLibLibLibLgbLsbRobR
hbRgLsbRgRsmbLgLsbRibLgbLgbLjbLjbLibLjLsLsmmbLgbLsbLsbLsbLgbLgbLgbsbLi
bLibRsRsmbRsbRgbRgbRjRsmbRgbRsbRcbRsRgbRiRsmbRgRsmbRgbRsbRsbRsbRgbRsbR
sb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 5; Drug: Control Apo 0.5 然
bRibLgbRhbRsbLibLgRsbRsbRjRsmbRjbLgbRibRgbRsbRibRobRcbLoRsRsmbLobLsbRo
bRcLsbRibRcLsLsmbLgRsbRibRobLiRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 6; Drug: Control Apo 0.5 然
bRiLsbLoLsmbRgbRobRgbRibRcbRibRibRgLsbLibRjLsbRhbRgbLibLcbRgbLcbRsbLib
LsbRoRsmbLgbRebLibRcbRjbLcbRibLoRsbRsbRibRcbLoRsbLoLsLsmmbRibRobRgbRiL
sbRibRibRsbLgbLibLibLsbRgbRibRibRjbRibLsbLjbLhbLibLjbRibRibRcbLibLobRs
bRcbLibLsbLgbLsbLsbLgbLgbLsLsmbLobLsbLsbRsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLjbRjbRebRcbLjbLebLjbLcbLsbRobLobLobRjbRjbRebLibRobLebLsbRobLebRjbLob
LebLsbRjbLcbLebLobLebRsbRebLobRebLcbRebRcbLjbLjbLobLebLcbLebRjbLjbRobR
obRjbLobLobLjbLebRobLobRobLebRcbLjbLjbLobRjbRjbLobRcbLcbLobLcbRgbRjbLo
bLebRobLobRebRjbRobLebRsbLebLobRebRobRobRebLcbRebLobRobRsbLobRobRsbLob
RjbRobLobLcbLobLebRobRsbLgbRebRebLcbLebRobRebLobRobLobRobRcbLebLebLebL
obRcbLebLcbLebLsbLebRobLobLebLobRobRcbRsbLcbRebLjbRgbRobLebRebRsbRgbLj
bLjbLsbLobLobRebRobLebLebLobLebRcbRobRebLobLsbLobRebLobRobRobRjbRobLeb
RebLjbLibLjbLcbRsbRsbLjbLsbLebRobLebRsbRcbRcbRjbLebRobLsbRobRobRjbRobR
sbLebLobLjbRcbRjbRjbLobRsbLsbLebLebLebRjbLobRjbLebLobLsbLobRobRebRobLs
bLebRjbRjbRobLobRebLebLsbRebRcbRobLobRobLobLjbRobRjbLebLebRebRobLebRjb
LobRsbRobLobLebLobRjbLsbLjbRobLcbLcbLjbRjbRobLobLsbRjbRebLcbLebRobRebL
jbLjbRobRobRcbRjbRebLjbLobRjbRebRobLobLebRebRobLcbRobRsbRjbRjbRobLjbRg
bRobLebLobLcbRobLobRebLsbLobRobRibLobLebLjbRebRobRobLsbRjbLebLobLobLsb
LebRcbLobRobRobRjbLcbLobLjbLobLjbLobLebLhbRobLobLebRcbRcbLobLebRjbLjbR
ebRjbLobLjbLsbLcbRobLobRcbLobRcbLobLcbRobLsbRobLobRebLobRobLobRobRobLo
bRsbLcbLebRobLebRsbRebLobRjbLgbRebLobRobRobRcbRobRebRgbLebRobLgbLebRob
RobLcbRgbLcbLobLebLobLobRobLsbRebLsbLobRsbRebLobLobLebLobRobLobRobRobL
sbRobLebRsbLebLebLobRobLobLjbRgbLobLebRobRebLgbRobRobRgbRobRjbRjbLobLj
bRebLobRebLebLobLgbRobRcbRjbRebRobRebRobLebLjbRobRebLobRgbLcbLebRibLeb
LcbRsbRjbLjbLobRebRsbRebLebLebLgbRobRjbLobRebLobLcbLebRjbLsbLjbLsbLebL
obLobLobRjbLjbRobLobRobLobRebLobRebLobRcbRebRjbRjbLcbLcbRsbLobRebLobLe
bLebRebRebLobLebLobLsbRebRobLobRebRebRobLobRjbLcbRjbLcbLjbLgbRebLsbLeb
RjbRjbLobRcbLebRcbLsbRebRibLobRjbRobRjbRebLebLjbRobLobRebRjbLsbRjbRobL
ebLjbLsbRobLsbRebLobLebRjbLsbLjbLobLobRjbRobLobLebRcbLcbRobLebLobLobLo
bLobLcbLebRcbRjbLibRobLebRobLebRebRobLobLebRobLebLhbRebRcbRjbRobRibRob
LobRsbLsbLcbRobLcbLobRsbRobRobRobLobLjbLobRsbLobRcbLobRobLobLebLebLebR
sbRjbLcbLsbRobRsbRjbRobRebLjbLjbLobRebLjbLsbRebLjbRcbLcbRobRobLsbRebRo
bLhbRobRebLobRobRebRobLcbLcbRobRcbRjbRcbRebLobRebLebRcbLcbLjbLobLjbReb
LobLobLcbRebRobRgbLobLjbRebLobRjbLjbRsbRebLobRebRjbLobLebLobRobLcbRebR
obLebLebLobRjbRobLobRobLobLobRobRebRsbLebRobLobRebLobRobLjbLebRobRjbLc
bLobRibLobLobRcbLobRebRjbLobLebLobLebLobRjbRsbLobLebLjbLobLsbRobRobRob
LjbLgbRobLsbRobLobLjbLebLjbRobRsbLobRgbLjbLjbLsbLjbRjbRobRebRebRcbLcbL
sbLsbLjbRobRsbRsbLobLcbRebRobLsbLjbLcbRsbRebLebLobRobRebLsbLsbRebLebLj
bRsbLebRobRjbLcbLebRebRobLjbLobRcbLobRjbLebLobLsbRsbRobRcbRjbLebLsbLjb
LsbRobLsbLebRjbRobRebLobRsbRebLebLobRebRobLsbLobLobRsbRjbLebRebRebLsbR
ebLobLobLebRobLebLobLhbLobLobLsbRibRcbRebRobLebRobLobLobRebLebRobRebRj
b

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRoRsmbRsRibLsbRcbLhbRibRgbLcbRibLibRibLjbLcbRhbRjbLjbRcbLcbLibRcbRiLs
bRjbRibRgbLibRsbRibRhbRcbRibRibLjbLibRcbRhLsbLhbRhbLibRibRcbRibRibRibL
gbRibRibRcbRcbRiLsbRjbLjbRhbLiRsbRibLjbLjbRibRjbRcbRobRjbRibRhbRgbRjLs
bLgbLgbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bLhbRcbRsbLcRsbRcbLsbLibRibLiRsbRsbLcbLcLsmbLobLsLcbRibRiRsmbRhbRobLjb
RjbRiLsbRoLsbLsRsbLsbLhbLoRsbRcbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bRcLsbRhbLcbRibRibLjLsmbRhLsbLcLsmbRibLhbRjbRobRibLibRgbRibRhbRibRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bLcbRgbLiRsbRjbLsbRgRsmbLibLobLobReRsmbLhbRsbRibLsLsmbLjbsbRibLsbRcbLc
RsbLibLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bRgbLoRsRsmbReRsLsmbRibLgLsbLcbRebLgbRcbRobRobRebRcbRcbRebLhbRcRsmbLcb
RjLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bRobRcbRcbRcbRibRcRsmbRgbRhbRibLibRiRsmbRsbRsbLcbLobLgbRhbLgbRsRoRsmbL
cRsbLgbLcbLsbRhbRobRgbRiLsbRibLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLgbRhbLgbRsLiLsbLsbRsLibRcbLibLhbLibLhbLgbLsRsbLebLgbLsbLibLhbLgbRsbL
gRsbLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bRibLjbLsbLibLibsbLsLgbRgLsRsbLibRsbLgbLgbRsbLibLgbRoLsbLjbLoRsRsmbRib
RobRobRjbLjbLhbRsLsbLgbRsRsmbRsbRsbLibLobLsRsbRibLgbRgbRjbLibLibRsLibR
ibLgbLoRsbRibRgbLibLibRsbRsRgbLsbLibRjbRcLsbRobRhbLgbLcbRgbRgbRsbLcbLi
bLibRibLgbLgbRgbLgbRsbLgbRsbLcbRjbRobRobRibLibLgbRgbRgbRsbRgbLjbRgbLhb
LgbLsbLobRgbLcbRiLsRsbLibLhbLibRibRsbLobRgbRsbsbLibRgRsmbRibLibLibRsbR
cbRibRsbRibRibLibRhbLjbRcbLjbLibLsbLgbRcbRobLibRsRsmbLjbLjRsbLcbRibRsb
RsRsmbRgLsbRsbLcbRibLibRoRsmbLjbLibLgbLsRsbLgbLobRjbLcLsmbRibRsbLgbLgb
RgbRsbLobRjbRibRobLibLcbLibRsbRsbRcbRgbLobLgbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLgbLsbLgRsbRsbLgbRsbLcbRsbRsbLcLsmbsbRgbRiLsLsmbLhRsbRsbRgbRsbRsbRsRs
mbLsbRsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bsbRebRcbLcbRcbLcbRoLsbRebRibLhbRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bRibRgbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bReRsRsmmbLgbLibReRsmbRcbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bRjbRcbLcbRjbRhbLjbLibRjbRibLgbLibRgbRgLsbRjLsbLibRjbLibRjbLjbLgbRebLo
bLibRibLcLsmbRjbRibLjbLgbLsbLgbRcbRibRibLjbRibRsLsbLcbLibRgbLjbRcRsLsm
bLjbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bLiLsbLoRsbRgbLebLiLsbRcbRgRsmbLcbRjbLcLsmbRhbRibLjbLgbRjbRiRsmbLgRsbR
hbRhbRibRibLibRobRjbRsbLcbsbRhLsbRsRsmbLoRsbLibRgbRjLsbRgbRgbLjbRjbLib
RibRcbLgbRjbRcbLjbRibRgbLobLgbRjbLcbRibRjRsmbLibsbsbRjbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 25; Drug: Control Apo 0.5 然
bLebLcbLibRibLibLibLibLgbsbLhLsbLcbLsLhbLiLsbLsbRhbRobLibLcbLgbRjbRsbL
hbLcbRsbRsRgbLjbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 26; Drug: Control Apo 0.5 然
bRsbRsbRgRgRsmbLobLjbLjbLsLcLsmbLhbRcbLiLsbRsbRsRsRsmmbRsbLsbRsLsbLibR
jbLcbLobRibLcbRjbLibRgbLgbRsbRgbRibLjbRgbLjbRibRibLsbLibRgbLjbLgbRcbLo
RsbRobRibLjbRiLsRsbRgbRgbLgbRcbRibRibRgbRibLibRibRjbLhbRibLjbRibLjbLhb
RibRobLjbLjbRhbRsLsbLhbLcbRjbRibRsbRgLsbLjbLjbLsbRjbRobRobLjbLibRibRcb
LjbRgbLgbRibLgbRjbRobRibLgbRsbRsLsbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbRibRiRsmbRibLgbLcbRjbRjbLcbRsbRhbLobRjbLsbLibLjbLibLsbRsbLgbRibRjb
RjbRibLcbRibRgbRibLsbLibRjRhbLibLibLcbRgbRsbRgbRgbRgbRibRgbLsRibLibLcb
LsbLibRjbLsbLjbLgbLibLjLsLsmmbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 28; Drug: Control Apo 0.5 然
bRobLobLibRebRebLobLobLhbLibRobRobLobLcbLgbLebLebLcbRgbLobRebRobRgbRob
RobLebLobRcbLebLcbLcbRcbRebLibRobLgbLgbRibRobRibRibRobLobRobRjbRobLcbL
obLobLobLibLobLobLcbLcbLebLebRobLebRebRcbRcbLobLebRcbLgbRibLebLobRsbRo
bRcbRebLebRobLsbRcbRobLobLcbRebRebRobLobRcbRcbRobLgbRibRobRobRobRobLcb
RobLebLgbRebLcbLibRcbLsbLebLobLobRebLobRebLobLobLhbRobRobRebLgbRsbRobR
ebLibLcbLcbLebLibLebRgbRhbRcbRgbLobRobLobLebLebRsbRcbLobRebRebLebLibRo
bRhbRobRobLobLobLobLibLobLobRobRebLcbLobLcbLobRebRsbRobLebLebRobLobLob
RobLobRcbRobLhbRobRsbRobRobLcbLcbLobRebRgbRebRebLebRobLcbLobRcbRobLcbR
ibLcbLobLgbLcbLcbLobRobRebRobLobRjbRobRcbRebRhbRebLibLobRgbRobLcbLobRo
bRobRobLebRhbLcbRibRibLobLgbLcbLobRobRobLcbRobLibLebLobLobLcbRibLebLeb
RcbLebRobLgbLibRebRibLcbLebLobLobRobLobLobLibRebRobLobLebLebRcbRibLibL
cbLcbRobRibLobLobLebRobLobLibLebLobRobLobLebLgbLebRebRobRebLcbLibLebLo
bLobRobLobLobLcbLebRobRibLebLebRobLebLobRobLcbRcbLcbRebLebLibRebLebLob
LobLibLobRibLibLcbLcbLobLcbRobRebRobLobLcbLobRibRsbRgbRebRobRobRobLobL
cbRobRcbRebLebRcbRobLebLobLobRebLobLcbRcbRgbRsbRobLobLebRobRobRebRobLo
bRobLibRebRobRobRobLebRgbLobRgbRebRibRobRebRsbRobRibRebLcbRebRibRcbLob
RibRebRebLebRobRcbLobLobLebRobLibRhbRobLibLsbRobRobRobRgbLobLgbRsbRgbL
sbRobRebLobRobLsbRcbLobRobRgbLobLobRobRcbLebRobRobRobLebRobLcbRobRobLe
bLobRobLcbRobRobRcbLobRebRgbRebLobRebRcbRcbRobLobLebLobLjbRobRobLobRob
RcbLobLebLebRobLebLgbRcbRebLgbRobLobRobRcbLibLibLobRibLobLobLebRobRobR
obRebRobRobRobLibRibLgbRibLebRobLobRgbRobRobRobLebLsbRobLibRobRcbLobLe
bRobRibLobRobRcbRebRhbLgbRebLcbRebRcbRobRobLgbRsbLobLsbLhbRobLobRobRob
RobLebLobRebRobLcbLcbRobRgbLcbLebLobRibRobLcbRsbLobRcbRobRgbRobRebRebR
obRobRobRcbRcbLibRobRobRibLebLobLobRobLobLebLgbRcbLsbRgbRcbLebLcbRobRc
bLcbRibLibRcbRobLobLobLobLsbRobLobLebLobLebRsbRebLcbLebRobRobLcbRobLgb
LobRcbLebRobRebLebRgbLobLibLobRebLobRobLcbRobLcbLcbRebLobRcbRsbLobLebR
cbLcbLebRibLibRebRebRobRobLebLebRobRebRibRebLgbRibRsbLobRcbRebRebRibRo
bRcbRebRibLobRgbLebRibLebLcbRobLobLcbLebLebRgbLobRcbRsbLobRebRcbLcbLib
RhbLebRobLibLobRcbRebLobLobLobLobRgbLebRebRibRobLcbRobLibLebRgbRobRcbR
obLobRebLgbRebRobLibLobLobRebRobLobLobRobRobRebRebLcbLebRebLebRobRobLe
bLebRsbRibRobLebLobLobRebRobRibRobRebRsbLibRcbLsbLobLobRebRobLobRobRcb
LebRebLcbLebLobLebLcbLjbRebRobRcbRgbLebRobRsbLobLcbLobRibLcbLsbLebLcbL
hbLobLobLobLebLobRobLebRebRebRebRibLjbRobRebRcbRibRobLobRobRebRobRcbRs
bLibLebRibRcbLcbLebLebLcbLobLebLobRebLcbLebLobLebRobLcbLcbLcbRebRcbRgb
RebRobLcbRebRebRobLobRobLebLgbRobRibRobRobRcbRibLcbLgbLebRhbRibLgbLobR
gbLcbRobRibLobLobLcbRcbRobLgbLebRcbLobRobLebRcbLobLebRobLcbLobLgbLebRg
bRebRibLcbLobRobLebRcbRibLobRebRobLobLibLsbRebRobLhbLobRebRobRgbRebLeb
RgbRebLebRsbRsbLobRobLobRobRhbLcbRebRobRobLebLobLcbRcbRobRebRhbRcbRcbR
obRibRobRobRhbLsbRebRcbRcbRobRobRcbLcbLobRibLgbRgbRgbLobRhbRcbRgbLcbRg
bRebRcbRcbRcbRebLobRibRebRobLobLibRebLobLibLobLobRobRcbLobRebLebRobLeb
LcbRgbLibLobLebRcbLebLsbRobLebLibLibRgbLobLsbRcbLebLobRebLgbLebRobRobL
cbRebRebLhbRebRebLgbRebRebLgbLobLcbRobLobLobRibRcbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 29; Drug: Control Apo 0.5 然
bLsbLcbLibLibLjbLjbLhbLjbLibLibLjbLgbLibRibLibRgbLibRsRsmbRibRgbRgbLcb
RcbLjbRjbRhbLjLsmbRcbRcbLhbLsbLibRsbRgbRhbRcbRcbLibRjbLjbRcbRhbLibLsLs
RsmbRcbLibLcbLjbLgbLibRcbRibRgbRgbRjbLcbRgbLsbLsbRsbRsbRgRsmbLebLsLibL
ibLsbLgbLsbLibLebLebLibLgbRsbLhbLgRsbLhbLibLibLibLsbLcbRebRjbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 30; Drug: Control Apo 0.5 然
bLibRcbRsbRgbLibRibRibRcbRcbLcbRgbRibLobLjbRjbLcbLgbLcbLjRsbLhbRjRjbRh
bRobRhbRhbReLsbLhbLcbLjLgRsbLhbLobLebLsbRgbLgbLsbLsbRibLiLsbLibRjbLiLs
bRcbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bLcbLhbLhbLcbLibLiLsLsmbLibRhbLgbRibLhRsbLcbLhbLhbLgbRsbLjLsmbLobLsLob
RgLsbRjRsmbRcRsmbLcbLgbLobLobRgbLobRsbRjbLcbLibLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bLgbLjbRgbRhbLgbLgbRhbLibRcbRsbLgbLgRsbRoLsbLgbLjbRgbRcLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bLsRsbRsbLebLib

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bLibLobLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bRibRgbRoRsmbRjRibLcbLsbRsbLgbRgbRibLcbLsbLsbLgLsbRgbRobLobLgbLsbLobRi
bRibRebLsLsmbRsbRgbRhbsbLcbLobRibRgbRiRsmbRibRiRsmbLsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bLsbRsRebsbLobRgRsmbRjRsmbRibRiRsmbLsbRgbLsbRgbLsbRoLsbLebRcbLgLsbRcLs
bRjbRibLsbLgbRcbRgRsmbLobRcbRebRsbLgbLjbRjbRsLjbRjRjbRcbRjRsmbRibRibRs
RsmbRgRsmbLsbRjRsRsRsmmmb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLgbRibLebLjbLgbLsLgbLgRsbLibLhbLjbLiLsbLibLhbLsLsRsRsmmbLsbLsbLgbLibL
cbLcbLibRsRsLsmbLgbLgbLgbLcbRhLsbLgbLjbLibLgbLgbLjLsmbLgRsbLgbLgRsbLsL
smb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLoLcLsmbLobLcbRgbLobLobRcbLiLsbLiRsbLibLibRjbLgbRsbRsbRiRsmbLiLsbRsLi
bRsbLsbLcbRgbLibLiRsbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bRhbLcbRibRcbLcbRcbLcbLcRsbLibRjbRsbLhbLibLgbLiLsbRgbLsbLobLcbLebLcbRg
bRgbLjbLibLibLibLcbRgLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLibRjbLsbLibLiLsbLgbRibRibRibLgbRsbRsbLsbLcbLgbRcbRsbRgbRgbRibRsbRibR
ibRhRsmbLcbRjbLibLibLobRsbLobRgbRgRsRsmmbLibRibLsLhbLsbLgbLibLibRjbRob
RsbRsbRiLsbLsbRobRhbLgLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bRibLcRsbRcbLibLsbRgbLibRobLcbRjbRobLobRcbLibLibRsbLsbLsLsmbRjbRibLcbR
cbRsbRgbRibRgbRgbRibRibRgbRjbLcbRgbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bLibRobRhbRsbLgbRsbRcbLobRgbLgbLgbLgbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bRiRsLsmbRibLsbRcbRiLsbRcbRiLsbRcLsbLiLsbLgLsbLibLsLsmbLgbLgLsbLsLsmbL
sLsmbLgbLsbLsRsbLgbLobLsbRsbRibRsbRibRcbLsbRiLsbRsLsbLoLsmbLsbRibRibRs
bLsRibRsbLsbRjbRobLgRsbRiRsmbRsbRiLsbRsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bRgbRiRsmbLjbRgbRcbRebRobLibRgbLgbRgbRsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bsbLhbLcbLhbRcbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bLsbLsbLsbRsbRsbRsbLsbLsbRsbLsbLsbRsbRsbLsbRsLsbLsLsRsmbRsbRsbRsbRsbRs
LsbLsbRsLsRsbRsbLsbRsbLsbLsbRsbLsbLsbRsbLsbRsbRsbRsLsbLsbLsLsLsmmbRsbR
sbRsLsbRsbLsbRsbLsLsmbRsbLsbLsbLsbRsbRsLsLsmbLsbLsbLsbLsRsbRsbRsbLsbRs
bRsRsRsmmbRsbLsbLsbRsbRsRsmbRsLsbLsbRsbLsbLsbRsbRsbLsbLsbsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bLibLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175435; End: 175935;
Recording: 3-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bRjbRebRhbLobLjbRjbRcbLcbLhbRjbRhbLcbRobRgbLgbLjbLiLsbLsbLgbRsbLibRibR
obLgbRsbRibLgbRgbLiLsbLjbRibLjbLhbRibRhbLibRibLsLsmbLgbLgbRsRsmbLiLsbR
ib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 1; Drug: Control Apo 0.5 然
bRhbLjbLgbLgbLgbLsLsmbLsbLgbLsLsmbLsbLibRjbRcRsmbRibRibRibLgbLsbRcbRhb
RgbRiLsbRibLhbLiRsbRsbRibRibRibLhbRibLobRsbRibRgbLsRsbRgbRsbRobRcbRibL
cbRsRjbLcLsLsmmbRsbRcbRiLsbRgbRjbLibRiLsbLcbRsRsmbLsbRjbRcbRibRsbLgbRi
bLsbRcbRobRgbRhbLobRgbRoRsmbRcbRibRgbRsbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 2; Drug: Control Apo 0.5 然
bLjbLcLsLsmmbLgLsbLibLsbLsbLcbLgLsbLgbLobLibLiLibRgLsbRcbRcbLibLibLcbL
ibLjbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 3; Drug: Control Apo 0.5 然
bLcbLcbLibRgbRsbRobRjbLgbRcRsmbLsbLgbLiRsLcLsmbRibRsLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 4; Drug: Control Apo 0.5 然
bRgRsmbRsbRgbRsbRgbRgbRibRgbRiLsbRjbRcbRiLsbRcbRsbLsLsmbRgbsbRsbRsbLib
RgRsmbRgbLibRsbLsbLjbLgbLobRibLsbRhLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 5; Drug: Control Apo 0.5 然
bLibRsbRoLsbRcbRcbLjbRjRsRsmmbRjRsmbLsbRibLgRsRcLsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 6; Drug: Control Apo 0.5 然
bLiRsbLibLgRsbLiRsbRhLsbRobLoLsmbLcRgbRhbLgbLcLsRsmbRgbRgbLgbRsbLsbLhb
LsLsmbLsbLsRibRsbRgbLcRsbLhbLcbRobRsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bRcbRsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRhbRoRsmbRcLsbRhbRibRcbRcbRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bRobLsbLobRebRgbLhbRobRcbLcbLobRibRobLebRjbRebLcbLobRobLebLobRcbLobRjb
RebRobRcbLobRobRebRjbRcbRobLsbRebRebLobRjbLobRobRobLobRobLcbRcbLgbRcbL
obRgbLjbRobRebLebRcbLibRebRcbRcbLobRobRcbLcbRobRcbLobLobLgbLebRebRcbRo
bRsbRebLebLjbLobLebLebRjbRjbRebLgbLhbLebLobRebRcbRibRjbRobLobRebRebLgb
RobLcbRebRjbRcbLebLebRcbRebLebRebRsbLibLebRobRjbLebRcbLjbLobLobLcbRobL
ebRobLobRcbLjbRobRebLobLobRsbRobRsbLebRjbLebRobRjbLobRebLebRobRsbRjbLo
bLcbRobRebRobRobRobLebLibLebLebLobLobRebRobLcbLobRjbLsbLgbRobRebRobLjb
LibLjbLobRjbLcbRobLobLobLjbLobRebLobLebLobRsbRgbRobRobRobLobLjbRsbRhbL
ibRebRebLebRebRobLjbLobLcbLjbRjbRobRjbRjbRebRebLebLcbRcbLjbLcbRcbLjbLo
bLjbLobLcbLobRobLjbLobRcbLebLobRebRobRebRcbRcbLgbLcbRobLsbRcbRobRcbLeb
RobLjbRsbLjbRebLobLobRobRobLobLgbRsbRcbLobRebLjbLebRcbRebLjbLsbRobLobL
gbLjbRsbLobRebLobLjbLebRobLobRebLobRjbLhbRcbRjbLcbLobLobLsbRobRobLobRe
bRobRobRcbRobLobRcbLgbLobLcbRobRobRobLebRcbLobLebLcbLobRobRobRcbRobRjb
LobRobLcbRsbLcbRobLobLobLjbLebRjbRsbLcbRsbLcbLobRobRobRjbRobRjbLebLobR
obLcbRebRjbRobRjbLsbRjbLobRibRobRebLcbRjbRebRjbRjbLcbLcbLobLcbRsbLcbRc
bRebLjbLebLebRobLcbLobLobLcbLebRebLjbRobRobLobLobLobRobRebLcbRcbRcbRob
LjbRcbRobLcbLcbRebLcbRobLsbRgbLobLebLebRobRcbLebLobRsbRobRobRobRjbLcbR
ebRobLsbRcbLebRobLobRebRobRjbRcbLjbRebRsbRebLsbRjbLcbRibLobRjbRhbRobLe
bLcbRcbRobRebLcbLjbRobLjbRebLobRsbLobLebLobRcbRebRjbLobLsbLibLebRobReb
LebRebRebRobRsbLcbLebRobRjbLobLobRibLsbLebRobRcbRobRobLebLjbRjbLobLobL
obRcbLcbRebLsbLebRjbLsbLebRobRebLebRjbRebLebLobRcbRebLobLobLhbLobLobRc
bLobRobRobRobLebRcbLobLibRobRcbLebLgbRobRobRebRibRibRebLcbLobRsbLibLob
LebRgbLibRcbRjbLebLobRebRobLebRcbRebLobLcbRebLebLebLobLobRobLebLjbRjbL
ebLobLobRjbRebRobRebLibLhbLobRcbLcbLebRobLobLebRjbLobLobLcbRcbLobRobLo
bRobLjbLjbLebRebLebRobRobRobRebLgbLsbLcbLgbRgbRcbLebLebLebRobLsbLobLeb
RebLobLobLobRgbRcbRibRebRgbRebRobLjbRebLebRebLcbLsbLebLobRobLobRobRcbR
gbRebRobLobRjbRcbLebRobLobLjbRobRobRobRcbRsbRobRobLsbLobRebRobLebRcbRe
bRobLebRebLobRebLjbLcbLobRobRebRobLobRibRobRebRobRobRcbLobRobLebLcbRob
RobLebLobLobRobRobLobLobRobLebLjbRsbRobRjbRobLjbLebRcbLcbLobLcbRcbRobL
jbLobRebLcbRebLebLebLjbRebLebRobRcbRobLobLebRobRjbRobLobLcbRcbLobLobLc
bLcbRobRebRobLjbLcbRobLobRobRebLjbRobRsbLjbRobRobLebLcbRobRebRobLobLjb
LobLjbLobRcbRobRcbRcbRcbLjbLcbLobRebRobRobLobLcbLebLsbRjbRobLjbRjbLjbL
obRjbLebRcbLebRebRobLebRebLobRobRobRobRebRobLobRobRebRcbRjbLjbRobLebRc
bLjbLebLebRebLobLobLobLcbRobLjbRobRebRjbLobLobRcbLjbLobLobLcbLjbLebLcb
RebLobRobRobRjbRebRjbLobLcbRjbLjbLjbRjbLebRobRebRobLjbLebLjbLjbRobLebL
obRobRebRobRobRcbLjbLsbLebLjbRsbRjbLebLjbLobLobLobLobRjbRebRebRebRobRc
bRobRsbRebLobLobLjbRebLobLcbRebLsbLjbRobLcbRjbRobRcbRcbRjbLcbRebRobRob
LcbRobLobRebRsbRobRebLebLebRebRobLobRjbRjbRobRjbLebRjbRobRcbRcbLcbRobL
ebLobRjbLjbRjbLjbRobLjbRjbLcbLobLobRebLobRjbLcbRjbRsbRobRcbRobRcbLebLe
bLebRsbLebRcbLcbLjbRcbRobRobRsbRobLjbLcbRjbRobRsbLobRobRjbRebRsbLebRob
RebLebLjbRobRjbLobRobLebLebRebLcbRcbRobRjbLsbRebLcbLebLcbRobLobLobLebL
ebLobLsbRobLebRobLcbRebLobLebLebLebRebLobRsbLobLjbLjbLjbLebLebLebRcbLe
bLobRebLcbRjbRjbLjbLobRebLjbRobRebRcbRebLjbRobRjbRobLebRebLsbLibRobLjb
RsbLgbLebLcbLsbRsbLebLebRcbLobLcbLobRcbLebRcbLobRobRobRcbLebLobRjbLobL
obRobRcbRobLhbRobRsbRjbRebLcbRobRsbRebRobLibRebRobLobRobLobLobLcbRobRe
bLjbRobRebRebLjbLobLcbRebLebRebRobLsbRebLebLebLobLebRobRsbLgbRebRebLjb
RjbLsbRebLebLobRhbRgbLobRsbLebRebLebLobRobRobRsbLebRebRsbRcbLebLcbRobR
obLebLjbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bLcRsbLjbLibRhbLibLibLhbLcRsbLsbLcbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bRibLsLobLsbsbLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bLibLibLobRsbRobLobRsbLsbRsbRjbRsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bRebLibLsbsbLgbLgRgbRjRibsbsbsbsbsbsbsbsbsbLsLiRsbLiLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bLibLgbLibLcbLibLjbLibLibLibLgbRsbRsbLgbLgbRoLsLsLsmmbLsbLsRsbLsbLgRsb
LcRsbRhbRgbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bsbsbLsbLsbsbsbsbLsbsbsbsbsbsbLsbRsRsmbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbRsbsbsbsbsbsbLsbsbLsbLsbsbRsbsbRsRsmbRsLsbsbsbsbsbsbLsbsbsbsbLsbLsbs
bsbsbRsbsbsbsbsbsbRsbRsbsbLsbsbsbsbLsRsbLsRsbLsbLsbsbsbsbsbRsbRsbsbsbs
bsbsbsbsbLsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbLsRsbsbsbsbRsbsb
sbsbLsbLsLsmbsbsbLsbRsbsbsbRsbsbLsbsbsbsbsbRsbsbsbLsbsbsbsbsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bLibLgbLibLgbRgbLsbRibLibLiRsbRibRibLibRgbLgbRhbLjRsbRhbLjbLcbRibLibRo
bRhbLibLjbRgbRcbRgbLibRsbLgbRobRibLhbLebRobLjbLhbLcLsmbLcbRibLibRibLsb
RgbLsbLebLibLgbLhbRibLcbRibRgbLsbLcbRgbLgbRobRcbLjbLjLsmbLhbRsbLibRsbR
obRobRsbRsbRgbLgbRcbRcLsLsmbRgbRgbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLgbLsbRsbRsRsmbRsbLgbLgbLgbRsbLsbLgLsbLjbLgRsbRobLobLjbRjbLsbRsbLoLsm
bLibRobRgbRjbRcLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bLgbRcRsmbRgLsbLgbLsbLgbLeRsbLobRgbRjbRjbLobLibLgbLibLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bRgbRjLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bLibRibLibLgbRhRsmbLiRsbRibLgLsbRsbLgbRgbLiRsLsbLsbLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bLibRibLjbLgbRibLibRgLsbRgbRobLobLcbRcbRibLibRsRibsbLiLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bRcbLjbLibRiLsLsmbLsbRsbLhbLibRjbRibLibRcbLjbLibLgbLibLiLsbRgbRebRhbLg
bLgbRgbsbLoRsbLsbLobLiRsbLsRsbRsbRgbLobLgbRibLibRsRsRsmmb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 25; Drug: Control Apo 0.5 然
bRcbRsbRcbRsbLcbLebLebLoLsmbLeLsRsbRsbLhbLcLsLsLsmmmbLgbLhbRjbLobLsLjR
sbLgbRcLsLsmbRebLiRsbRsbRjbRcbLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 26; Drug: Control Apo 0.5 然
bLobRobRjbLsbLjLsmbRjbLgbRjbRjbRobsbsbLcbLgbRcbLebRcLsbLcbLobRcbRibRib
LjbRsbRsbLhRsbLibRgbLjbLhbLhbRibRgbLsbRsbRgbLjbRjLsbLibRob

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbRsbRiLsbRhbRsbRhbRibRibRobRibRjbRobRhLsbRcbRhbRcRsmbRcbRobLsbLgbLh
bRjRsmbRjbRibRobRibLiLsLsmbRibRsLsRsbRsbRcbRibRjbRibRjbLgLsbRsbRsbRcbL
sbRcbRgbRibRibLgRsbRhRsmbRibLsRgbRiLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 28; Drug: Control Apo 0.5 然
bLcbLobRebLobLibRobLebRobLebLobRobLibLobRgbRobRobRcbLcbRobRobLobRobLeb
LobRgbRgbLcbLobLobLgbRcbRcbRgbRebRibRibLobLcbLobRcbRobLibLebRobRobLobR
obRobRobLsbRcbRcbLobLobLobRebRobRebRobLcbLsbRcbRebRebRebLebRobLgbRcbRo
bRebRcbRgbLgbRobLibRibRcbLcbRcbRcbRebLobLcbLobRobLobLobLibRobRebRebRib
LhbRobLebLebRgbRobLgbRobRcbLobRebRcbRgbRobLhbLobLobLobRobRobRibRobLobR
cbRobRobRcbRobRebLobRobLcbLebRobRcbLibLobLobRobLcbLibRcbRobRgbLobRobLo
bLibRgbRsbRgbRebLebLobLobLobLebLcbRsbRcbRibRebRgbLebRobLobLobLibRobLcb
LebLobRcbLcbLobLcbLobLebRcbRcbRobLibRibLcbRobRobLobRobLebLobLobRebRobR
ebLobLobLibRobRobRebLebLibRebLobLobLcbRhbLcbLobRobLcbLcbRhbLhbLobRobRo
bLobRcbRibRobRobRobRobRobLobRobLebRcbLobLobLebRsbLobRcbLobRobRebLcbRob
RgbRcbRobRcbRobRebRobRsbRsbLcbRebRebLcbRibRobRobLhbLobRobLcbLobRobRgbL
cbRobLobLobRcbRebRobLobRobLobRobRebRibLebLobLobLjbLobLibLebLhbLebLebLs
bLhbRobLobRcbLhbRobRebLobLobLebRobRibRobLjbLobLhbRibRgbLebLebLebRsbLhb
RobRobRebLobRobRobRhbLcbLcbLcbRobLebRcbLobRibLibLobRebRobRcbLsbLobRobL
ebLcbLebRebLobRobLebRobLgbRcbRobLsbLobRobLobLobLobLcbLibLebRobRobLcbLi
bRobRcbLgbRcbRebLibLcbRobLebLebLsbLgbRobLgbRsbLebRobLibLibLebRobLibLeb
RobRebRibLcbRebLebRcbLcbRgbLebRobLobLebRebRgbRobRobRibRcbLebRobLobRebL
obLobRcbLibRobLibLebLebRobRobLobLobRobLjbLsbLobLcbRobRebRebRobLgbRgbLo
bLgbRibLibLobLobLebRobLhbRobRgbRebRobLobRibRobLobLibRobLibRobLobLobLeb
LsbRobLebRgbLibLsbRjbLobRgbLsbRibLebLcbRsbRobRebRobRobRgbLcbRobRebLebR
obRebRcbLebLebLebLsbLobRebLobLobRobRibRebRsbLobLgbLcbLebLobRobLgbRobRe
bRhbLgbRobRgbLsbRebLobLcbLsbRibLobRobLebLgbRsbRobLobLobLobLgbLibRobRcb
RobLobLebLobRcbRcbRsbRobLsbLjbRebLobLobRobRobRgbRobRebLobRibLcbLcbLcbR
ebRebLcbLobLobLgbLobLcbRibRebRobRhbLcbRebRibRebRobLebRobLobLobRebLobLs
bLsbRibRobLobLcbLibLcbLibLcbLobLsbRebRcbRobLobRobRebRebLobLobLhbRobRob
LobLebLobLibLobRobRebLcbLobLibLcbRobRcbRebLobRebLobRobLebRebRgbRibRebR
ibLgbRcbRobRcbRebRebRobRebLebRgbLcbRebLobRobLgbRobLcbRebLcbLibRobRibRi
bLobRobLebLobLcbLcbLcbLebRobLcbLobLobRobLebLobLcbLobRebRibLibLcbLibRob
LibLobLcbRebLobRcbLobRebRebLobLcbRobRobRebLobLgbRjbRebLcbLobLibRebRobR
obLsbLobRibLibLebLcbLobLibLhbRobLobLobLebRcbRebLebLobRebLebLebRebRobLo
bLobLgbRcbRjbRcbRobRobLebLobLcbLebLebRcbLebLobLebLobRobLebRobRebRobRgb
LcbLibLebRcbRcbLgbLsbRsbLebLcbRebRobLobLgbRobRobLgbRobLobLebRobRobRsbL
obRobLgbRebLobLebLobRcbLebLobLebRobRgbRgbLobLgbLibLebLobLobRobRobLsbRc
bLsbLebLibLebLobLobLcbLebRobLsbLobRhbLcbLebLhbRobLcbLobRcbLibLobRebRob
RibRebRobLcbRcbRebLobLgbRibRobRobLgbRebLsbRobRobLgbRobLobRebRebRgbRsbL
obLsbLcbRobRobRobRebRhbRcbRcbLibRibLobRibLibRebRebRobRobRobLobRobLobLe
bLibLobRcbLebLobRgbRsbLgbRcbLebLebLobRibLebRobLobRobLsbRebRobRibLebLeb
RebLibLibRcbLgbLcbLobLsbRobLsbRebLobRcbLebLgbRobRebRhbRebLhbLhbRobLobR
obRhbRcbLcbRobLgbLibRebLobLobRcbLobRebLebLobRebLobLobRibLobLobLobLebLs
bLobRebLibRgbLobRhbRjbRobLcbLobLobRobRgbRebRobRobRibLibRgbLgbRebRobLob
RgbLgbLobRobRobRibLobLibRobRobLobRobLcbLobRobLcbRobLebLobRhbLgbLobRcbL
sbLobLobRobRsbRsbRjbRobLebLob

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 29; Drug: Control Apo 0.5 然
bLjbLjbLibRsbLjbLsbRcbLoRsbRebRcRsmbLgbLsbLgbLgbRcbLsbRebRibLebLibLibL
gbLsbRgbLsbLjbLibLibLibLsbLibRgbLiLsbLsbLjbRgbLibLjbLibLgbLibLgbLibLjb
RjbLibLibLibLsbLgbLibLibRgbLsbLibLjbRcbLoRsbRsbLcLsmbLibLgbLgbLsbRebLi
bLcLsLsLsmmmbLgbLsbLsbLgbLsbLgbRgbLgbLsbLgbRsbRgbLibLsbLgbLsbLsbLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 30; Drug: Control Apo 0.5 然
bRgbRgRsmbRsbLjbRjbRiLsbLjbLibRsbRebLjbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bLcLcRsRsmbLibRsbLibRibRgbRibRhbRibRcRsmbRiRsmbRobLgbRjbRjbRibRiLsbRsR
sRsmmbRibLsbRibRcbRiLsbRgbRibRibRgbRebRcbRibRibRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bLjbRsbRsbLsbLgbRgbRsbLgbLjLsmbRsbLsbLsLibRjbRjbRcbLcbRjbRgbLibRibRibR
gbRgLsbRsbRgLsbRgbRgbRsbLgbRgbRibLgbLsbRsbRibLgbRgbRibLsbRgbLsbLjbLcbL
hbRgbRsbRjbRjRsmbRgbLgbRibRsbRsbRsbRgbRobLgbRsbLibRsbLobRsbsbRsbLgbRsb
RsbLsbRgbLhbLsbLgbLgRsbLsbLibRgbRsbLsbRiLsbLobRsLsbLhbLsbLibRsbRsbRgbL
sbRsbLsbRgbLobLibLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bLib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bLoRsbRibLsbLsbRjbLjbRjRjbLibRgbRoLsbRibLiLsbRibRgbRcbRjbRhbRiRsmbRibR
gbLsbRgbLcLsmbLsbRoLsLsmbLgRsbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bsbRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLgbRgLsbLibRcbLsbLsRsbLgbLsLsmbLsLsmbLcbLibLgbLgbLibLgbLgbLibRgbLgbLg
bRsbRsbLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bRjbLhbLobLhbRobLcLsmbLcbRsbRjRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLhLsbLcbRgLsbLcRsbLsbLgbRcbLjbLcbRsbLibLgbLsbLobLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLgbLsRsbLgbRgbLibLcbRgbRsbLibRiRsmbLobRsbRibLjbRibRcbRsbRgbLgbLibRsbR
ibLgbLibLiLsbRobLgbLibRobRsRsLsmbLsbLjbLgbLsbLibLiRsbLibLibRsbLibLiLsb
RibLcbLjbLsbRibRoRsmbLgbLsbLiRsLsbLibLsbLibLiLsbRsRsmbRgbRhbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bRhbRibRjbRcbRcbRcLsbLobLsbLsbLcbLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bsbRoRsmbLsbLgbLsbLibLgbLgbLiRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bLobLibLhbRobRhbLoRsbRobRjbLobRgbRibRibRibLjbRiRsmbLibRgbLgbLsbRjbLibR
sbRsRgbLjbLjbRhbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bLcbLjbLsbRebRobLsbLjbRobLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bLcbLgLsbRsbRibsbLibLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bLsbRibLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 175936; End: 180436;
Recording: 4-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bLjbRiLsbRsbRjbLibRibLsbLebLibLsbRsbLsLsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 1; Drug: Control Apo 0.5 然
bRhbRcbRjbRjbRcLsbRibRgbRibLjbLhbLibRjbRibRibLjbLebRcRsmbRgbRsbsbRgbRs
bRgbRgbLsbRgbRgLsRsRsLsmbRsRsmbRibRsRsRsmmbRsbLsbRgRsmbRiLsbRcbRobRhLs
bRcbRcRsmbRibRgLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 2; Drug: Control Apo 0.5 然
bLobRibLobLibLiLsbLibLsbLsbLsLsmbLiLsbLibLcLsmbLcRsbLsbLcLsmbLcLsmbLhb
RsbLsbLsbRgRgbLiRsbLibRhbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 3; Drug: Control Apo 0.5 然
bReLsbRobLibLibLoLsmbRiLsbLsLsmbRibRoLsbRsbLsRsbLsbRcbLcRsbLcbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 4; Drug: Control Apo 0.5 然
bRsbRibRsbRgbLsbRibLjLsmbRsbRjbRiRsmbRobRsbLgbRsbRgbRgbRhbRobLgbLgbRib
RsbRgbRjLsbLhbRsbRgbRgbLcLsmbLgLsbLsbLgbLcLsLsLsmmmbRgbRibLgbRgbLjbRiL
sbLibRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 5; Drug: Control Apo 0.5 然
bRebRjLsbRcRsmbLjbLhbRsbRebRsbRsbRgbRhbRibRgbLsbLsbRcbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 6; Drug: Control Apo 0.5 然
bRjbLcbLoRsbRcbLhRsbRiLsLsmbLiRsbLgbRcRsmbLiRsbLcbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLobRcbRobLobLobLobRibLebLebLobRibRobLcbLobRcbRcbLhbRhbRibRobLobRobLob
LcbRobRobLibLebRibLobRobLebLibRobRebLobRobLcbRobRcbRcbRibLibLgbLebLcbR
obLobRobLhbRcbLgbRcbLebRhbRebRobLcbLgbLebRgbLobLgbRgbLobRebRebLobLhbRs
bLebRibRobRobRobLobLgbLcbLobRibLjbRebLobLobRobRgbRobLebRgbLobRobLebLcb
RobRebLsbLcbLgbRibLobRebRcbLobRebRjbRebLobRebLebLobLgbLcbRobRcbLobRcbL
ibRcbRobRobLsbLebRobRgbLibLcbRcbLcbLobLcbLcbLobLobRibLobLobRobRobRobLg
bLobRgbRcbLebRhbRobRebLobLcbRcbLobRcbLobLebLobLobRcbRcbLcbLibLobLsbLob
RibRobRibRcbLgbRobLcbRibRsbLsbLcbLibRibLebLobRobRcbLcbLobRgbLebRjbLobL
obRhbLobRcbLgbLcbLhbRobLobRgbLcbRobRobRcbLobLcbLibRobRhbRcbLsbLibRobLi
bLsbRgbRebLobRebLebRjbLobRebRsbLobLcbRobLobLobRcbLcbLebLebRhbRobRobLob
RcbRebRobRobLebLobRebLobRebLhbRobLgbRebRobLobLhbRobRebLcbRebRobRobLcbL
ebLobLobRibRobRibRobRcbLebRibLobRobLebLhbRibRcbLgbLgbRobLibRobLobLebLo
bLobRcbRcbLobLcbLebRebLobLobRobRobRebRobLobLgbLobLobLcbRebLebRcbRcbReb
LebRibLebLcbRcbLebLgbRcbRibRebLobRibLobLcbLobLebRhbLcbLcbRcbRebRebRgbL
obRobLgbRobLebLobLobLobLobRcbLobLebRobLcbRcbLobRcbRebLobLcbRobLobLobRe
bLgbRobLgbRebLibRibRcbRsbRobLgbRsbRcbRcbLobLcbLobLobRcbLobLibLebRobReb
LobLsbRobRobLobLobLobRsbLhbLcbRobLebRcbRobRgbRebLebRobRobRsbRobLcbRcbR
ibRebRebLcbLcbRebLobLobRibRebRgbLebLebLebRgbRjbLebLsbLsbLobLebLebLgbRg
bLebRhbLobRebRebRobLebLobRobLobLebRcbRcbLcbRsbRhbRebRgbLhbRobLsbRebLeb
RebRobRobLebLobLobLcbLebLcbLcbLobRebLebLcbLobLobRcbRobRebRebLobLobRebL
obRobLibLobRobRebLsbRsbLsbLobLcbRebLcbLebLobLobLobRcbRebLobRobLobRobLo
bLibRobRobRcbLebLgbLobRcbRcbLcbRcbRebRgbLobRibRebLcbLcbRgbRobLobRcbRob
LcbRebRgbRibLobLobRcbLobLcbRebLebRibLobLgbLebLcbRcbRobRibLibLobRgbRobR
ibLebRebRsbRobRobLobRebLgbRobLobRebLebLibRibRsbLobLsbRebRibRcbRcbLcbRo
bLcbLcbLobLebRobLcbRebRebLobLobRcbRgbRobRebRobRgbLcbRibLobLobRgbLibLeb
RcbLobRibRobLcbLibRjbRobRjbRebRobLcbLobRebRcbRebLobLebLobLibLsbRobRcbL
obLebLebRsbRobRobRobLibLjbRebLcbLebLebRobRobLgbRobRcbLibRobRebRobRcbLo
bRobRobRibRcbLobRobRobRobLibLobRibRebLobLebRebRcbRhbRebLsbRobLobLobLcb
LobRsbRobRebRjbRjbRobRobRebLgbRobLsbLcbLcbLobLebRobLcbRgbLebRobRebLcbR
cbRebRhbRobLobLobRobLobRebLhbLobLgbLcbLcbLgbRcbLebRobRgbRsbRobRobLobRo
bRobLibRobLcbLcbRebRobRobRebRobRgbLebLobRcbLsbLobLobRibLcbLobLcbLebRob
LobRgbLcbLebLibRobRobRibLsbLebLebRobLobRobRhbRobLobRobRibLebRebLobRebR
obLobRgbLobRsbLcbRebLebRebLobLobRcbRcbRebLibRcbRibRgbLcbRobRebLobLgbLc
bRobLcbRobLobLcbRjbRsbLcbLebLebLibRcbRgbLibRobRobLebRibRhbRibLebRhbReb
RsbRobRibLjbLhbLobLebLebRjbRhbLebLebRobLjbRobRebLobLebLibRebRobRcbRobL
ebLebLebLebLobLobRobLebRcbRibLobRjbLcbLjbLobLobRebLobLobLcbLcbRebRobRe
bLhbRjbLebLobRobRibLobLobLjbRobLcbLobRebRsbRobLjbRobLcbLobRebLobLobRob
RobLjbRjbRobLobRebLobRgbRebLcbRebRebRcbLebLjbLobRobRobLcbLobLjbRjbRobL
sbRobRjbRobRebRobRebRobRebLebRcbLjbLobLobLjbLobRobLobRobLebLobRebLobRs
bLobRebLobLebLebLobRebLcbLebLjbRobRcbLjbRjbRobRebLjbLjbLsbRibLobRobLcb
LcbRobRobRobLobRobRobRcbLobLjbRobLcbLobLebRobLebLjbLobRobLobLcbRobRcbR
obRcbRebLjbRebRobRobRjbRobLcbRobLebRcbRobRobRsbRobRcbRobRebRjbRobRobRc
bLobRobLcbLjbRobLcbLjbRobRsbRobLjbRobLcbRcbRobRcbReb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRgbLibRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bLsLsmbsbsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bLobRcbLsbRobLib

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bLobLobLgbLcRgRjbLobRsbRcbRgbRibRoLsbRcLsbLobRibLcbLgbRcbLgbRgbRsbRcbL
sbLsbRoRsmbLsbRobRiLsbLsLcLsmbLhbRgbLibLgRsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bLobRsbLgbRibLibsbRgbLebLsLsmbLgbLhRsbLsbLsbLebLcbLsbRcbRcbsbRsbsbRsLs
bLjLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bLcLsmbRiLsRsbLgRgbLobRiRsmbsbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bLcRsbLgRsbLcbRiRsmbRiLsRsbLeRsbLsbLiRsbLjbLibRgbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bRcbRebLsbLobRobLsbRoLsbLcbLoLsmbLobRsbRcbLcbRobLsbLcRsbLobLibLcbRhbRc
bRjbRcbLgbRsbLibRobRsbRsbLjbRjbsbLibRobLcbRsbRsbRobRibRsbRgbRsbRsbLsbL
hbRibRsbRsbRgRsmbRsbRsbRsRsmbRsbLjbLjLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLjbReLobRgLsbLgbLibRsbLibRgbLcbRjbLcLsLsmmbLsLgbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bRoLsbRobRcLsbLibRibLibRobRibLjbLcbLgbLgbRobRibLsbsbLibLhbLcbRsbLobLcL
smbLcbRiLsbLibRiRobLobRibLgbLsbRcRsmbRoLsbLhbRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLsbRgLsbRibRibLgbLsbRsbLsbRgbRsbRsbRsbRsbRsbLgbsbLgbLsbLsbLsbRgbLgbLg
bRgbLsbLgbLsbLsbLsbLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bLgbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bRsbRjbLsLobRobRebRobLob

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bLibLibLsbRsbRgbLsbLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bLsbLsbLsRsbLsbRsbRibLibsbLsLsLsmmbRsbLsbLgbLgRsbLsbLsbLsbRhLsbLgbRgbL
gbRgRsmbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bRgbLsbLjLibRebRibLsLsmbRobLjbRibRibLgbReLgLsbLsbLsbLgbLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bLcbLiLsbRsbLhbLibLibLsLsmbRibLgbRgbLiRsbRgbRsRsmbRsbLgbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 25; Drug: Control Apo 0.5 然
bLgbLjbRobRgRsmbLhRsbRhbRgbLcbLgLsbLibLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 26; Drug: Control Apo 0.5 然
bLibLobLjbLobRhbLcbLobRsbLgbRgbLsbRibLcbLcRsRsmbRhbLobRcbRcLsLsLsmmbLe
bLibLgbRgbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 27; Drug: Control Apo 0.5 然
bLibRoLsbRcRsmbRcbRibLiLsbLsLsmbRibRebRhbRsbLsbRsbsbsbRsRsmbsbRsLsRsbR
sbLsLsRsRsmmbRsbLsbLsLsLsmmbLsbRgbRsbRgbRgLsbRibRibRsbLsbLsbLgbRobRibR
gbRsbRibRjRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 28; Drug: Control Apo 0.5 然
bLebRebRsbLobLobLobRebRebLobLjbRjbRobLebLobRobLobRobLgbRcbLebRjbLjbLcb
RobRcbRcbLsbLcbRebRjbLebLobRibRobLjbRobRobRobRobLobLebLjbRobRjbRjbRcbL
jbRobRebLobLjbLobRobLjbLcbRobLcbLcbLebLobRebRebLebLsbRcbLjbRjbLjbLebLo
bRebLobRibRobLcbLebRobRobLjbLebRobRjbRebLcbLebLebLobLebRobRjbLjbRjbLjb
RcbRebRebRjbLebLobRebRebRebLjbRebRobRjbRcbRsbLcbLsbLebRcbRobLebRobRjbR
obRobLobLobRobRobLebLcbRobLebLjbLebLebLobRcbLjbLobLebRebLcbRjbRobLjbLo
bRcbLjbLobRebLobRobRjbLobLebRjbLcbLobRebRjbLebLobRjbLjbRjbLcbLcbLjbLob
RebLobLebRjbRcbLobRcbLobRjbLsbRobLcbRcbRebLobLjbRebLhbLjbRebLobLjbLjbR
obRjbLcbRebLobLjbLobLobRjbRebLobLjbRebRobRcbRjbLobLcbLsbLebRjbRobLebLi
bRcbLebLhbRcbLibRobRsbLcbRgbLobRebRebLebRebRobRhbRobLobRobRcbLgbLebRcb
RebRobRcbLgbRobLibRobLhbLcbLibRobLibLobRobRgbLobRobRsbRcbLobRobRcbRebL
ibRcbLibLobLobLobLcbRcbRcbRebLcbRobRobLobRebRcbRobLobRcbLsbLobRobLibRo
bLcbLebLcbRobRobRcbRebRsbLibLebRsbRcbRobRebRobRebRibLobRobRobLebRebLib
LobLibRebLebRobRsbRebLebRibLobLcbRjbLobRcbLcbLobLebRsbRobLobRebRcbLobL
cbLebRobRebRibRobRobRcbLobLcbRobRibRobRobLsbLebLobRgbRebRgbLcbRobLcbLh
bRgbLebLobRcbRibRebLhbLobRgbRebLobLgbRgbRobRobRcbRobLcbRibLobLebLibRsb
LgbRobLcbRobLebLcbLobLebLcbRobLobLgbRobRobLibRobRebRcbLobLgbRebRcbLebL
cbRobLebLibRobRcbRebRibRebLibRobRcbLibRobRebLobLibLhbLcbRibRobRebLobLo
bRebLobRcbLibLobLobLobRobRebRsbRobRcbLhbLobLsbLibLobLobRhbRsbLgbLobRcb
LobLebRobLobRobRcbRcbRibLobRebRobLobLebLobRobLebLobRgbRobLcbRsbLsbRobL
obRobRcbRebRobLcbLcbLibLsbLebLcbLgbLebLcbRibRebRcbRcbRobLibLcbLebRobLo
bRobLebRobRobRobRgbRcbLcbRobRobRobLobRobLobLibLobRebRobLibLobRobLobLob
RobRobRobRebRsbLebRcbRhbRibLobRobLobLobLobLibLebLobRgbRobRobLcbLcbRobR
obRcbLebLebLsbRibRgbLobRcbLebLebLobRobRobRobRibLobRobRsbRobLobLobLobRo
bLobLobRobRobRobLobRobLobRcbRobLibLcbLsbLobRcbLcbRsbLobLobRobLobRibLhb
LcbLcbRebLobLebRebRobRobRobLobRobLebRebRobRsbLobRebRgbLobRibRcbLgbLobL
cbLgbLobLebLobRebRgbRcbLebLcbRobLebLhbLcbRgbRebRobLobRobLgbLgbRcbLobLe
bRibRobRebLebLobRebRobLebRebLobLcbLcbRobRsbRobLibRobLobLebRobLibLebRsb
RebRebLcbLobLobRibRobRobRobRcbRibRhbLcbRobLebRebLobRhbLobRobRhbLobRobL
ebLcbLebRobLcbLebLcbLebRebLobLebRebRobRobRgbLcbRgbRobRobLsbLcbRobRcbLo
bRgbRibRebLibLebRobRobRebLebRgbRobLcbLcbLebLsbLibLobLgbLcbLibLebLebLcb
LgbRgbRebRcbRobReb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 29; Drug: Control Apo 0.5 然
bLgbLebRgbRsbRgbLgbRibRhbRobRsbLhRsRsmbLoRsbLsLsmbLhbLibRgbLsbLsLsmbLi
bLgbLgbLibLibLcbRcRsmbLhbRgbLsbRsRebLcbLhbLibLsbLgbLibLibRcRsmbLgbLjLs
mbLgbLsbRcbLhbLibRcbLsbRcbLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 30; Drug: Control Apo 0.5 然
bLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bRgbRsLsbLjbLibRibRgbRibLhbRcbRibRcLsbLjLibLcbRsbsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bRsbRgbLsbLibRjbLibRibLobRsbRibLsbLsbLgLsbLsbLgbLcRsbRgbRsbLsbLsbRjbLc
bRsbRgbLjbLibLgbRgbRsbRjbLjbLhbLibRgbLsbLgbLsbLgbLibRsbRhbRjbLjbLgbRjb
RhLsbLsbLjbLgbLibLgbLgbLsRsbLgbLsbLsbLgbRsbRgbLsLsmbLibLgbLsbRsbLsLsmb
LsbLgbLsbLgbRgbLgbRiLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bRiLsbLjbLobLob

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bRobRebLobLobLcbRobLebRsbLobRjbLobRjbLgbRcbLjbRcbLcbRebLebLcbLcbLcbLcb
RebRebLebRcbLobRebLobLobLjbLebRobRobRsbLobRsbLobRjbLsbLobLobRcbLobRibL
jbLebRcbLebRobRobLjbLcbLobRobRobRebRebLjbRobLcbRcbLobRjbLebRobRobRobLe
bLobLobLobLsbRebLebRobLjbLobRcbLebRebRobRobRgbLobLobLobLebLgbRobLobRjb
RjbLobLobLobLebRobLobLibRobRobRobLibRebLobLcbRcbRobLgbLobRobRobRobLebL
ebLobLebRebRsbRobRebLjbRebLebLebRobLgbRobRgbRsbLjbRgbRobLcbRobLcbLobLo
bRcbLebRgbLjbRobLebRobLebLobLebLibLobRobLibLobRobLsbLobRebLobRobLobRob
LobRebRebLobRobLebRebRobLgbLebLcbRebRobRobRebRjbLjbLsbRsbRebRobLobRobR
obLibRcbRibRebLobLobRebLebRibLcbRgbRhbRobRjbRobRcbLobLibLobLobLhbRgbRo
bLebRobLibRcbLobLobRobLobLebLsbLebRcbRcbLebLebLebRebLcbLobLgbRebRcbLeb
LobLebLobRobLebLjbRebRobLobLcbRebRobRcbRobRhbRobRsbRobRebLebLcbRobRobL
obRebRgbRcbRebRebLobRgbLobRobLgbLibLcbLgbRobLobLgbRcbLhbRobLibLibRebRe
bLsbRobLobLobRobRibLobLebLsbLobRobRobLgbRebLebLebLobLobLibRjbLebRibLob
LebRjbLobRebLcbRobLobRebRjbLobRebLjbLcbLibRobRobRgbLobLobLobRjbRobRjbR
ebLobLobRebRobLcbLobLobLobLcbLebLobLgbRebRobLgbLsbRcbRcbLebRhbLobRebRi
bRjbRobLcbLobRobRjbLjbRsbRebRcbRsbRobLebLebRgbLjbLjbLobRjbRebLcbRebLeb
RobRjbRobLobRobRobLibLjbLebLcbRobRcbLsbLobLsbLebRobLsbRobRobRobRobRobL
ebLebLobRsbRobLcbRobRjbRebLebRobLobRjbRcbRjbLebLebRobLobRobRsbLobLgbLc
bRobLjbRcbLobLobLsbRcbRcbRjbRjbLebRebRcbLsbLobRobRebRebLcbRebLebRebLob
RsbLjbLobLebRibRibRebRobLjbRjbLobLebLsbRsbRebLebLobLjbLobLobRobRobRsbL
ebRgbRebRebLobLebLebRobLebRobRobRobLjbLobRobLcbRjbRjbRgbLebRebRjbLcbLi
bLebRebLsbLebRobRobRobLebRebRcbLobRcbLobLjbLsbLjbLjbLobRobRcbRebLsbRsb
LobRjbLhbLjbRjbLsbLobLsbRcbRsbLcbLsbRsbLobLjbRobRjbLobLobRcbLebRebLobR
sbLcbLobRebLsbRobLjbRsbRjbRobLobRobRjbLebLebRjbRcbRjbLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bRcbLoRsbRgbRhbLibRcbLsbLsbRsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLjbLoRsbLibLgLsbLgbLgbLgbLgbRsbRsbLgLsbLsbLgbLsbLgbRibLgbLcbRibLcbLgb
LjbLcbRgbLgbLgbLiRsbLsbLibLsbLsbLibLibLiRsbLibLibRsbLebLeRsLsbLgbLibRi
b

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLsbLobLibLcbLsLsmbLgbLibLoRsbLibRoLsbRsbRgbRobRsbRibRobLsbRsbLgbRjbLi
LsbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLgLebLgbLhbLgbLgbLibRsbLibLgbLoRsbLibLsbRsbLgbLcbLcLsmbRjbLoRsbLibLgb
LsbRsbLsbLibLobRiRsmbLgbLgbLibLhbRibLgbRsbRsbLibLibLgbLibLibLiLsbLsbLg
bLgbLsbLgbRcRsmbLjbLjbRcbRjLsbLcbLibRgbLcbRiLsbLcbRsbsbRsbRgLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLobLibLgbRibLsRsbLibLobLjbLibLibLgbLibRsLsLsmbRgbRcbRjbLiLsbLgbLibRsb
LobLgbRsLsLsmbRobLsLcbRgbRsbRgbRiLsbLibLjbRsbLsbRsRsmbRgbRgbRibRsbRsRs
mbLhLsbLibRibRsbRibLsbRibRibRgbLsLsmbLgbLibLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bLgLsbsbsbLgbRsbsbsbRsbsbRsbsbsbsbsbRsbLsbRsRsmbLsRsRsmbLsbRsbLsLsLsmm
bLsRsLsLsmbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bRebRsbLobRsbLebRjbRebLebRebRobRcbRebLobLjbRobLebRobRebRebRsbLobLobLob
LobLebLobRobRebRsbLebRjbRobRebRcbRjbRobRobRebRobLcbRsbLobLobLjbRobRobR
ebLibLsbLcbRobLjbRobRebLobLobLobRcbLobLcbLebLobLsbRobLobRibRcbLhbLjbLe
bLcbRebRcbLobLcbRobLobRobRobLebLjbLebLobLebLjbRobLebLobRobRebRobLobRcb
RobRobRcbLjbLobRobLobLgbLcbRobRcbLcbRhbRcbLebLcbLjbRjbLebLhbRebLobRcbR
sbLobRgbLebLcbRjbRobRobRebRobLcbRsbLobLgbLsbLcbLgbRebLobLebRobRobRjbRc
bLobLobRobLsbRibRcbRebLobRebRobRibLcbRebLobRobRobLebRobRebRcbRebRebLeb
LcbLobLcbRcbLobLobRobRobLebLobRobRobLebLebRobRobLebLsbLcbLcbLibRcbLcbR
obLebRobRobRibRcbLobLobLcbLgbLobRobRgbLobLebRibLobRcbLobLobLcbRjbLcbRc
bRibRobLibLjbRobRebRcbRobRebLebLobRhbLobLebRebRebRebLhbRebRcbLobRebLgb
LcbLebRcbRjbRobRcbRobRgbRebLebRcbRcbLebRcbLebLobRobLcbLibRebRobLobLebR
ebLgbRobLebLcbRgbLhbRebLobLobRhbLobLebLobLcbLibRgbLobLebLobRcbLcbRobLh
bLobLebRcbLobLobLobLobRobRibRebRebLgbRhbLobLobRebLebRebLobLebRobRobLob
RgbLobLebRhbLgbRobLebLobRgbLjbLobRebRibRcbRobLcbRcbRobLibRobLhbRcbLobL
obLcbLcbLobRobLcbLobRcbLebLobLcbLebRcbRebRgbLhbLebRobRcbLebLobLebLobLo
bLobLibRcbLebLobRobLgbRebRebRebLcbLobLobRobLobRobLibLebLcbLobRobRibLib
RebLebLsbRebLobLgbRgbLebRobRebRobRgbLsbLgbLobRebRjbRobLobLobRobLobRcbR
ebLobLobRsbLebRobLobRibLebLobRgbLobRcbLgbRcbLobLobLobRobRhbRgbRobLebRo
bLcbLibLebLobRgbRebLobLebRebRobLobLcbLcbRobRcbRobLobLhbRcbRobRobRibLob
LibRcbRebLebRobLobRgbRebLobLobLebLobLebLebLebLobLobLcbRibRcbLobRebRebR
ebLebLebLebLobLobLebRcbRebRobRebRibRebLcbLobRobRobRcbRobLobRebRcbLobRo
bLebRgbLobRobLgbRcbRobLobLebRibRebLgbRobLcbRobLibLebRobLgbLobRobLcbRib
RcbRgbLobRobRebLobRgbRebRsbLsbLebRgbRebRebRobRebLebRebRcbLobLebRobRcbR
ebRebLgbLobLobLobLobLebRibLebRcbRobRobRebLgbRobRobRibLcbRebLcbRobLobLs
bRobRcbLebLgbLobLebLebRebRobRcbLibLcbRebLebRobLebRebLebRobRgbLcbRobLcb
LobLibRobRebRobRobRobLobRgbLcbLobLobRobLobLibLcbRibLebLobLobRebLebLobL
ebLobLcbRobRebLebRcbRsbLcbRcbRebLibLobRebLobRgbLebLcbLcbRobLobLcbRebLg
bRebLobLcbRebLsbRobRebLgbRibLebLsbLebLibRebLobRebLibRebLobLobRobRebRob
RobLgbLobLibRobRibLobLcbLebLobRcbRebRobLebLobLcbLebRobRibLibLebRobRgbR
obRcbLebRibRebRebRibLebLobRgbRcbRobLibRobLobRobRgbLgbRobRcbLobLobLcbRe
bLsbLebLhbRcbRobRgbRebRobRobRobRibRobLcbLgbRobLobLcbRcbRsbRobLobRcbRob
LebRobLebLibLgbRcbLgbRcbRobLobLobRebLhbLcbLebLobLibLibRibLobLobLebLhbR
obRobRobRobRebLebLibRobLobRebLobRcbRobLobLobLibRobLobLsbLcbLobLcbRsbLo
bRebLcbRibLibLebLebRobRobLgbLobRobLgbLebRebLebLobLobRobRcbRhbLibLcbRjb
RobLebRobLobLobLgbRobRobRobLgbRobLebRobRebRcbRgbLobLebRobRibRhbRcbLobR
cbRobLebLobLcbLebLcbLobRobRebLobRcbRobLobRcbRebLcbLobRcbRobRibLobRebLc
bLgbLebRebRobLebLobLibLobLobLsbLcbRibRcbLebLobRobRgbLgbLebLcbRebRcbRob
LebLebRebRebRebRgbRobRcbLobLcbRebRobLcbLobRcbLobLebRcbRsbLgbLjbRobLobR
obLjbRgbLcbRcbLgbLibLcbLsbRobRcbRebLobLobRobRobLebRcbLebRobRcbLobLcbLs
bRgbLobLibLgbRobRobLobLobLgbLcbLcbRebLobLgbRobLibLebLcbRobRgbRebRobRob
RobLsbLebRobLibRcbLhbRcbRibRobLhbLobLobLobLcbRebRobRebRobLobRobLebLobL
cbRebRobLibRhbLobLobRebLobRgbRjbLcbRcbRibLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bLjbLobLgbLgbRsbLsbLoRsbLibLsbRibRsbLgbRoRsmbLsbLgLsbRjbRhbLibLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bRcbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bLsbLsbLsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRsbRobRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180438; End: 180938;
Recording: 5-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bRsbLsbRibLibLjbRjbRobLobLebRibRoRsmbRibRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 1; Drug: Control Apo 0.5 然
bRib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 2; Drug: Control Apo 0.5 然
bRoRsmbLibLjbRgbRgRsmbRibLgbLibRobRsRsmbRsLsLsmbRoLsbRsbLsbLsLsmbRobLj
bLoLsLsmmbLsLsmbLsLsmbRoLsbLsbLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 3; Drug: Control Apo 0.5 然
bLsbLiRsbRgbLibLhbLibRgbRobLibRgbLsbLsbRsbLsRib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbLjbRhbRgbRgbRibRsRsmbLsbRibRgbLgbRiRsmbLhbRsRsmbLobLobRsRgbRsbRsbR
sbRgLsbRsbRobRgbRjbLibRhbLjLsmbRjRsmbRhbRsbRgbLibRobLgLsbLsbLoLsmbRibR
sbRibRgbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 5; Drug: Control Apo 0.5 然
bLcbRsbRjbRiRsmbLsLsmbRhRsmbRsRsmbRcbRsRsLsmbRibRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 6; Drug: Control Apo 0.5 然
bRoRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRibLcbRibLib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bLobRjbRobRsbRebLjbLgbRjbRcbRcbLobRsbLebLjbLobLebRibRobLebLobLobLcbLob
RobRobLjbLjbLebRebLgbRsbRebRobRebRsbRebLebRebRobRobLobLjbLebRcbRobLebR
ibRobLgbRcbRjbRobRobRobRebRjbLebLgbRebLobLobRjbRgbLjbLjbRobRgbRebRsbRo
bRjbRcbRcbRobRjbLcbRobLcbRjbLibRcbLebLjbLjbRobRjbLebRobRcbLobLcbRobLhb
RebLgbLobLobLsbLsbRebLobRobRhbLcbLibLobRcbLcbLebLcbRsbLcbRebRcbRebRibR
ebRcbLebRobRcbRobRsbLobRebRobRgbRebRobLcbLobRobRebLebRebRebLobLobLobLo
bRobLjbRcbRebLobRobRobLobLobLibLcbLjbRobLcbRjbRcbRobRobLobRobRjbRsbLob
RcbRcbLobRebLcbRcbLjbRcbLibRcbLobLobRobRobRebRcbLcbRobRjbRcbLebRebRobR
obLobLebRsbLobRcbRsbRobRcbRebLcbLjbRibLsbRobRcbRebRcbRobRobRgbLobLcbRg
bRebLebRcbRcbRobRebLobRhbRhbLebLebLobLsbRjbLibRebLcbRsbLobLjbLebRebLcb
LebLobLibLobLebRobRjbLcbLebRobRjbLobRjbLsbLobLobLobLsbRsbRobLebRsbRcbR
obLsbRsbRebRcbLebRebRjbRjbLibRcbLebRebRobRebLebLobRebLebRsbLebRjbRebLj
bLcbLobRjbRebRcbLobRcbLcbRcbRobLsbLsbLobLsbLobRcbRobRobLsbLcbLebLsbRob
RsbLcbLcbRebLsbRobLsbLebRjbRcbRobRebRebLebRsbLebRobLsbRcbRobLgbRebRebL
jbLobLobLoLjbLsbLebRebLjbLsbLebRebLobRibLebLobLobLobLobRjbRobRobLgbLob
LebRcbRebRobRebRcbLjbLobRcbRobLcbRjbRcbLgbRcbLobRebRsbLobLsbLsbRobRobL
ibLsbRobLobLcbRgbLjbLebRjbLobRobLobRebLcbLebLjbRcbRcbRsbLebLibLobLobRj
bLebRibLobLsbLibRjbLobLibRobRibRjbRsbLobRobLobRobRebLobRcbRcbRobRobLcb
RjbLobLjbRobLobRcbLgbLobLobLebRcbRcbLobRobRcbLobRobRobLobLcbLobLobLebR
jbLebRebRjbLcbRibRobRcbRebLcbRsbLibLebRsbRobLobLobRcbRcbLobLsbLebLobRo
bRebRgbLsbRjbRcbLobRibRebRjbRsbLcbLobLcbLobLebLgbRebRobLobLsbRobRcbLeb
LobRobRjbLobRebLcbRcbRcbLjbRebLjbRebRebLobLhbRebRebLebRobLcbLcbLobRobR
obRobLsbRobRcbRibLjbRebRobRebLobLcbRebLobLcbLcbLobRebRebRobRobLjbLobLo
bRebRebLobLibLcbLebRebRobLobRcbRjbLebLobLjbLobLgbLcbLobRobRhbLcbLcbLeb
LebLcbLjbLcbRobRjbLibLobRobLobRebLebRjbLobLcbLsbLcbLcbLobRobLobRibRobL
cbRebLjbLobRebRsbRcbRebRsbRsbRjbRsbLsbLebRsbLebLobRsbRobLjbRsbRsbLsbLg
bRsbLjbRebRcbLsbRobRebRjbRsbLjbRebRsbRjbRjbLobLjbRjbLsbRsbRjbRjbRsbRjb
LcbLsbLebLobLebRsbLebRjbLjbLjbLebRobRebRebRobRobRobLjbRjbLobRebLebRjbL
ebLcbLcbLjbLjbLobLcbRebLcbLcbLebLobLebLobLebLobLsbRebLcbRebLebRcbRebLe
bRjbLsbRobRobRsbLebRsbLcbLjbRcbRjbLebLobRjbLsbRcbRjbLcbRsbRjbLebRcbRsb
RobRobLjbRebLebLebLebLjbRebRsbLebLebRjbRobLebRebRebLobLebLobLcbRsbRebL
jbLebRjbLcbRebLjbLcbRobRebRebRobRobRebRebRsbLobRebRobRjbRebRobRebLcbLo
bLobRjbLjbRcbLcbRobLobRebLobRcbRcbLebLobRsbLebLebRcbRjbLebRebRobLobReb
RebLobRobRebRsbLcbLobRobRobLebRjbRobLobLobRsbRjbLobLjbRjbRjbLjbRebRobL
ebRobRsbLcbRcbRsbRobLobLebRebRcbLjbLcbLjbRjbLsbLobRebRobLjbLebLebLjbLo
bRobLobRobLebRobLsbRcbRebRobRjbLcbRobRebRjbLjbRcbRcbLobLobLjbRobLjbRjb
RjbRobRcbLobLcbRcbRebRjbLobLjbLcbLebLebLjbRcbRobRobRobLjbRebRebLcbRobR
obLjbRjbLjbRjbRsbRobRobRjbRobRcbLebLobLebRjbRobRjbLobRcbRebLsbRebRcbLe
bRjbRobRcbRobLjbRobLobLjbRobLebLobLjbRjbRcbLebLobRebLjbRebLebLjbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bRoRsmbRoLcbLeLsLsmbLsbLgbLoRsbLsRsbLebRcRsmbRhbRhbRcbLibLsbRsbLibLibL
sbRgbRcbRjbLhbLobRjbRhbLsbLjbLcbRcbRibLibRhRsmbRhbRcbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bRsbRjbLebRebRebLjbRcRsmbRhRsmbLibRobLobLebLobLobRobLjbRobRobLobRjbLob
LebLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bLjbLobRjbLobLobRobRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bRsRibLeLsbRjbLebLhRsbLibLcLsmbLibLhRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bLibLsbLgbRgbLjLgbRgbRcbRgbLjbLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLeLsbLsbRsbLibLobLibLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bLhbLgLgbRobLjbLibRcbLjbLibRjbRhRsmbLjbLsLgbLsbLgbLsbLhbLcLsmbRibRgbRg
RsmbLgbRcbLibRgbRgbRsLhbRibLhLsbRjbLibRhbRibRobRibLibRcbLibRcbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLibLsbLsbLsbLsbLgbLsbLebLgbLsbLibLibLsbLibLcbLsRsbLsbLobLsbLsbLsbLsbR
gbRgbLsbRgLsbLgbLsbLibRsLsbLibLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bLgbLsbLjbRsbRjbRcbRgbLsbLsLsmbLsbRjbRibRsbRibRsLsbRibRsbRoRsmbRgbLibL
sbRgRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bRcbRobRebLsbRobLebRcbRgbLebLsbRebRebRebLobLobLgbLsbRcbLobRebRgbRsbLgb
RobLebLcbLebLcbLgbLobLibRebRsbRebLebLobRcbLobRebLcbLebRgbLobLebLebLibR
gbRobRebLebRebLobLcbRobLobRobRobLobRobRjbRobRebRebRobLgbRobLobRhbLgbLc
bRobRebRcbRobRobLhbRobLobRebRobRcbLibLcbRobLobLobRebLebLobLibLobLobLob
RobRsbLcbLebRobLhbLebLobLebRobLcbLcbRsbRebLobRcbLibRebRcbRgbLcbRobRobL
cbLibRgbRebRibRebLobRobLobLobLcbLobRobRobLibRgbLsbRhbLobLobLobRcbRebRo
bLcbLobLibLobLcbLobRgbLgbLebLcbLcbLebRhbRcbRcbLobLobRibLobRsbLebLcbRgb
RobLobRobLobRcbRebRgbRgbRobRibLebRobRebRobLobLobLgbRhbRcbRebRobLibLcbR
obRobRebRebRebLobRobLsbRobLobLsbLhbRobRebRgbLgbRobRobRcbRibRibRobLsbRg
bRebLibRebLebRcbLebLgbLibRobLobLobRobLobLobLebRibLobRobRebLebRebLebLob
RcbLcbRcbLebRobRobRobLebRebLebRobLobRebLobRebRebRibRebLgbLibLobRcbLgbL
ibRebRcbRebRebLobRcbLebRobRebRebRobRcbRobRibLsbRebRobLcbLjbRobRebLebLe
bLobLibRobRebRobRobLcbRobRcbLobLobRcbLobLebLebLobRobRcbRebRobLobLgbLob
LebRobLcbRcbLobRobRebLebLebLobRobLcbLcbRobLobRobLgbLobRcbRobLobRobLibR
obLebLebLcbLobLobLcbRgbRobRobRobRsbLobLobRebRibLibLsbLcbLobLcbRobRjbRc
bRhbRobLobRsbRobRobRebLsbRobRgbRebLobLgbRebLobRgbRebLgbRcbRebLebRibRob
RebRebLcbLcbRebRobRebRcbLebLebLcbLebLebLsbRebRibRebLcbRobRobLgbRobLobR
gbRobLebLobRgbRcbRebRebRibLebLebLobRebRhbLebRcbLsbRebRobRobLebRcbLobLo
bLcbRibLcbLsbLebRebLcbLebRobRhbLobLobLibLebRsbLcbLobRebLcbLobRebRobLcb
LebRcbRebLobLebLsbRebLebRcbRcbRobLebLobLebLsbRcbRebLibRobRcbRibRobRebR
obRobLibLobLsbRobLebLobRobLjbLebLsbRgbRgbRcbRobRebRebLebLcbLsbLobLcbRi
bLcbRebRobLebLobLgbRobLgbRebRcbLcbLobLcbRsbLobLgbLobLhbRobLebRobRgbReb
LcbLcbLebRobLibLcbLebLobLebRobLebRibRebLobRobRobLobRebLcbRobLgbLcbRgbR
obRobLebRobRebLobRobLsbRebRebRebLobRebLobLcbLobRibRebLobLobLcbRebRebLe
bRobLobLcbRebLebRibRcbLobLobRobLcbRobRobLebRobRhbLebRobLebRobRsbLobLeb
LebRebRcbRobLobRobLobRobRebLcbRcbRobRcbLgbLobRgbRebLobRhbRibLsbLobRobL
obRcbLcbRobLjbRgbLebRobLobRobRibRobRobRsbRobRebRebLebRebLcbRgbRebLobLo
bRobLcbLobLobLgbLobLebRobRebLebRobLgbLobRibLebRobRobLgbRhbLebRibLobRob
RsbRebLobRobLcbLcbLsbLebRgbLibLebLgbLobRobLhbRobRsbRcbRcbLgbRibRobLebR
obLgbRcbLsbRebRibRebRsbRhbRcbLobRebLobRibRobLebLebLebRgbLhbRebRobLjbRo
bRhbRebRebRebRsbLcbLobRobLobLobLobLcbRebRjbLcbRcbLobRcbLcbRsbLobLcbLob
RobLobLsbLebRobRebRcbRobLobRobRobRebLebLobLcbRcbLgbRobRibRobRhbLcbRgbL
hbLebLcbRobRcbRobRobRcbLobLobLobLcbLjbLobRobLhbLcbLobLcbRcbRebRobLebLc
bRcbLobRobLhbRcbLobRobLgbRcbLhbRjbRobRobRobRjbLobRobLobRobRcbRobLobLeb
RcbLcbLjbLebLobLgbLjbLobLcbLcbRcbRibLebRobRgbLebLobLobRobRobRobRobRobR
obRebRobRobRsbRsbRobLobRobRobRobLcbRobLhbRcbRebRcbLobRobLebLcbRebLobRs
bLobRcbLibLobRsbLhbRcbRobRobLcbLobLobLebLibLsbLebLsbRebLobRobLcbRcbLob
LibLgbLebLcbRobRebLobRobRobRibRgbRgbRobLgbRsbRibLobRcbRcbLgbLobRobLobR
ibRobLobLobLebLgbRgbRobLibLobRhbLobRobLcbLibLibLobRhbLobLibRobRebRgbLo
bLobRcbRobRcbRebRcbRebRebLobRobLibRebRobRebRgbRibRcbLibRobRcbRobRebLob
RobLebLobLobRobLobRhbRobRgbLobLsbLgbRobRobLobRobRcbLgbLobRobLjbRgbRsbR
ebLobLebRebLibRebRcbRobRobLcbLebLibRobLgbLebRobRobRhbRobLobRobLcbLgbRo
bRebRcbLobRcbRobRibRobRobRobLobRjbRebRobRobRobRobLsbLobLebLgbLobLcbRob
RobRsbLobLcbLobRobRobLibRibLibRgbRebRcbRcbLobLcbLebLsbLsbLobLebRobRobL
cbRobRcbLgbLibLgbRobRsbRsbRobLgbLobRebRibLobRobLsbRobLcbRobLebLhbLobRi
bRobRebRebLgbRobRsbRobLobLobRcbLobRobLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bLsbRgbRsbLgbLsbLgbLsLsmbLgLsRsbLsbLsbLsbLgbLsbRsbLsbRsbLsbLsbRsLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bLgLsbRsbLsLsmbLgbLgbRjbLgLsbLsbLgbLobRibLhbLcbRgbLibLsLsmbLibRgbRibRi
bRgbLibLsbLibLibRsLsbRsbRsbLgbLibLsLsmbLsbLgbLsLsmbRjbLjbLsbRjbRibRsbL
gbLsLsRsLsmbRibRgbRibRgbLgbRgbRjbLsLsmbLibRibLcbLsbLgbLgbRsbRcbRebLgbL
obLsbRsbRgbRcbLgbLobRcbRcLsbRcbRgbLgbLgbLsbRsLsbRjbRibRsbLiRsbsbLibRsb
sbRobRibRcLsbRibLgbRcbLiLsbRibLgbRgbLsbLsbRsbLsbRgRsmbReLsbLsbLgbLsbLc
b

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bRiLsbLibLsbLsbLsbsbLsbRsRsmbRsbRsbsbRsbsbsbsbRsbLsRsRsmbsbRsbsbRsLsLs
LsmmbRsbRsbLsbRsbRsLsbRsbLsbLsbLsbRsbLsbLsbLsbLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 25; Drug: Control Apo 0.5 然
bLebRsbLiLsLsmbLsbLgbLsRsbLiLsbRsRsmbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 26; Drug: Control Apo 0.5 然
bRgbLsbLjbLcbLebLcbLcbLhbLoLsmbLsLsmbLgRsbLjRsbLibRoLsbLcbRsLsbLsbLgbR
sbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 27; Drug: Control Apo 0.5 然
bRobRobLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 28; Drug: Control Apo 0.5 然
bLsbRebRibRobLebLsbRobLebLobLcbRobLobRsbRcbRibRhbRibRebRebRobRgbLibRob
RibLobLcbRobRobLobLobLibLobLsbRebRobRcbRibLebLebRobRebLobRcbLibRhbLobL
cbLhbRebLobRcbRebLcbLjbRebRgbRcbLibLsbRebLobLebRhbRobLebRobLebRebLobRo
bLebLebRcbLobLibLobLebRcbRebLgbRibLebLebLebRcbLobRebLsbRibRobRobLobRcb
RgbLobLebRebRobLgbRobRibRobLobLcbLibLobLebRebRibRobRsbRobLgbRcbRobRhbL
obLcbLobRcbLibRcbLhbLobLebLcbRobLebRobLebLobRcbLgbRobLobLcbRjbLobLobLe
bRgbLobRebRebRobRebRgbLsbRibRobLcbLobRcbRobLcbLobRobLsbRebRgbLibLebLeb
LobLcbLibRebRjbLebRgbLobLcbRcbLebRobRibLibLgbRibLobRcbRobLobRobLobLcbL
obLsbRebRobLebLgbRhbLibRsbRjbRcbLcbLcbLobRebLcbLobLobRebRobLobLgbLobRe
bLibRebLcbLgbLgbLobLcbRobLebLibRobRobLobRcbLebLobRebLgbLibLobRibLebLob
RibRobLsbRgbRobLobLobRobLcbRhbRebLobRebRobLobLobLsbRobLebRobRobRgbRgbL
obRgbLjbLebLcbLebLcbRobLebRobRobLebRebRcbRobLcbRobRcbLobRebLobRcbLcbRo
bRobLgbLhbRobLobLjbLhbLebRobRobLebRibRcbRobRsbRebRgbLobRebLobRsbLobLob
LobRebRebLebRobLobRobLibLgbLcbLobLobLobLcbLebRjbLcbLcbRobRebRobRgbRibL
ebRebLcbLebRsbRobLobRebLibRgbLobRobLobRebLhbRjbRobRebRsbRebLobLcbRobRo
bRebLgbRebRebLebRobRobLobLibRcbLebRcbRobLobLebRcbRcbLobRobLcbRebRebLcb
LobLebLebLobLebRobRobRebRebLebLcbLebLobLebRobRobLebRcbRebLibRgbRebRobR
gbRobRobLobRobRcbRobRobRcbLcbLcbLobLebLobLobRobRobRobLobRhbRobLobLobRe
bRobRebLsbRobRobLobRcbLcbRebLobRgbRobLobLgbRebRgbLobLcbLcbRgbRobLsbLhb
LibLebRebRhbRsbLebRebRobRobRcbLhbLcbRhbLibRibRcbRcbRebRebLobLebRobRebR
obLobRebLebRobRebLcbLobRcbRebRobLobRcbLebLobLobLobLobLcbRobLibLebRhbLi
bLobRobLhbRgbRcbRobLobLsbLebRebRebRobLcbLibRebLsbLobRobLcbLobRhbRibReb
RobRobRsbLobRcbLobRcbRcbRebRhbLobLibRcbLcbRobRobRcbLebRcbLcbLgbRcbRebR
obLcbRibRobLobLebLibRsbLobRobLibRobRobRcbRgbRgbRobLobRgbRcbRibLobRebLc
bRobRebRcbLcbRobLebRjbRcbLobRobRobRebRgbRobRobLobRobLebLgbLcbLebRobLob
RobRebLobLcbRobRebRcbLibRcbLebRgbRebLobRgbLobRobRobLobLcbLobLebLcbLsbL
obLcbLobRobLebLgbRobLebLcbLhbLobRibRobRhbRobLobRebLcbRebRobRobLgbRobLc
bRibRobLsbLgbRobRobRcbLobLebRcbRhbRobLcbRobLcbLcbLobRobLcbRibRebLsbLsb
LibLobRebRobRobLcbRebLibLobRobRsbRhbRsbLobRobRcbLcbRibLgbRobLebLebRobL
ebLcbRibRobRcbRibLobRebRebRobRobRcbRebRobRebLebLobRcbRobLebLobRobRobRi
bRobLobRebLebRebRibLhbLcbLhbRobLebRobLgbRobLobLgbLobRcbLsbRobLobLobLeb
LobLebLcbLobLebRsbRobLebRobRcbRobRobRebRebRobLobLebRsbRebRobLebLcbLebL
cbRgbLcbLobLhbLobLobRibLibLcbRobRobLobLobRobLebLebRcbRebLobRobRcbLibLg
bRsbLebRobRebLobRebLobRibRgbLobRgbLobLebLcbRgbRobLhbLebRobRebRobLgbRsb
RebLibLgbRobLobRobRobLebRobRebLobLcbLebLebRsbRebRobLcbLsbRebRebRobLsbL
obLobLebRobLebRobRobLobLobRobLobRobRcbLebRobLobRobLobRobLobRobRgbRebRo
bLebRebRgbRebRobRibRobLebLobRobRhbLebRobRgbRhbLcbLobLobRcbLgbRebLobRib
RebRobRobLebRobRsbRhbLobRcbRcbLibLcbLobRobLcbRcbLcbLibLsbRobRcbRcbLobR
gbLebLobLobRsbRibRcbRcbLsbRebLebLebLobLobRgbLobLhbLebRsbLobRsbRibLobLe
bLebRobRibRobLobLebLhbRebRgbLebLobRgbLgbLgbLcbLobLobLobRobRcbLobLebRob
LobLobRobLobRcbRebRobRibRhbLcbLcbRcbLobLobRibRobRebRobLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 29; Drug: Control Apo 0.5 然
bLjRsbRjbsbLcbRcRsmbRsbLoLsmbRsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 30; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bRobRcRsmbLsbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bRhbLsbLgbLibLiLsbRcbLcbLsbRsbLhbLjbLhLsbLibLsbRsbRsbLcLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bLobRsbRgbRobRobRsbLsRsbLobRibRibRcRsRsmmbLgbRibRgRsLsmbLsbLobRsbRsbRs
bRsbLobLsbRsbLgbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bLoRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLgbLgbLiRsRsmbLibLhbRibLgRsbRhbLsRsbLibRobLgbLgbLgbLgbLsbRsbLgbLsbRgb
LebLibLgRsbLcbLibLgbRoLsbLsRsbLsbLibRgbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLjLsmbLjbsbRcLsbLsbRcbRsbLobLibRsbRsbLobRsbLobLcbLsbLibLhbRibLib

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLobRhLsbRhRsLsmbRgbLhbLibLibLibLibLibLibLgbRgbRjbLcbLsbRibRgRsmbRoLsb
LibRgLsbRgbRgbRgLsbLsbLgbRgbLcbLiRsbRhbRibLobLjLsmbLibRibLhbLobRgbLiRs
bRgbRgLsbRcLsRsLsbLsbLsbRgbLsbLibLibRiLsbLcbRobLgbRsbRcbRjbLibLgbRgLsb
Lsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bRiRsmbRgLsLsmbRibLebLgbLgLsbRjRgbRobRcRsmbRsLsbRsLsbLiRsbLibLgLgLsbLg
bLiRsbRcbLibLsRsbRsbLcbLibRgbLsbLgbLgbRoRsmbLgbRsbLiRsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bLsLsmbLsbsbRcbLibRgbLcLsmbLgLsbLgbLsbLsLsLsmmbLsbLsLsmbLsbLgbLsbLibLs
bLgLsbLsbLsLsmbLsbLsbLsLsLsmmbLgbLsbLsbLoRsbRhbLsLsmbLsLsLsmmbLsbLgbLs
bRgbLsbLsbRobLgbLsLsmbRhbRcbLsbLsbsbRiLsbLiRsbRhLsbRibLibLsbLsbRobLsbR
cLsbRcbLsLsmbLoRsLibLcbRgbLsbRcbRibLjbLjbLcbRcbLsbRsbLsbsbRjbLgbLjbLsb
RcLsLsmbLgLsbLsLsmbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bLobLsbLobLob

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bLgbLgbLsLsLsLsmmmbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bLsbRgbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRsbRsbRsbRsLsbLsbRgbRsbLjReb

>ZF Recording 2016-03-15; tW: 300s; Start: 180940; End: 181440;
Recording: 6-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bRibLibRibLibLsLsLsmmbRsbsbRsbRibLsbLobLibLibRobRhRsmbLsbLibLhbRsbLebR
jbRobRiLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 1; Drug: Control Apo 0.5 然
bRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 2; Drug: Control Apo 0.5 然
bRobRibLibRgbRoLsLsmbLsbLsLsmbLsbLhbLsbLsbLsbLgbLibLsbRgbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 3; Drug: Control Apo 0.5 然
bRcbLgbRsbReRsmbRoRsmbRsbLibLobRoRsRsLsmmbRgbReRsmbRibRibRsbRsbLgbRsbL
ibLgRsbLibRobLgbLhbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 4; Drug: Control Apo 0.5 然
bLsLsRsmbLsbLibLjbRsbRsbRsRsmbRibLgbLsRsbLjLsmbLibLibLiLsbLjLsmbLsbRsb
LsbLjLsmbLsLsmbLsbRobRhLsbRibsbRsbRgbRibRsRsmbRgbRgbLgbRoLsbLibRsbRgLs
bRgbLgbRsLsbRgbRobRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 5; Drug: Control Apo 0.5 然
bRoLibLhbRobRobLhbLiRsLsbLgbLhbsbRgbRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 6; Drug: Control Apo 0.5 然
bLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLsLcbRebLgRsLsbLsLsmbLsbsbsbsbLsRsbRsLsbLsbLsbLsbsbsbLsbLsRsbsbsbsbsb
LsbRsbsbRsbsbLsbsbsbLsRsbsbsbsbsbRsbsbLsbRsbRsLsRsbsbLsbLgbRjbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRjRsmbLobLsbRsbRsRsLsmbsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bLhbRobRsbLcbLobLcbLcbRcbRcbRhbLobLebLjbRhbLobRebRobRobLsbLobRcbRcbLob
LcbLibLebLobRebLebLebRjbRebLcbRobLobRobRobLebLebRobLobLebLibRcbLibLobR
obLobRibLgbRjbLcbLjbLobRobLjbLcbLebRebLcbRebLobRjbLobLibLobRobLibRobRe
bRebRcbLobRebRobLebLebRebRibLobLcbRibLcbLcbRjbRcbRcbRcbLebLobRebRebReb
LjbRobLobLobLebRobLebLibLibLobLebRebLobLebLobRibLsbLebLgbRobRhbRebRobL
sbLsbLgbRobRobLebRobLibLebRebLibLobLobLjbLsbRcbRebLobRobRgbLcbLobRebLo
bLebRobRsbRsbLgbLebLebRobRobLebRibRobRibRobRobLibRebLobRebRcbLobRebRgb
LjbLcbRcbLibRobRjbLebLjbRebLebRebRobRebRibRgbLobLobLobRebRebRebLebRjbR
ebRobRobRobLcbRcbLobRobLobRobRjbLcbLobLebRibRobLsbRobLobLobRcbRobRibRj
bRjbLsbLjbLcbLebRobLebRobRjbRcbLcbLobLobRebLebRebRobRibRhbLcbLobLibRib
LobRcbRgbRcbLibLobLcbRobRobLobLobLebRobLibLebRhbRebRibRcbLebLebRcbRhbL
obRebRebRobRcbLobRobLobLobLobRebRcbLcbRebLebRebLibRobLobLobLgbLcbRibLo
bRebLobRibLobLcbRobLobLobLebRebRhbLcbRobLobRebRsbLebRobLcbLobRobRebRob
LobRobLgbRebLebRebRobRobLobRibRobRgbLibRebRibRgbRebLgbRgbLebLobLobLsbL
gbLebLhbLcbLobRsbLcbRebRebRibLebLebRcbLhbLsbLibLebLobRebLebLebLibLebRi
bLcbRcbRobRobRcbLebRgbLebRibRobRobRcbRibRcbRobRobLcbRebLobLebRibRebLob
LcbRobRobLobLebLebLobRobRobLobLebLobLgbLebLhbLgbRobLcbRcbLibRcbRjbLobL
gbLobLobLcbRobLobRhbRcbLobLobRgbLobRebLobLebRcbRebLibRcbRobLebRebLsbLe
bRobLcbRcbRobRebRebLibLcbLobRebRsbRcbRobLobRsbLebLebRebRebRcbLobLebRob
LebLobLebLobRsbRgbRobLgbLebRhbRsbLobRgbLobRcbLebRcbRebLobRobRobRobRobR
cbLobLcbRsbLcbLobRobLebLebLebRobLobRobLjbLibRobLibRobRobRebRobRobRcbRo
bRebLcbLebLebLsbLobRebLjbLcbLebLebLsbRcbLhbLjbLobLibLgbLcbRebRcbRobLeb
RibRibLhbRobLsbLcbRcbRebLobLjbLobLobLobRobRebLebRcbRobLcbLobLgbLcbLibR
ebLobLibRobRcbLobRobRobRcbRobLobLobLobLgbRobLibRobRebLobRobRobRsbRobLh
bRobLebLobLebRobLobRobRibLobLebLgbLgbRobRobLobLobRcbRobRobLgbRebLjbRib
LobRobRobLobLcbLcbLcbRhbRobRobLibLobLcbRebRebRebRcbLobLobRsbRebLebLcbL
obLcbLgbRjbLobLibLebRobRebLhbLobLobLgbLibLgbLobRcbRobRibRebRebRebRibRc
bLebLgbRobLebRebLibRjbLsbLebRcbLhbRebLcbRobRebLobLcbLebLcbRobRsbLobLeb
RcbRobRobRobLebRebLebRgbLcbLobLobRcbRcbLcbLobLobLobRcbRgbLobRobRebLjbR
gbRsbRcbLobRebLcbRibLebRsbLobLebLgbLsbLebRobLobRobRcbRebLobRjbLcbRebRg
bLjbLobRcbLobLobRobRcbRobRobRobLobRobLobLobRibLebLobRcbLebRobLobRobRib
LobLibLobLcbRobRjbRebRobLobRobLcbRebLebLibLebRobLebRobRcbLgbLibLgbRobR
obLebRobLibRobLhbLobRcbRobLebLebRgbLobLobLobRobRcbRibLcbLobRobRobRebLe
bRebRobLobLibLobRobLcbLebLobRobLgbLebLcbRcbRebRobRobLobLgbLsbRibRebLcb
RebRhbLebLebLobRjbRcbLhbRcbLebLgbRebLobLgbRibRebRobRsbRebRgbRobLcbRobL
sbLobLobLibLobLibLibRhbLcbLsbRebRgbRgbLebLibLhbLobRgbRgbRebRjbLebLobRh
bRobRsbRgbRhbRebRhbLebRibRgbLobLcbLebRobRibLebRobRebLgbLobLsbRobLsbLsb
RjbLgbLobLcbLobLebLobLsbLobRebLgbLsbLcbLsbLebLobRsbRobLobRebRobLebRebL
cRsLsbRebRibLcbRcbRoLibLcbLebRobRjbRsbLsbLebLcbLobRobLebLjbRebLjbLjbLj
bRebRobLsbLobRobRobRebRebRsbLjbRebRobRobLobLsbLjbRebRebLcbRebRebLebReb
RebRjbLobRebLobRcbRebRebRebRhbRobLebLebRebLobRebLebRjbRebRebLcbLjbRsbR
ebLjbRcbRebLobRjbLjbLjbRjbRcbLebRobRcbRobLebLobRobLjbLebRjbRsbRebRjbRe
bLebLobRobLjbLobLcbLjbRebLcbLcbRobLobRcbLjbRjbLebRebRcbRjbRobRobLjbLcb
RebRjbLcbLobLsbLcbLjbLobRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bLcbRcLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bRibsbLsbLsLsmbRsbRcbLibRcbLgLcLsmbLiRsbRcRsmbLcbLgbLgbRcbRibLsbLebLib
LcbLiRsbLsbLjbLibLibLgbLsLcRsbLhbLibRsbLsLsRsmbLhbRsbLgbLsRgbLgRsbRsbL
cbLhbLibLibLibRibLebsbLcbLibLgbRsbRsRsRsmmbRibRebRibLjbRjbRibRsbLibLgL
sbLcbLgbRsbRibLgbRibRhbRgbLcLsmbLgbRcbLebRcbRcbLibLcbRibLibLgbLcRsbLjb
RcbRgbLiLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bLobLebLebRcbRebRgRsmbRsbRsRgbRsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bRsbLjLsLsmmbRsbLjbLoLsmbRjbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bLsbLsbRsbLjbRgbLcbsbsbLjRsRsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bLobLobLgbLsLgLsbLobLobLhbRgRsmbRsLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLsRsbLsLsRsmbLeRsbLsLobRsbLsbRsbLobRsbRsbLsbRsbRsRsmbLsbLsLsmbRsRsmbR
sbLobRsLsbLsbLsbLobRsbLsbLoLsmbRsbLsLsLsmmbLsbReLsbRsRsmbRoRsmbLsbLsbL
sbRsRsmbRsbRebRsbRobLsbRsbRsRsmbLsRsbRebRsRsmbLoRsbRobRebRsLsbLsRsLoRs
bRobLobsbRsbRsbLsbRsbLobRsbsbRsbRsRsmbReRsmbRsbRsbRsbLsbLsRsbRebRsbRsb
sbLobRsbLsbRsbRsbRsbRebRsbLsLsmbRebRsRoLsRsbRsbRsbRobLoLsmbLobRoLsbLsb
RsbLsRsbRsRsmbRsbLsbRsbLsbRsbLsbLobRsLsbLobLsbLsbLsLoLsmbLsbLsbRsbRsbL
sLeLsbRobsbRsLebRsbLebRsbRsLsRsbLsbRsLsbRsRoLsbRsbReRsLsmbRsbLsbRoLsbL
sLeLsbRsbLsbRsbLsbLsbRsRsmbLsLsmbRcbLsLsmbRebLsbLsbLobRsLsbLsbLcbLsLsm
bLsbLcbRsbRsbsbLsLsmbRsbRsbLsbRsbRsbLsbLsbRsbRsbReLsbLsRsbLobLsbRsRobR
sbRsLobLsbReRsmbLsbLsbRsLsRsbLsbRsRsRombRsLsbLobRsbLsbLsRsbRsRobLsRsbL
obRsbLsbLoRsbLsbRsbRsLsbLsbLsRsbRsRsRombReRsRsmmbLsbLeLsbRsbLobRjbLsLs
mbRsRebLobRcbRsLsbRsbRobLobLoRsbRsRsmbLsRsbRsRobLsbRsbRebLsbRoRsmbLobR
sbRsLsRsbLsLobRobRsLsbLobRsbRsbLsbRobRjbLoLsLsLoLsRsmmmbLoRsbLobRsbRsb
LjbLjbRsbRsbLebRsbRsbRsbRcLsbLsbLobLebLsbLsbReLsbRoRsLsmbRsbLobRsRsmbR
sbRsbLsRsbLebLsbLobRobLsLsmbLebRsLsbLjbLobRebRsLsbRebLebRsbRsbLsbRebLs
bLsbLsRsbRcbLsRsRsLsmbRobLsbRsbRebRsbLjLobRsRsmbLsbRsLsbLobLjbRsLsbRob
ReRsmbRobRsbLsbRsbLoLsmbLebRsbRsbRsbRsbsbRobLobLobLobLebRsbLcbLobLsbLj
RsbLsbLsbLebLsbLsbRsbsbRjbRobRebRsbRsbReLsbLsLjbRsbRsRsmbRsbRsLobLsbLs
bLsbRobLsbLsbLsbLsRsLsbRebRobRsLsLobLsLsmbRsbRsbLebLoLsmbRebLsRsbLjbRs
RsLsmbRsbRsbRsbsbLobLsbRsLsbLsbLsbLsbLsbRsbRsbLsbRobLsbRsbRsLsbRsRsmbR
cbRsRsmbRcLsLsmbLsbLsbLsRsbRsRsmbsbRsbsbLsbLsbLsbLsRsbLsbRsbRsRsmbRsbR
sbsbLsbRobRebRobLsbLsbRebLsRsbRsbRsbsbRsbRsbLoRsLsRsbRcbRsbRjbRjbsbLsL
obRsbRobRsbLsRsbsbLsRsbLsbRobLobRsbRsbLsLoRsbLsbLobLsbRsbRsLsbLsLsmbLs
bLobRobLobRsbsbRsbRsbLobLsbRebRjbRebRobRsRsmbRsbRebLsbRsbLsbLsRsRsmbRs
bLobsbLsRsbLsbRsbRsbsbLsbRsbLsbRsLsbLsbLsRsbLsbRgbRsbRsbLsbLsbRobLsbLs
RsLsbLsRsbRsRjbRsbRsRsmbReRibRsbsbRsbLsbLobLsbRebRsbRsbLsbLjbRebLsbLob
LsbRsbLsbLsLobLsbsbRsRsmbsbLsbLsLsmbRsbLsbRsbLsbLsbRsLsRsbRsbLebsbLsbL
obLsLsmbLobLobRsbsbLsbRsbRobsbRsbRsRsLsmbRsRobLsbLsbRsbRsbRsbRsbRsbLsL
smbRobRsRsmbRsbLobLsbLsRsbRsbRsbRobLobLsbRsbsbLsbLobLobRsbLobLsbsbLsRs
bLsLsmbLsRsbRsLsbRsRsmbLsbLjbLsbLsRsbLsLsmbLsbLsbLsbRsbLsbLsbLsbLobRsb
LsbLobLsbLobLsRsRsmbRsRebRsbRsRsmbRsbsbRsbLobLsbsbsbRsbRsLsbRsbRsbRsbR
cbRobLsbsbLsbLsbRebsbLsbLobLsbLsbsbLsLsmbRsbLsbsbLsLsmbLsbLsbRsRsmbRsb
LsRjbRsLsbRsbLsLsmbLsbLsbRsLsbRsbRsLsbLsbLsbLsbRsRsmbRsLsbLsbLebRsRsmb
RsLsbsbLsbRsRsmbRsLsLsRsmbLsbRsLsRsbRsbRsbLsRsLsbRsbRebRsbLsbRsbRsbLeR
sRsmbLsbLsRsLsLobRsbLsbLjRjbLsRsRsmbLoLsmbRsbLsbLsRsbLsbRsLsbRsLobRobR
sbRsbRebRsLsbLsLsmbLsbLsbLsbLebLsbRsbRobLsLsmbLsbLsbLsbLsLsmbRsbRobRsb
RsbLsbsbRsbLsLsmbRsbRsLsbRebLsbLsbLsbRsbRsbRsbRsbLsbLsbsbRsLsbsbRsbRob
LsbsbRsbLsbLobLjbLobLobRebRsbLsbRsbLobRsbLjbRebLsRsbRsRebLsbLsLsmbRsbL
sbRsRebLobRsRsmbLsbRsbRsbsbRsRsmbsbLsbRsbLobLobsbRsbReLsbRoRsmbLjRgbRc
LsbLsbLsbRsbLsbRsLoRsbRsbLsbRsLcbRobsbLsbLsRsbRsRsmbLsLsmbRsRsmbLsbLsb
RsRsRsmmbRsbRsLoRsbRsbLsbRsLobRebLebLsbLsbRsLeLsbRsbRsRsmbLsRsRsmbRsbL
sbRsbRsbRobRsRoLsbRsbRsbLsbRebLsbLsbRsbRsbLsRsbLsLoRsbLsRsRoLsbRsbRsLo
bRsReRsmbRsLsRebRsbLsRsRsmbRsLsLsmbLsLsmbLsRsbRsRsmbLsbRsRsmbRsbRsLsbR
sbRsbRsRsmbLsRsbLsbLsLsmbRobRsbLsbRsbLsbRsLsbLsRsbLsLsRsLsLsmmbLsbLsLs
mbLgbRsbRsbLsbRsbRsbRsbRsbLsbLsbLsbLsbRsLsRsbRsLsbRsbLsbRsbLsbRsbLsLsm
bLsbLsbLsbLsRsbRsbRsRsmbsbLsRsbLsbLsRsbLsbLsbRsRsmbLsbLsLsmbLsRsLsbRsb
RsbLsLsmbLsLsmbLsbLsbRsbRsbRsRsRsmmbLsbLsRsbLsbRsbsbRsbLsbLsbRsRsmbRsb
LsLsmbRsbLsbLsLsLsmmbLsbRsbRsbLsLsRsLsmbRsbRsbRsbRsLsbLsLsmbLsbRsLsbRs
bRsLsbRsLsRsbLsRsRsmbRsbLsbRsLsLsmbLsbRsbRsbLsbLsbLsbLsbRsLsbLsbLsbLsL
smbRsbRsbRsRsmbLsbLsbRsbLsbLsbRsRsmbRsbLsbRsRsmbLsbRsbRsbRsbRsRsmbRsbR
sbLsbRsLsbRsLsbsbRsbLsbRsbLsbLsbLsbRsRsmbRsbsbLsRsbLsbLsbLsLsmbsbsbRsb
LsbsbLsLsLsmmbLsbRsLsbLsLsmbLsbLsRsbLsbRsRsmbLsbRsbRsbRsLsRsbLsbRsLsbR
jbRsRsmbRsLsbLobRsbRsbRsLsRsLsbLsbRsbLsRsbLjbLsRsbLsbLsRsRsmbLsbLsbLsb
LsbLsbLsbLsbRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bRgbLgRsbLsbLgbLsRsbLsbLsbLsLsmbLsLsmbLsbLsbLiLsbLsbLsRsbRsLsbLsbRsLsb
LgbLgbRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bsbLsLsmbLgbLebLjbLobRsRsmbsbRsbRgbRgRsmbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bRgRsLsmbLebRoRsmbLebRob

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bLsbLebLhLsbLsbLobLgbLsbLoLsmbLibLibLsbLsbLhbLsbLsbLsLsmbRgLsbLsbLsLsm
b

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bLsbRsRsRsmmbRsLsbLsbLsbLsbLsbRsbRsLsbLsbRsbRobLobLsRebRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bLoRsbRcbLoRsbLcLsmbRiLsbRgbLsbRsLsbLsbLgbRjbRhLsbLsbLgbLibRjbLiLsbLsb
RoRsmbLcbRhbLcbRibLibRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bsbRsbLsbLsbRsRgbLibLobRsbRcRsmbRgLsbRsbLgbRsLsbsbRsbsbRsbRobsbsbRsbLs
bsbLsbRsLsRsbsbsbsbsbLsRsbLsRsbRsRsmbLsbsbRsbRsbsbRsbLsbLjbRgbLobRsbLi
bLibLjbLgbRiLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 25; Drug: Control Apo 0.5 然
bLcbLcbLsbsbRobLhbRibRiRsmbLgRsbLsbRsbRibRgbRibRgbRsbRibLgLsbLjbRgbLiR
sLsbRibLoLsmbLiLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 26; Drug: Control Apo 0.5 然
bRcRcbLoRsbLcbLibRsRsmbRsbLoRsbLgbRebRobLcbLgbRjbLcbRcbLibLeRsbLobLibL
cb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 27; Drug: Control Apo 0.5 然
bRoRsmbRobRcbLobRibRsbLoRsLsbLcRsbLsbLsbLhbLiLsbRsbLsbRsbLibLsbRhbRsbR
ibLobRcRibRibRsbLsbRsLsLsmbRgbRgbRsbRsbLsbRsLsbRsbRsbRsbRgbRiLsbLsRsbL
sRsbLgbRsbLsbRoRsmbRgbRjbLsbLsLsmbRgbRsbRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 28; Drug: Control Apo 0.5 然
bRebRibRhbLjbRebLobLobLobLgbLebRcbLebRibRgbRobLobRibRobRcbRobRibRgbLob
LobLgbRobLebLebRobRobLobRebRsbLibLgbRobRebLobRebLebLibRobRsbRobLobLcbL
cbRebLobRobRcbRobLebRgbLobRobRebRibRhbLebRobLcbRcbLebLobRobRebRgbRhbRe
bRobLebRebLgbRobLobLobLhbRgbLsbRhbLibRebLebLebLcbRebLgbLobRcbRcbRgbRob
LgbRebLobLjbLsbRobRcbLobRcbRcbRcbRcbRsbRgbLebRebLibRobLobRibLsbRcbRobR
sbRobLebLebLibLcbRgbRobRobRgbRgbLebLebRobRhbRebRcbRobLebLobLjbLobRcbRe
bRcbRibLobLobRebRebLcbLibRobLebLgbLobLibLobLebRebLcbLobLgbLobLcbRcbRgb
RobRjbLcbLibLobLebLobLebLcbLgbRobLebRobLobRebLcbRobRibLibLhbRebRobLcbR
hbLebLgbLebLcbLobRobLobRobRobRcbLebLobLsbRibLobRibRobLobRobLcbLcbRebLe
bRobRobRcbLsbRebRcbRsbLebRibLobLebRcbRgbLibLobRobLibRcbRcbRhbLibRebRob
RhbLcbRebLcbLebRcbRebLcbLobRcbLhbRebRobRobRobRobRgbRebLobLebRobLibRibL
ebLibLobLobRobLobLcbRebRsbRcbLcbLobRobRobRobRobRebRebLebLgbLebRebRebRc
bRgbRobRobLsbLgbLebLobLobLcbLobRcbLobRcbLcbLhbRcbLebLibRebLebLibRjbLob
RgbRobRcbRobRobRgbRobLobLobRobRobLebRebRobRebRobRobRebRcbRcbLcbRebRgbL
gbLebRsbRebRebRobRebLebRobRebLibRcbRobLebRobLcbRcbRobLcbLobRgbLhbRsbLo
bRibLobLobLibRebLsbLobLobRobLibLobLsbLobRibLibRgbLobLcbLobLobLebLcbRob
LobRgbLobRibLobLobLibLebLebRsbLebRcbLobLebRebRobLcbLebLobLobLgbRobRebL
ebLebLebRibLebLebLcbLsbLobLobLobLebLobLibRobRebLibLebRcbRcbRobLobLibRe
bRsbRebLobRcbRibLobLibRebLhbRobLobRobRebLcbLcbLgbLebRcbLobLobRgbLebLob
LobRcbRebLcbLobLobLobRgbLobRcbLibRcbLcbLcbLebLgbRebLibRebLibLcbLobRcbL
cbLcbLebRebRobLobLcbLebRibRebRebRebRebLobRcbLobLobRebLebLebRobLebLobRo
bLebLobLgbRobRgbLebLgbRcbLibRcbRcbLebLobLebRcbRhbRjbRcbLebRcbLibRibRhb
LobLobLgbLobRcbRebRobRobLebRibLhbRebLgbLobRgbLcbLebLcbRebLebLebLobLgbL
ebRobLobLobRcbLobRgbLsbLobRcbLobLebRgbRebRebLsbRebLcbLsbLebLobRcbRebLo
bRebRcbLebLebRobLobLcbLebLobRsbLebLobRobLebLobRsbRebRcbLobRobRibRobLob
LobRgbLobLcbLibRobRhbLobRebRobLhbLebLobRobLebLobRebRobRobRebRobLebLibR
obRebRcbRcbLebRebRgbLobRcbRobRobLobLcbLibRobRobRcbRobLibLobLcbRibRebRg
bRjbRsbRobLsbRebRibRcbRobLobLgbLgbLobLobRcbRebLobRebRobLobLobRgbRcbRcb
RcbRhbLcbLcbLcbLebLcbLibRsbRebRobRobLobRcbRcbRobRebLobLobLgbLebLcbRcbR
cbLcbRobLebLebLgbLibLhbLcbLcbRcbLobRgbRibRibLgbRsbLebLcbRebLcbRebLcbLe
bLobRgbLebLobLobRobLobLsbRcbLebRobRobRebRcbLebLobLobLobLobLebRebRebLhb
RcbRsbLebRobRgbRgbLobLibLobLibLobLobRcbRobLcbRgbRobLebLebLobLobRebRgbL
gbRibRobRibRobRobLobLcbLobLsbLebLobRobLobLobRobRobLobLsbLobLebRobRcbRe
bRebRobLsbRebLebLobRebLobLcbRobRibLobRobRobLcbRebRgbRobLgbLobLgbRobLcb
RibLobLobLebLobRibRgbRobLobRobLobRebLibLobRebLobLobLobLobLobLebLebLebL
obLobRobLobRobRobLibLebRobRobRcbLgbRhbLobLhbLsbRibLebLsbLobLebRcbRebRo
bRibRgbRcbLebRebLobLcbLebLobLobLsbLobRebRebRibRobLobRsbRobRobRobRobRob
LhbRobRgbLgbRebLsbRobRebLobRobLebRebRobLcbRsbLobLgbLibLobRgbRobLibRgbR
obLobLobLobLgbLobLcbLsbLobRcbRobLibLobLcbRobLcbLobRgbRebRsbRobRebRsbLo
bLobRebLobRobRgbLobRobLobLobLcbRhbLcbLobLgbLhbRebRhbLebLobRebRebLobRob
LcbLebRobRobLobRobRobLobRobRcbRcbRcbLebLgbLobLsbRobRobLgbLobRobLobLobL
obLobRobLibLcbRobRgbLobLobLgbRebRobRobLebLebLobLgbLebRobLob

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 29; Drug: Control Apo 0.5 然
bReLsbLibLjbLoRsbLcbLoRsLsLsmbRsbRcbRibLjbRgbRsbRibLjLsmbLcbLcbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 30; Drug: Control Apo 0.5 然
bLobLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bLsbRcbRhLsbLobLsLsmbLcbLebLcbLsLsmbLgbLgbRsbLgRsbRsRsmbLgbLiRsbLcbRiL
sbReLsbRibLibLsbRobRcbRibLsbLsbRsbRcbRibLjbLobLcbLgbRibRjbRibLjbLibRib
RgbLgbRcbLibLsbLsbLjbRobRgbLibLsbRibRibRcbLibLjLsLsmmbRjbLoRsbLgbLhRsb
RgbLjbRgbLhbRjRsmbRibLsbRgbLibRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bRjbRibLobRsbRsbRcbReLcbRsbRgbRgLsbLsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bLsbRiRsmbLsbRibRcbLjbLgbLsbLsbRsbRsbLibRsbLsbLiLsbRsbLgbRsbLgLsbLsbLg
LsbRsbLgRsbRsbLgbLgbLebRsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bLgbRsRsLsRgmbRhLsbRibLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bLoRsbLgbLjbRsbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLgbLiLsLsmbLsLsmbLobRjbLibLcbLibRhbLiRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLcRsbLiRsbLcbRibLibRsbRsbRobLcRsbLhRsbLiRsbRobLgRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bsbLoRgbLibRhRsmbRcRsmbLsbLgRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLobLgbLgLsbLgbRibLobRsbRgbLobLibRiRsmbRsbRgbRhbRgbRsbRibLcbLsbLibLsbL
gbLgbLgbRibLgRsbLgbRibLgbLgbRsRsmbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bLsbsbRgbLibRgbRsbRsbRgbRsbLoLsmbRsbRsbRgbLsbLsbLobLcbLsbsbLsLsmbLoRsb
sbsbRoLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bLgbLsbLobRoRsmbRgbRsRsmbRgbRsbRsLsbRgbRgbLsbRgbRgbRgbLsRsRibRgbRsbRgb
RgbLsLsmbLsbLhbLgbLibLsbLjbLsbRsbsbLgbLsbRjbRcbLobRgbRsbRhbLibLjbLsbsb
Lsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bRibRibLibRibRsbRibLcbRgbRgbLibLcbRsbLsbRsbLcbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bLobRhbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRcbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181441; End: 181941;
Recording: 7-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bLcbLcbLoRgbLibLgbLgbLsRsbRsbLsRsbRsbRsbLsbLhb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 1; Drug: Control Apo 0.5 然
bLobLibRhbLsbRgbLcbLibRobRcbLebRjbRcbLebRobLibLobLsbLsbRibRobRobRcbLob
RobRgbRobLobLobLebRibLobLobRebLobRobRibLhbRebRgbRcbLcbLcbLebRobRcbLcbR
ibRcbLobLibRebRobRobLobLobRebLebRcbLgbLobLobLobRobLebLebRjbLcbLebLobLe
bRobRobLgbRobRibLibRsbLobRsbRebRebLobLcbLcbRsbRobRobLcbRebLgbRebLobRcb
LobRobLebLcbRebRobLobRebRgbRobRobRjbRobRobLcbLobRcbRibRobRebRobRebRcbL
gbRhbRcbLhbRgbLobLcbLebLebRebLobRjbLibRgbRibLobLcbRsbRobRgbLebLebRgbLe
bRobRcbRcbRebLobRebRibRobRibLobLebLobLobRobLgbRsbLcbRobRcbLibRgbRobLob
RobRobRebLobRobLebRobLhbLobRcbRcbLibRobLobRobRobLcbRsbLobLgbRobRgbLobR
obLobRebRobRgbRobLobLcbLobRibRobLibRebRebLgbLcbRobRobRjbLebRobRibLobRc
bLobLebLebLobRobLebLebRobRobLcbLebRobRebRjbLcbLgbRcbLebLsbRobRobRobLeb
RjbRcbLgbLsbRsbRebRobRsbRobLobLebRebRebLobLobRebLibRobRobLobLebLibRobR
sbLebRobLobRcbLebLobRhbLebLobLobLcbLobLcbRgbLebLcbLgbLebLobRobLebRsbRi
bLobRobRobLobLibRebRibLebLobRebRgbRebRibRcbLobRcbRgbRobRobRcbLcbLibRcb
RobLobRebLebRebLobRcbRobRjbRgbRobRobRobRebLcbLobRebRobLobRobLebLcbLgbL
cbLebLsbLobLebLobRsbLobLebLobRobLobLobLsbRebLebLobRsbRobRjbLobRsbRgbLe
bLobLebRgbLobRcbLgbLobLebRobLobRebLhbLebLebRebLcbRobRgbLcbRcbRcbLebLcb
LobLcbLebLobRibLhbRibLebRcbRobRsbLobLcbLobLcbLobLebRobLcbLgbLebRibRcbL
obRcbLobRobLobLsbLobRibRebLobRobLobRobRcbRcbLcbRobLobLobLcbLcbLhbRibLe
bRebRebLcbRcbRobLcbRcbRobRobRgbRobRebRsbRebRobLobLebLcbRcbLobLcbLsbLob
RobLcbRebLebLobLebRcbLibRobLobRibRgbLgbRebRcbRcbLibLobLebLcbLobRebRibR
ebRsbRgbLebRcbLobLebRsbLobLobRobRgbRebRebRebLibRobLebLjbRebLcbRibRobLe
bLibRgbLobLebLgbLobLobLobLcbLcbLibRebRobRobRebRobLebLobRobLobRibLobLob
LebRgbRcbRgbLgbRebRsbLebRobRobRobRebRebRgbLobRsbLobLobRebRobLcbLcbLibR
gbLgbRobLibLcbLobLobRobRebLhbRebRibRibRcbLobLobLibRibLibRcbRobRebRobLg
bLcbLobRebLcbLobRobLcbRobRibRobRebRebLobLebLobLebLsbLcbRobRgbRebLobLob
RcbLebRobRcbLgbRsbLcbLebRsbLebRobRebRebLobRobRibRobRebLobLobLebRobLobR
obRobRgbRibRebRobLobRcbLebRebRibLcbLibLgbRobLobRcbRobRgbLsbRgbRgbRobLs
bLgbLebLebLcbLobRobRibRhbRobLgbLgbRobRjbLobRibRobLebLibRcbRobRebRobRjb
RcbLobRobRobLcbLibRgbLibRibLebLobLobRebLcbRcbRebLobRobRobRobRhbRebLebL
obRobRcbRsbLobRobLhbRebRobRobRebRebRobRcbLobRebRobRobLibRebLebLebRobRo
bRobLhbLsbRebLobLobRebLobLcbRobLcbRibLebLebLebLebRgbLcbLgbLebRebRgbLhb
RobRobLobRcbLobLibLobLobRjbLibLcbRcbRebLebRsbRobLobLsbLobRebRobRobLcbL
cbRobRsbRebLobRobRibLgbRhbLebLgbLobRhbLobLobRobRcbLcbRobLsbLobLsbLebRe
bRcbLobRgbLcbRebRebLobRcbRsbLobLobLebLcbRcbLobRobRibLgbRobRobLobRcbLeb
LcbLcbLcbLobLcbLebRebLhbRebRcbLobRjbLcbRobRobLobLcbLsbRcbLobRebLebRgbR
obRcbLgbRobRobRobLgbLcbRebRobRobRobRebLobRebLhbRobLebLebLobRebRibLebRo
bRebRcbRobRebRebLobLgbLobLcbRobRgbRebRobLobRebRcbRebRgbRobLebRobRebRob
LebLibRobRgbRobRebLobLobRobRgbRgbRebLebLebLebLobRhbRebRobRibRobRibLcbR
obLebRobRsbLcbLebLcbRcbLibLhbRobRhbLobRobLibRobLgbLobLhbRobRibLsbLibLo
bLobLcbRobRgbRobLcbRhbRcbLibLobLibRsbRcbRebRobLobLcbLcbLebLsbLsbRcbReb
RcbRebRebRobLobRobLebRobRebRobRobRobRobLebRebRebLcbRibRobRobRebRsbLebL
ebRobRcbLcbRebLgbLebRibLobLebLcbRjbRcbLcbRobRebLobLobRibRgbLobLibRsbRo
bRobLsbRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 2; Drug: Control Apo 0.5 然
bRgLsbRgLsbLsbRcLsLsmbRoRsmbLsbLibLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 3; Drug: Control Apo 0.5 然
bRobsbRcbLiRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbsbRhbRgLsbRibLgLsbLsbsbRsbRoRoLsbLsbRsbRibRsbRiLsbLjLsmbLgRsbRgbLs
bLgbLsbLgbLsbLgbRsbRgbRhbRiLsbLcbLcRsbLcbLhbLibRgbLibLibLobLiRsRsmbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 5; Drug: Control Apo 0.5 然
bRcbRsbRiLsbLcbRcRsmbRcbLiRsbRsbLsbRcRsmbRcbRcbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 6; Drug: Control Apo 0.5 然
bLsLsmbRcbRobLobRjbLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLjbLjbRjbLgbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRsRsRsmmbLgbRgbLsbRobLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bRcbRcbLobLobRobLobLcbRobLebRsbLobLcbLobLsbRobRobLibLebRjbRobRebRobRob
RjbLobRobLcbRobRjbRobRgbLgbLebRebRobLobRobLobLebRgbRcbLsbLobRobRebRebL
ibLobRgbLobLebRhbLsbRgbLebLcbLcbRebRibRjbRjbRsbRobRcbRebRobRcbLobLebRe
bLobLebLobLebRobLcbLibRhbRobRobRobRobRebRobLobRebLgbRcbRobRebRebRobRjb
RobRobLebRobLcbRobRobRsbLebRibRjbRobLcbRcbRsbLobRhbLebRebLibRsbLebRjbR
obLobLgbLjbRebLcbRobLobRobLibLebRjbLebLebRcbRobRcbLsbRebRgbLobLjbLsbLo
bRobRcbLebLibLebLcbRebLgbRcbRebRobRobRcbLjbRsbLjbLebLebRebRjbRibLobRob
LobRcbRobRebLsbRobLebLcbLebRhbLobLebLhbLjbRebLebLebRobLobRobLebRobRjbR
obRgbLebRcbLibLobRebRebLcbRcbLcbRobLcbRjbLgbLcbLobRobLebRobRsbLcbRobRo
bLebLobRibLebRobRgbRebLobLobRibLjbLcbRebLobRgbRibLcbLobLobRcbRobLgbLib
RobRgbLobRobRobRobLobLsbRobRebRcbLobRcbLobLobRjbLebLgbRjbRobRobRcbRobR
ebLsbLjbLobLebRobRebRobLebLcbLebLebLobRcbRcbLcbLcbLebLibLjbRobLgbLobLo
bLcbRjbLobLobRebLibLobLobLobLcbLsbLobLobRobRebLcbRobRobRobLebLobLcbLob
LcbLcbRibRebRobRibLebLobRjbLebRobLebRobLebRebLjbLgbRebLcbLebRebLsbLebL
cbRebRobLobRcbLibRobLobLcbRobLobLibLcbLebLjbRcbRjbRibLobRgbLcbLebRobLg
bRebLebRjbRsbRcbLobLobRcbRcbLobRobRobRgbLcbRcbLebLobLebLcbRebLobLcbLob
LjbLcbRebLjbLobLobLobLobRibLibLobLjbRgbLsbLhbRjbLcbLsbLebRobLobRjbRobR
obRgbRobRobRobRcbRcbRcbRcbRcbLebRcbRcbLcbLibRobLobLcbLsbRobLhbLobLibRe
bLjbLobLobLcbLobLebLcbLobLobRebLobLobRobRobLibRcbLjbRobRsbLebRebRobLob
RebRcbRsbLjbLcbLobLebRibLobLobRobRjbRobRcbRobRobRobLobRobRobRobRobLobR
cbRobLobRibLhbRobLebRjbLcbLcbRobRibLjbLibLebRibLcbLobLobRebLobLjbRjbRj
bLcbRebRobLebLobRobRcbLcbRcbLcbRjbLebRcbLsbLobRjbRsbRebRebLobLjbLebLob
LcbLebRobRebLjbRibRsbRobLobLjbRjbRobRebRgbLobLjbRcbLsbRebLobRsbRjbRobR
gbLebLobLobLebRebRobLobRjbLobLobRobLcbRobRobLobRebRjbRobLcbRobLcbLebRo
bLjbRebLobLobRobRobLobLsbLibRibRebRobRsbLobRobRobRhbRcbRobRobLhbRebReb
LebRjbLsbLobRobRebRibRhbRcbLibLcbRobLebRebLebLjbLjbRebLebRgbRcbRibRobR
obLcbLhbRebRebRobLsbLsbLobRgbLobRobLobLobLobRcbLobRobRobRobLgbLebRebLc
bRobRcbLobRibLobLobRobLobLibRibRobRebLobRhbRibLgbLebLobLobLgbLobRebRob
LcbLcbLsbRobLebRobRcbRobLibLgbRobRebRobLibLebRobLebLobRebLibLobRobLebL
ibRgbRgbRebRsbRebLobLhbLobLgbLebRobRobRibLobLobRobLebRebLibRcbRobLcbRe
bLcbLsbRobLcbRebRsbLcbRcbRhbRhbRgbRcbLobRobLgbRobRcbRgbRobRibLobLobRob
LcbRebLobLcbRobLobRebRebRcbLgbLobRobRobLobRcbLcbRcbLobRobRebRobLobRobR
gbRibRobLebRobRibRebRobRibLobRobLjbRobLsbLebRobLebRebLsbLgbLcbLobRebLc
bLgbLebRibLobRcbRobLcbRgbLebRobRobLobLobRobRcbRobLobRobLobRcbLobRebLgb
RibLebLobRcbLebLobLsbLebRgbLebRobLobRebRobLebLcbLcbLobRcbRobRobRibRcbR
obLobLibRcbRebLibLobLebRebLebLobLobRobLobLobLobLebLibLobRhbRibRobLobRi
bRebRobLobLobLobRsbRcbLobRebRebLebRcbRebRobRobRobRebLebLobLobLibRcbLeb
LgbLcbRobLibRcbRebRobLsbLobLgbRobRgbLcbLobLcbRobLcbRhbRobRobLsbLgbLobR
ebRebRobLobRebRgbRobLsbLobRebRibLebLgbRebLcbRhbLobLebRebRobLcbLcbLcbLe
bRebLgbRobRcbRobRebLsbRobRcbRgbLobRobRibLobLebRebRebLcbRobLcbLcbRebLeb
LebLhbLibRobLobLobLobRobLobLibLgbRobLobLcbLebRibLebRcbLobLebLobLibRgbL
ebLgbRhbRobRobLebRcbLcbRobLobRibRobLebLcbRobRsbRobRibLibLobLebRobRobRe
bRcbLobLgbRebLebRebRobLcbLgbLibLobLsbLobRhbLsbLibLcbRobLobLebRcbLobLob
RebLobLibRcbLobLgbRobLebLsbRobLcbLobLsbLibLobLobRebRibRobRibRebLobLebL
obRobLobLobLibRgbLcbRcbLobLcbRebRobLsbLobRcbLebRebRobLobRcbRebRobLobRg
bLebLcbRcbLhbLebRobRcbRebRobRobRibRobRobLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bLgbLobLjbLgbLibRsbRiLsbLgLsbLsbLiRsbLoLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bLibLgbRsRsmbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bRcbRiLsbRgbRhbLobLibLcbLgLsbRsbLsbRsbRsbLibLiRsbLgbLhRsbRsbRgRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bRobRibLcRsRsmbLobsbRoLsbLobLgbLcRsbRjbRgbRiLsbLsbRsbLobLhbRiRsmbRcbRs
RibLjbLcbRsbRebRoLsbRibRcbRsRsmbRibRsbLsLjbRhbRsbRsbRibRsbRsbRibRgbRgb
RgRsRsmmbRsbRsRsmbRhLsbRiLsbRsbRsbRcbRiLsbRibRsbRsRsmbRsbRibRgbRsRsmbR
sRsRsmmbRgRsmbRsRsmbsbRsbRsbRiLsLsRsmbRgbRibLsRsbRgbRgbLcbRsRsmbRjbLob
RobRibRgbRsbLsbRjbRcLsbLsLsmbRibRgbRsbRsbRibRjbRcbLgLsLsmbRgbRgbRcbRgL
sbRsbRgbRsbRibRsbLgbRjbLsbLcbRsbLsLsLsmmbLgbLsbRgbLiLsbRsbRibRib

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLsLcRsRsmbLcbLibLebsbRebReRsmbLoLsmbLsbLsbRibLobLoLsmbLhbLibLobLibRsb
LiRsbRsbLibLsbLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bRibLobLob

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLoLsRsmbLsbLebRcbLjbLcbRsbLcbLcLgbLsbLjbLsbLgbLgbLsLsmbLsbLsRsbRebRgb
LibLsbRibLcbLjbLobRgLsbLebLibLibLgLsbLsbRcbRibLgbLjbLsbLhbLsbLgbRsbLgb
LcbLsbLcbRgRsRsmmbRsbLsbRibLobLgbLibLcLsmbLibLsbRsbRgbRsRsRsmmbRsRsmbR
sbRsbRsbRgbLsbRiLsbRobLsbRgbRsbRsbRsbRgbRsbLobRobLsbLjbRiRsmbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bLgbRcbRibRgbRsLsbRsbRiRsRsmmbRgRsmbRsbRgbRsbRsRcbRibLsbLsbLsRsbRcbLib
RgRsmbLsbLsbRobRgbRsbRsbRcLsbRibRgbRsbLsbRjRsmbRibRibRsbRsRsmbRgbRsRsm
bRibRcbRsbLsbLsbLgbLgRsbLgbLsbRsRsmbRsbsbLsbsbRsbLcbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bLiLsLsmbLiLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bRsLsbRgRsmbLsbLcbLsLsLsmmbLgbLsbLsbLsbLgbRsLsbLsbLsbLsbLsbLcLsmbLsbLs
bLsLsmbLcbLsbLgbLsbLcbRgbLsbLgLsbRobLsbRibRhbLiLsbLsbLsbRsbRsRsmbRsbLo
b

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bRjbLebLobLgbRsbRsbLsbRsbRsbRebLgbLsRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bRsbLobLcbLibRoLsbLhbRhbLcRsbRibRgbLsbLsLsmbRcbLgbLjbRibLsbRjbLibRsbRg
bLsbRcbLibRjbLeLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bRgbLhbLobLsbRoRsmbRoLsbRgbRhbRsbLibRcbLgbRsbRgLsbRsbRibRgbRsbLgbLsRsR
smbLgRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 25; Drug: Control Apo 0.5 然
bLhbLsbLgbRibLhLsbLjbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 26; Drug: Control Apo 0.5 然
bLhbLibLcRsbLoLsLsmmbLcbLibRsRsmbRsbLibLjbLoLsmbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 27; Drug: Control Apo 0.5 然
bRsbRgbRgbRibRsbRsbLgbLsbRsbLoLsRsmbLsbRjbRibRsbRgRsmbRsbRibLgLgbLjbRi
bLobLcbRgbLsRsbRsLjbLsRsbRibLsbRgbRsRobRjbRjbRjbRebRsbRibLcbRibLsbRcbL
hbLhRsbLgbRibLcbRibRjbRibLjbRhbLjbRcbRhbRgbRibRsbRibLgRsbRsbRgbLsbLsbR
iLsbRgbRsbRsbRjRsmbLsRsbsbLsLsmbLobRibLsbRsbRibRhbRcRsmbRsbRcbLsRsbRsb
RibLsbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 28; Drug: Control Apo 0.5 然
bRobRobRobRobLcbRcbRobRsbLcbLobLobRcbRobLobRobLobLobRobLcbLobLobLobRob
LcbLobRobRobRebRibRobLcbRgbLibRgbRcbRebLebRobLebRjbLcbLcbRobLsbLebRobR
gbLobRgbRcbLebRgbLgbRebRebRebLobRebRibLobRebRebRcbRebLobRcbLobLebLobLo
bRcbLgbRobLcbRebRibRebLcbRobRcbLobLobLsbRibLgbLebRcbRcbLebLobRhbLobRcb
LobLobLebLobRibLobRcbLebLhbLebLgbRobRobLobLcbRcbLobRcbLcbLobLgbLibLobL
obRebRgbRebLcbLibLebRcbLcbRgbLobLgbLsbLebRsbRobLebRobRobLobRobLsbLibLo
bLobRebRobRobLcbLcbRobLobRcbLobRebLobLebRcbLcbLcbRobRcbLcbLgbRebLobLeb
RgbRcbRobRibRgbRcbRobRobRobRobLobLhbLhbRsbLgbRhbRebRobRcbRobRcbLobLsbR
ebRebLgbLobRibRobRobLobLebLebRibRobRcbRobLhbRgbLobRibLobRebRobRcbRobRo
bRebRobRebLebRgbLhbRebLobLobLobLgbRsbLsbRobRobLobRsbLobLobLobRcbRebLib
RobLcbLebLobRcbRebRebRobRobLcbLobLebRobLebRcbLebLobRibRcbLobRibRgbRobR
hbRobLhbRebRebRobRebLgbLobLsbLibLgbRobLcbLebLobRebRobRcbRhbLibLebLibLi
bRobRgbRobLebLobLobLebRsbRobRgbRobRebLebLobLobRcbRobRobLcbRebLobRcbRob
RobRibLobLibRobRcbLobRcbRobLebRobRebLobLobLebLobRobLibRobRebLebLcbLebR
cbLobRobRjbLcbRcbLobLobRsbLebRobLcbRibLobRobRobRobLsbLobRobRobRhbRobRe
bLobRebRobLcbLgbLebLsbRobRhbLibRobLobRobLebRobLcbLcbLibRgbRobRgbLcbRgb
LcbRobRcbLibRcbRebLhbLcbLobLobLhbLobRebRibRobLebLobRibRobRibLobRobRobR
obLebLobRobLobRebRsbRebLobLobRobLibLhbRebRibRobRobRobLebLgbLebLebRebLo
bLgbRobLibLcbLsbLcbLcbRebRgbRcbRebLgbRebLobRobLgbRhbRobLebLebLibRobRgb
LobRgbLjbRibLgbLebLcbLobLobLobRebLcbLsbRebLobLgbLgbRebLobRebRebLobRebR
ebLobRhbLobRebRobRcbLebLibLcbLcbLobLibLcbRobRhbRcbLhbRebLibLobRobRcbLo
bLebRgbLhbRobLebRhbRgbLobLhbLobLobLebLobLhbLsbLebRgbRcbLgbRobLebLebLob
RobRgbRobRobLcbRobLebRobRibRebRebRebRobRcbLobRobRcbRebRebRobLgbRobLobL
ebRibLobLsbRobLobRibLcbRobRobLsbRobRobLcbRobRobRcbRebRobLcbLcbRibLsbRe
bLibLobRcbRebLgbLibLgbLobLobLcbRebRobRcbLcbLsbLobRebLebRcbLsbLebLobLeb
LobLsbLebRcbRobRsbRobLibRibRebLobLibRobRebRjbRobRobRebLobLobRibLcbLcbR
cbRobLobLibLobRobRebLebRobRebRsbLibRobLobRobRobRobRobRobLcbRcbLobRobLj
bLebLsbRcbRobRobLobLcbLobLobRobLibLobRibLobLibRcbRebRebLobRobLobRebLeb
LebRobLebLebRcbLobLobLobRobRhbLobRgbLcbRobRcbRgbLobLcbLebLcbRgbLcbLebR
obRobLgbLebRobLobRcbLcbRobLebRobLobLobRebLobRebRobLcbLebLcbRobRgbLobRc
bRibLsbRobRibRebRobRobRcbRcbLobRgbRcbRibRobLobRobLobRobRcbRibRibRibLcb
RobRcbRebLcbRobLibRibLsbLcbRibRebRibLobLjbRcbLobLebRobRibRgbLobRobRcbL
obRcbRibRobLcbRebLibLobRebLgbRgbLobRobLcbLibLjbRsbRebRcbLcbLgbRgbLgbLo
bRobLcbLcbLobRobLgbLcbRebRibRobLobRobLebLebLcbRcbLgbRgbRebRsbRebLobLcb
LebRsbRibLobRgbRobLgbLobRobLobLobRebLobLobRibRebLebRhbLcbRebRobLobLobR
cbRibLobLobLebLebRebLebRcbLobRibRcbLsbLobLhbLcbLgbRebLcbRcbRhbLgbRebLo
bRobLobRgbRobRebLcbLcbLobLibLobLobRsbLobLobLcbLibLebRsbLibRibLobRebLob
RobLobLobRebRcbLebRobRibLebLebRobLebRgbLebRebRobRcbLebLebRobLobLhbLobR
ebLgbLobRgbRobRobLobRobLebRcbLgbLgbLebRcbRobRgbRibLcbLsbRobLebLsbLgbRo
bLobLebLebRobLsbLgbLibRcbLgbRibRobLebLcbLobRebRebRobLobLobRobLobLobLob
LcbLibRgbLobLsbRsbLobRobLobLcbLibLobLcbLcbRibRebRgbLcbLhbLobLebRsbRebR
obRebRobLobLcbLebRgbRibLobLibLobLhbLobLgbLibLebRebRcbRcbRobRsbLobRjbLo
bLebLebLobRcbLibLobRgbLgbRebLcbRobRobLibLcbRcbLobRgbRobRebLcbLgbLcbLgb
LebLebLcbRcbRobReb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbLibRgbLjbRibLibRibRhbRsRsmbLsbLibLcbRcbLcbRsbRsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 30; Drug: Control Apo 0.5 然
bsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bRibRgbRibRcbLibRibRibRsLsbRgbsbRibLsbLsbLjbLcbLcbRcRsmbRgbRibLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bLgbRsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bLgbRgRsRsRgmmbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bLgbRjRsmbLsbRsRsmbLhbLobLsbLsbRoRsmbRgbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLibLibRgbRsLsbLcbRcbLgbLjbLjLsmbLcbLcbLjLsLsmmbLiRsbLcbLibLiLsbLiLsbL
ibLib

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLcbLcbLiLsbLcbLcbLcbLibRjbLhRsbRsbRoLsbLjbLibLibLjbLibLcbLjbLhbLibLhb
LgbRibLgLsbRsbRsbLibRcbLiLsbLibLgbLgbRcbLibRsbLjbLobLgbLcbRhbRibLcbLcR
sbLhbLcbLcbLibLhbLgbRibLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLcbLgbLobLcbLhbLjbRibRibRibLsbLsLsmbLsbRiRsmbRsbRgbRsbLebRobRhbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bLibRibLcbLibRgbLoRsbRsbLibLsbRsbRsbLibRgRsmbLhbRgbLhbRsbLsbLsLsmbLhbL
sbLsbLgLsbLsbLcbRgbRibLibLsbRgbRibRibLgbRibLsLgLsbRsbRcbRsLsbsbLsLsLsm
mbLgbRibLsbsbRoLsbRsbRibLiLsbLsbRhbRgbLcbLcbLsbLobRsRsmbRgbRgbRsbRsbRs
bRsbRcbLibRgbLibLgbRsRsRsmmbLhbsbRsbLgbLsbLsbLsbLsbLsbLiRsbLsbLsbLsbLg
bRsbRebRibLsLsmbRibLgbLjbLhbRsbRhLsbRgbRgbLjbLcbRgRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bLsbLsbRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bLibLibLibLgbsbsbRibRib

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bLgLsbRgbLgLsLsmbRgRsmbLsLsmbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bRob

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRgbRsbRsbLibRgLsLsmbRsbRobRibRebRibRsbsbRsbRsbLsRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 181943; End: 182443;
Recording: 8-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bLsbLsbRgbRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 1; Drug: Control Apo 0.5 然
bRsRsLsmbRsRsmbRgLsbLsRsbRiRsmbLgbLobLgbLsbLgbLibRobLsLgbLgRsbLsbRsbLh
bLgbLsLsmbLsbLgbLgRsbRsbLibLcbLgbRsbRgbLgbLhbLgbLgLsbLgbLsbLgbLsLgbRgb
LsbRcbRibRgbRgbLsbRgLsbRiRsmbRsLsbRsbRgbLsbRibLsbRibRibRsbRgbRsbRsbLjb
LgLsLsLgmbLgbRsLsLgLgLibLeLsbLsbLgbLsbLsbRibRsbRsbRgbRsbLjbLibLiRsbLgb
LsbLgbLsbLsbLsbLcbRjbRobLsLsmbLsbLsRsbRgbRsbRsbRsbRgbRsbRsbRgbRsbRgbRs
RsmbRgbRsbRgbRgbRgbRsbRgbRgRsmbRgbRgbRgRsmbRsbRgbRsbRgbRgbRgbRsbRgbRib
RibRsbLgRsbRsbLjbLgbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 2; Drug: Control Apo 0.5 然
bRsbLsbLgbLsbLsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 3; Drug: Control Apo 0.5 然
bRcbLsLsmbLgbLsbRgRsmbRcRsmbLgbLobRsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 4; Drug: Control Apo 0.5 然
bRibRsbRsbLsbLgbRsbLiLsbLibRoLsbLibLibRsbLgbLeLsbRsLsbLgRsbLgbLsbLsbLg
bRsbLsbLgbLsbLgbLgbRgRsmbLgbLgRsbLibLhbLobLgbLgbLgbLobLgLsbLgbLgbLgbRg
bLobLsbLibLgbRsbRsRsmbLgbLgbLiRsRhbLsRsbLgbRgbRebLgbLhRsbLsbLsLsmbLibL
cb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 5; Drug: Control Apo 0.5 然
bRiLsbLcbRgRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 6; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLjbRjLsbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRibLgbRgbLgbRgbLgbLibLsbLiRsbRcbRobRgbRibRibLibRsLsbRgbRhbRcbRibLgbLs
bLsLsmbRsRhbRobsbLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bRjbRsbLcbRiRsRsmmbLcRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bLcbLcbLcbRibRiRsmbRcbLsbLsLsmbLibLobLibLibLibLsbLcLsmbLibLibLhbLsLsmb
LebLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bRjbLsbLsbRebLcbLobRjbReb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bLoLsmbsbsbsbsbsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bRgbRsbsbRsRsmbRgbRgbLsbRgbRgbLobLibRsbRcbLibRjbRgbRsbLibLibLhbLibLibR
ibLhbLgbRjbRibLhbLibRcbLcbRcbRjLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bRsbsbLibRcbRgLsRsbLsbLsbLoRsbRsbRgbsbsbRebRoLsLsmbLgbRsRsmbRoLsLsmbLi
bLobRgbRsbRsbRsbRobRsbRsbLsbRsbLcbRsbRgRsmbRsbRcbLcLsmbLgbLibLsbLgbsbR
sLsbLsbLobLsRsbLsbRsbRsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bRjbLgLsLsmbLgbLgbLsbLsbLsbLibLiLsbLgbsbLgLsbLgbLsbRsbLgbLsbLgbLgbLsbL
gbLsbRobLcbLgbRcbLsLsmbLcRsbLsbLsbLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bLcbLjbLibRebRsbRhRsmbRhRsmbRsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bRsbRsbRsRsmbLsbLobRcbLsLsLsmmb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bRcbLgbLsbLsbRcbLsbRibLsbLsbRcbLsbRibLsbLsLgbLjLsmbLgbLcbLsLsmbLgbLsLs
mbRsbsbLcbLsLsLsmmbLsbLsbRjbRgRsmbLgbLgbRsLsbRiRsmbLgLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bLsLsLsLsmmmbLgbRsbLgbRsbRgbLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bRiLsbLsbRjbRobLcbLgbRibLsbLsbLobRgbRibRsLsbLsbRcbLsbRjbRibRcbRhRsmbLg
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bLobRsRsmbRgbRsRsmbRobLgLsbLsbLiLsbsbsbLgbsbRsRsmbLhbLgbRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 25; Drug: Control Apo 0.5 然
bLibLcLsmbRoRsRsmmbLsLcbLcbsbLcbLibLcbLhbRobRhbRcbLibLcbLjbLcbLcLsLsmm
bLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 26; Drug: Control Apo 0.5 然
bLobRibRcbLgbLsbLsbLibLiRsbLcRsbRgbRjbRsbRcbLoRsLsRsbRcbLsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 27; Drug: Control Apo 0.5 然
bLcLsmbLobRoLsbLcLsLsmmbRibRsbRibLibLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 28; Drug: Control Apo 0.5 然
bLibLebRobLobRsbRobRobRcbLcbRebLebRhbRebRebLobLgbLebLobLcbRobRebRcbReb
LobRebRobLibLobRsbLebLibRobLobRobRcbLhbRebLobLobRgbRobLebLebRibRibRgbL
gbLebRibLsbRebRibRebLebLcbRobRebRibLcbLcbRcbLcbRobLhbRibLobRobLebLebRe
bLobLhbLobRebLebLebRobLobRibRobRobLcbRcbRebLobLobRhbRgbLebLcbLibRcbRcb
RobLobRobRgbLibRgbLhbRobLobLgbRobRibRobRobRebRobLobLebLibLobLcbLcbLobL
obRobLcbRcbLobRebLobRebLcbLcbLobLobLobLibRcbLibRgbRhbLobLobLibRobRebLi
bRobRgbRobRsbRobRgbRebRobRgbLobRsbLhbLobRebLobRsbLebRobRobLebLhbLcbLob
RcbLobRibLebLebRibRobRobRobRobRobRibRgbRobLebRcbRobRebRobRcbLcbRobLgbR
gbRsbLobRobLibLebRibLobRobLibLcbLobRebRcbRobLcbLobRsbRibLobRobLsbRebRe
bRebRebLebRobRebRhbLobLibRobRibLebLobRobRobRibRgbLebLobRhbLebLgbLobRob
RobLgbRobRobRebRebLobRebLebLcbRobLebLobLebRobLibRebLcbLobRcbRcbRobRobR
gbLobLebRebRcbLebRibRcbLebRibLobRcbRebRcbRobRobLgbRsbRobLobRcbLobLsbRh
bLebRebLebRcbRobRobLcbRobRobRsbLebLobRobRhbRhbRobRobRobRibRobRobLebLob
LobLsbRcbLebLobLebLobRobLcbLobRobLobLobRibRebLcbRebRobRcbRibLobLhbRobR
ebLebRibRebRobLebLobLibLobRobRibRgbLobLobRcbLcbRsbLsbLebLcbLcbRobLcbLh
bRobRcbLebLebLebLcbRebRgbRobLebLebRebLobLcbRcbLobLobRobLebLobLsbRcbLeb
LebRebRsbLcbLcbLcbRsbRobLibRibLcbLobRebRebRobLobLobLcbLcbRobRsbLebLebR
obLobLobLjbLcbRibRebLebLobRsbRobLcbRcbLebLebLsbRcbRcbRgbRebLobRebRebLg
bRibRgbRcbLebLobRobLgbLgbLebLobLebLebLobRebLobRobRebRebLobRobRcbLebRcb
RibLobLcbLibLobLobRobRebRobRebRobLhbLobLsbRobLobLobRobRibLobLcbRebRcbR
obLgbLobLcbRobLobLobLcbLcbRebRobLebRobLcbRobRcbLebLobLobLgbLhbLobLebLo
bRibRobLobLebRebRobRobRebLebRcbLcbRobLcbLebLobLobRobLebRebLebRobLibLgb
RobRobRobLobLobLcbRobRgbLgbLobLgbRobRobRcbRcbRobLcbLobRobRebRcbRobLobR
obLobLobRcbRebRobLobLebLcbLobRobRibRibRobRobLcbLobLebRcbLebRebRobLjbLg
bLobRobLsbRobLobRcbLcbRebLcbLobRibRgbLebLsbRebLgbLibRibLebLgbLobRebLcb
RibLobRobRhbRobRobRibLcbRebLobRebRebRcbRobLcbRebRibLebRobLibRcbLebLobL
obRobRgbRobLebLibLibLcbLebLebRobRobRcbRebLibLgbRgbRebLsbRgbRobRibLcbRe
bLcbRhbRcbLobRibRcbRgbLcbRobLobLobLebRgbLobLibLebRibRgbLebRobRobLebLeb
LsbLebRobLcbRibLgbRobLobLobLcbLobRebLibLobRibRibRobLibRebRobRobLebRebR
ebLcbRgbRobLobRobRcbLgbRobLcbRebLgbLcbLgbRobRebLgbRcbLibLobLebLobRcbLo
bLobLibRhbRcbRobRobRebRebRebLibRcbRobLibLebRebLobRhbRcbLcbLcbLcbLsbLeb
RobRgbLcbLobLobLcbLibLobLobLobRobLebRcbLobRebLobRgbRobRgbLobLobRebRgbL
ebLobRcbLobLobRhbRobLobLsbLibRobRobLgbLobLobLobLgbLcbLobRobRobRjbLobRe
bLgbRebRobLsbRobLcbLibRobLobRebRobLebLobLobRcbRobLibLsbLobLgbRcbRibLhb
LebRcbLebLcbLcbRgbLcbRobLibRobRebLcbLhbLebLobLebRebRobRobLcbLcbRobLebR
obLcbRobLgbLobRobLcbRebRibRobLsbLobLobLobLobRgbLobLobLebLobLobRobLobLo
bLebLobRobLebLebLebLebRobRobRobLgbRcbRebRgbRobLobRebLgbRgbLobLebLgbRcb
LibLobLebLebLobLibRobRebLsbRobLgbRebLcbLobRebRibRobLebRobLobLgbRgbLcbR
obLjbRsbRibRobLobLobLobRibLgbRsbRobRobLobRjbRibLobRcbLebRgbRcbLobLebRo
bRobLobRobRobRebLsbLebRobRibLcbRobLobLcbLsbRsbLcbLobLobRobRobLobRobReb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 29; Drug: Control Apo 0.5 然
bsbLjbRjbLibLcbRcbLjbLcbLjbLibLebLibRcbLgbRhRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 30; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bLcbLibLiRsbRhbRgLsbLsbRhbLsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bRsbRjbRobLebRobLcbLobLebLsbRjbLjbRobRsbRobRebRjbLcbLobLsbRobRjbLcbLob
RobLsbRobLobRobRobLobRobLsbLebRsbLsbRebLebLcbRobLsbRjbLebRebRsbRobRobR
jbRobLjbRobLcbRobLebRobRcbLcbRsbLgbLjbRobRebLebRsbRjbLcbRebRobRobRcbLc
bLsbLobRcbLobRgbRebRebLebRsbRebRebRjbRobLobLobLcbRcbLgbRsbLobLjbRobRob
LobRsbRcbRobRsbLobRobRebRjbRjbLobLobRebLhbRobRsbRebLobRebLjbRebLcbReRs
mbRjbLobRebLcbLobLebRobRebRjbRobLebLobLobLjbLjbLobRcbLobRebRobLobLebLo
bLobRcbLebRcbLjbRebLobLsbLcbRebRobRebLcbRebRebRcbLobRobLobRcbLobLsbRjb
LebRobRebLobRobRjbRsbLsbRobRjbRcbLobLcbRjbRjbLjbRobLsbRobLsbRobLobLebL
jbLebRobLebRobRjbRjbLobLcbLobLjbRcbRcbRsbLobLsbRobLebLjbRebRsbLobLobRo
bRsbLobLjbLsbLebRobLsbRebLobRjbRjbRcbLobLsbRebLobRobLebLobRobRobLjbLcb
RebRobLobLebRobRebLsbRobLebLebLobLjbLjbRsbRebLobRebLobRoRobLobRgbRebRo
bLibRcbLebRjbRobLcbLsbLobLsbLobLebRebRjbRebLobLobLebRsbRebLsbLebLobRob
LobLobLobRcbLobRcbLebLobLobRjbLebRobLcbLobLobRobLobRobRobLebLcbRcbLcbR
cbRobRobLobLebRobLcbRgbLsbRobRobRobLobRgbLcbRobLsbLobRcbLibRebLobLjbLs
bRobRjbRcbRobLobLsbLobRsbRsbLebRobLobRobLebLcbLebRobLobLobLcbRgbRobLcb
RobRobLobLsbLcbLebLebLsbRobLjbRobLobLobRobLobRsbRcbRobLobRsbLcbLgbRjbL
gbRebLcbRobLgbRcbRobLebRobRobLibRobLebRobRobLsbLsbRsbLebRobLjbRobRibLo
bLobLebLobLobRebLobRebRcbRobLebRebLebRjbRobRibLobRcbRcbLcbLjbRgbRebLob
LobLobLcbRobLsbRjbLebLcbLjbRcbLsbRjbLobLobLcbLsbRobRobRobRjbRobLebRobR
obRobRobLobLobLebLobLobLobRebRobRobLibLgbRcbRibLobRobRobRobRobRebRobLe
bLgbLjbRobRcbRobLobLobRibLgbRobRcbLobRobLobLobLebLobRebLsbRcbLebLobRsb
LobLcbRcbLsbRobLjbLobRobRcbRobRcbLcbRsbLebRobRobRobRobRebLsbLcbRjbRobL
obRebLebRobLobLcbLobLcbRjbLobRgbRobLobRebRobLobLobLobRobRobLjbLobLebRo
bLobRobLsbLobRobLobLebLebLebLobRobRebLsbLobLobLobLobLjbRobLobRebLsbRob
LobRobRobRsbRobRobRcbRobRcbRebLebRobLsbRsbRobLebRobRgbLobRobLebRobLebR
obRobRebRgbLsbLsbRebLobRcbRsbLcbLobLhbRebLobLcbRobLobRobRcbLjbRibRobLo
bLgbLebLobLgbRebLobRcbRgbRobLibRobRobLebRgbRcbLcbLibLobRcbRibRibRebLob
RebLobLjbRebRibRcbRebRobRibRcbRobRsbRobLobLobLcbRobLobRibLibLsbLebRebL
obLgbRebLebLobLcbLsbLobRebLobLobLibRjbLobLobRobLebRcbRobRobLobRobRcbLo
bRcbLobLgbRebRibRobLebLobRebLcbRgbRgbRebLibLobLobLebRsbLgbLobLobRebRob
RcbLcbLobRibLebRibRibRgbLjbLsbLcbRcbRibLebLcbLebLibRibLobRcbLobLsbRhbR
ebRebLebLgbLebLobRobRcbRcbRhbRibLcbRebLebLjbLobRebLobRcbRobRcbRebLjbRe
bLgbLsbLobRobRcbLobLebLobRibLebLhbRobRobRgbRebLibRcbLcbRobLobRobRobRcb
LobLebRobRebLobLobLebLcbLobRcbRibRhbRebLebRobRobRobRobLibRebLebRebRobR
obLebRebRebRobRcbLobRobRsbRcbLebLibLebLebLibRcbLobLobLcbLjbRobRobLobRg
bLobRebRobLobRobRobLcbRobLcbRgbLebRobLibRebRobRsbRobLgbRebRobRsbLobRcb
RobRobRjbRebRobRobRjbRjbRobLobLcbRsbRobRebRobRcbLobLobRgbLobLobRhbRobL
gbRobRcbRjbLobRobRibRebLobRobLebLjbRjbRsbRsbLobRebLobLgbLgbLjbRsbRebLs
bRjbLobLebLobLjbRjbLobLebLebRjbRjbLobLsbRebRebRjbLobRjbLobLcbLebRjbRob
RobRjbRebLjbLcbRobRcbRobLobRobRcbRcbLobLhbRobRcbLjbRibLobRjbLgbRobLobL
obLobRobRobRobRebRobLobRcbRobLobRcbRobRjbRobLobLjbRobRebRobRcbRjbRgbLc
bLcbRobLobLobLebRcbRibLebRjbRobLebLobLjbRobLebLobLobLebRobRobLebRsbLeb
RebLebRobRebRjbLobLcbRobRcbLobLobLobRobLobRgbRebLjbRjbRobLebRebRobRjbL
obLebRebLebLebLebLebLebLobRobRjbLjbLjbRobRjbRebRcbLobRcbLsbLobRebRebLo
bLobLobLobLebLsbRcbLjbRjbLcbLobLobLebLebRjbRjbRobLobLsbRcbRjbLobLebLcb
LobLjbLjbRjbRebLobRobLebLebLcbRjbLobLsbRobLcbRobLcbRsbRebRebLobRjbRebL
jbLobLcbRobRobRobRcbRebLob

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bRebRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bRcbLsbLsRsbRsbLgbLgbRcRsmbRhRsmbLgbRgbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bLobLobRgbRgbRsRsmbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bRgbRiRsmbRgbLgLsbLgbLsbRibRibLgbRcRsmbLsLsLsmmbLibLibRgbLsbRgbLibLsLs
mb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bRgbRjRsRsmmb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLsbRibRsbLiLsbLgbLibLgbLibRobRgbRsbLoRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bRiLsbLsRsbRgbRsbRsbLiLsbLoRsbLsbLsLcbLjbRobRib

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bLoRsbsbsbsbRgbLsbRibLsbLcbLsbRgbLgLsbLgbLsbRsbLoLsmbRgbLsbRgbRgbLsLcb
LsbLcbLsbLsbLsbRsbLsbLibRgbLjbsbsbLsbLibLibLsbRgbRgbRsbLgbRcbLsbLibLib

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bLsLobRcbRgbRsLsRsbRsRsmbRsbRsbRsbRsbLhbRcbLsLsmbLcRsbLsbRgRsmbLsbRgbR
sbRsbRsRsmbRcbLcbLsLsmbLsLsmbLgLsbLcbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bLoRsbLsRsbRgbRsRsmbRoLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bRsbLsbRsRsLsmbLsLsRsLsmbLsbRsbRsLsbRsbRsLsRsbRsbRsbRsbRsbLsbRsRsLsmbL
sLsmbRsbRsbRsbLsbRsRsLsmbLsbRsbLsbRsbLsLsmbRsRsLsmbRsRsRsLsmmbRsbsbLsb
RsbRsbLsRsbRsRsmbLsRsbLsLsmbRsLsbRsbLsLsmbRsbLsbLsbLsbRsRsmbLsRsbRsLsR
sLsbLsLsmbRsbLsbRsbLsbRsbRsbRsbLsLsRsmbRsbLsLsLsmmbRsbRsbLsbRsLsRsbRsL
sbRsbLsRsbLsbRsbRsRsmbLsbRsbLsLsLsmmbLsLsLsmmbRsbLsRsbLsbLsLsmbLsRsbRs
LsbRsLsRsbLsRsbRsbLsbLsbRsbRsRsmbLsLsmbRsbLsbRsbLsbLsbLsbRsRsmbLsbLsRs
bsbLsbLsbLsbLsbLsbLsRsbLsRsbRsbRsbLsRsbRsRsmbRsLsRsbLsRsLsbRsLsbRsLsbR
sbRsLsbRsLsbRsLsbRsbRsbLsLsmbRsRsLsRsmbRsbsbRsRsmbRsRsLsmbLsRsbRsLsbLs
LsmbLsRsbRsLsbRsLsRsbLsbRsRsmbRsRsLsRsRsmmbLsbLsLsmbRsLsbLsLsmbLsbLsbR
sbLsbRsLsLsmbRsbRsbLsbRsRsmbRsbLsbRsbRsbLsbRsbRsLsbsbLsbLsbLsbRsbLsbLs
bRsbRsbRsbRsbRsLsRsbRsLsRsbRsbLsRsbLsbRsbLsbLsLsmbRsbRsbRsLsbRsbLobLsR
sbRsbRsRsmbRsbLsbRsRsmbRsbLsbRsbRsbRsLsbRsRsmbLsbRsLsbLsbLsRsbLsbRsbRs
RsLsLsmmbRsRsmbRsRsmbLsbRsbRsbLsbRsbRsLsbRsRsmbRsRsRsmmbLsbLsLsmbRsRsm
bRsbLsbLsbRsbRsLsbLsbRsRsLsmbRsbLsbRsbLobRsLsbRsLsbLsbRsbRsRsLsmbLsLsm
bRsbRebLsbRsbLsbRsbLsbRsbLsbRoLsbRsbRsbLsbLsLsmbRjbRobRsLsbRsLsbLsbLsb
RsbLobRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbLsbRsbRsbLsbLsbRsLsbRsbRsbLsbLcbRs
bLjbLsbRsbLsbLsLsmbRsbRobLebLsbLsbLsbLsbRsRsmbRsbLobLobLsbLsbLsbRsbLob
LsRsbRsbRsbLsbRsbLsbLsbLsbLjbRoLsbLcbRsbLcbRjbRsbLsbRsbLjbRobLobRsbLsb
LobRsbLsbRsbRebRsbRsLsbLsbRsbRsbRsbRsbRsbLjbRsbLsbRsbRobRobRsbLsbRsbLo
bRsbLsbRsbLsbRsbLjbRobRsbLsbLsbLsbLsbLebRsLsbRsbRsbRsLsbRobLsLsmbLsbRs
bRobLsbRsbRobRebRsLsbRjbRsbLsbRsbLjbRsbLjbLsbLsbRsbRsbLsbLsbRsbRsbLsbR
sbLsbLsbLsbRebLsLsmbLsbRsbRsbLcbRsbLobLsbLsbLsbLsbLobRsRsmbLsbLgbRsbLs
bRsbLsbLsbLsbRsbLsbRgRsLsmbRsbRsbLsbLsbLsbLsbRsbLobRsbLsbLsbRsRsLsRsmb
LsbRsbLgbRebRsbLsbRsRobRsLsbLsbLobRsbRsbLsbRsbRsbRsbRsbLsbRsbLsbRsLsLo
bRsbLobRsbRsbRsbRobRsbRobRobLsRsbLobRcRsmbLsbLsbRsbRjbLsRsbLsbLsbRobLs
bRsRsmbLsbLsbRobLobLobRsbLebRsbLsbLsRsRsmbLobRebLebRebLsbRsbRsbRebRobL
sLsmbRsbRjbLebRsLebLsbLsLsmbRobRobRsbRsbRebRsbLebLobRsbRsbLsbRgbLsbRsb
LebLsbRsbLgbRsbRobRsbRjbLsLsmbRjbLebRobLcbLsbRjbRobLjbRobRebLibLsbLobR
ebLjbRebRebRobRsbRebRebLobRebLobLobLsbRsbRsbLobRsbRgbLsbRsbRgbRsbRsbRs
bLsbRebRsbRsbRsbRsbRsbLsbRobLobRsbLsbLsbLsbRsbLsbLsLsmbRsbRsbRsbRsbLsb
RsbRobLebRsbLsbRobRsbRobRsbRgbLsbLobRgbLsbRsbRsbLsLebLebLsbRsbRsbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bLebLob

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bLsRsbRsbRsbRsRsLsmbRsbRgbRsRsmbRsLsbLobRibLobRcbRgbRgRsmbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182444; End: 182944;
Recording: 9-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bRsRsmbLsRsRsmbRsLjbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 1; Drug: Control Apo 0.5 然
bRcbRgRsmbLsbRsbLjbRgRsmbRsbRsbRgbRsbRsbRsbRibRsbRsRsmbRsbRgbRgbLgbRob
LgbLsRsbRcbRibRibRsbRsbRgbRgbLsbRgbLjbRgbRjbLcbLibRjbLjbRjbLjbLibLsbLi
bRgbRcbRibRgbLsbLsbRgRsmbRsbLjbLgbLibRebLjbLgbRibLjbRjbRibLsbLcbLiRsbR
jbRibLibRjbLjbRcLsbLsbLcbLgbRsbLgbRhbLcbRibLcbRjbRibLsRibLjbLcRsbRjLsb
LibRjbLgbRsLsLsmbLgbLsLsmbRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 2; Drug: Control Apo 0.5 然
bRgbRsbLjbLsbLsbRsbLsbLsbLsbLsbLebRsbRebLobLobRobRsbLsbRsbRsbLsbRsbRob
RsbLsbLsbLjbLsbLsbLjbRsbLsbLsbRsbRjbRsbLebLobRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 3; Drug: Control Apo 0.5 然
bRsbRjbRgbRsbLgbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 4; Drug: Control Apo 0.5 然
bRiRsmbRsbLcbLibRcbLobLgbLhbRjbRibRgbRsbRgbRjbRobLgRsbLgbLgbLibLibRsbR
gbRcbLibLibRjbRcbRobLgbLgbLsbRibRgbLjbRsbRgbRiLsbLjbRsbRgbLgbLibRjbRgR
smbLibLsbLgbLibLobRibLsbLsbLibRgbLgbLsbLibLibLsbLsbLgbLgbRsRgbLgbRobLi
bLgbLgbLsbRgbLgbLgbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 5; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 6; Drug: Control Apo 0.5 然
bLjbLgbRgbLgbRobLebLgbRsbRsbLjbLsbRgbLibRjbRebRibRebRgbLjbLsbLsbLibLsb
LibRgbRjbRsbRibLsbRjbLgbRjbRsbLjbRgbLebRjbRsbLebRjbLgbRjbRsbRgbRibRibR
obRjbRsbLgbRjbRsbRjbRsbLsbRgbLjbLsbRsbLgbLibLjbLibLibRjbLibLjbRjbLebLj
bRjbRobRgbRsbLibLibRgbLobRsbRebRibRibLsbLsbRjbRjbLobLsbRjbRsbLobLjbRsb
LjbRjbRsbLsbLjbRsbRgbRsbRsbLjbLobLjbLjbRgbRjbLsbLjbLjbLjbLebLobRsbRsbR
jbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLcbRcbLjbRsbRibRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRobRibLsbLsbRsbLsbRiRsLsmbLjbLibRsbRibRiLsbLibLibRobLcbLsbRjLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bRobLobLsbRebRobRgbLobRobRobRobRobRobRebRsbLebLcbRobRobLcbRobRobRebRcb
LobLjbRgbRobRebLsbLhbRgbRobRjbRcbRobRsbRebLobRobRgbRebLobLcbRcbRsbRibR
obLobRobRobRsbLcbRebRsbLjbLibRebLcbLebLebLjbRebLobLcbRebLobRobRobRebRe
bLobRebRebLebRcbRobRebLobLebLobLobLobRcbRhbRibRobLobLebRcbLobLcbLjbRcb
RebLebRibRobRobRebRobRebLobLgbLibLebRobLcbRibRobRibRobRobLobRobLobLobL
ibLobLebRebRobLgbLcbLebLcbLhbLobLibRebRobRebLobLobLobRobRobLobLobLgbLo
bLobLibLsbLobLsbRobLebLobLobLobRebRhbLobRebLobLebLebLsbRebRobLcbRobLeb
RcbLebLebLgbLcbRobRjbLobRcbLcbRobLobRebLobLobLobRebLcbRebRcbLebLobRobL
gbRcbRobRobRebRibLcbRhbLcbLebRebRobRobRcbRobRcbLobLobRcbLjbLibRebLobRh
bLobLebRebRobLebRcbRgbLjbRobRobRobRcbLobLcbLobRobRebRobRebRsbLibLobRcb
RgbLsbRebLcbLcbLebRsbLcbLobRebRobRebLobLibLobRjbLebLcbRobLcbLobRobLebL
cbLebRcbRebRobLebLebRobRibRobRobLebRebLobRebRgbRobLcbLcbLobRibLcbRebLo
bRobLsbLebRcbLobRobRgbRobRobLgbLjbRobLibRebLgbRibLebLebLobRgbRebLebRob
LobRobRhbLobRebLebLobRobRobLebLobLcbLobRobLobLobRgbRobLobRobLobRebLibL
cbLobLcbLebLjbLobRobRgbLobLobLobLobLcbRobRjbLgbRobRibLobLgbRibRebRobLo
bLebRobRgbRobRcbLcbRobRobLobLobLobLobLobRobLebLobLsbRibLobLebRobRobReb
LcbRsbRobRebRobRhbLebRebRcbRebRobLgbRcbRcbLibRobLebRobRcbRebLobRebLobL
ebLcbRgbRobLebLcbRobLobRebLobLcbRebRobRcbRobLobRcbRobLebRebLebLibRobRe
bRgbLcbRobRgbRcbRobLgbRibRebRobLobLobRobLebLobLsbRgbLobRebLibRobLsbRib
LobRobLebRobRobRobRcbLcbRobRcbRobRibRgbLebRibRobRcbLcbLcbRebRobLebRobL
cbLcbLcbRgbLobRibLebLsbRebRobRobRcbLobLsbRobRcbLobLobRsbLgbLobLebRibRo
bRobRobRobRibLsbRobRcbLobLibRibLsbLcbRgbRobRobRcbRgbRgbLobLcbLhbRobRob
RgbRsbLebRobLobRcbLobLibLobRebLebRobRcbLcbLobRgbLebRgbRobRgbRobLebLobL
obRcbRebRgbLcbLobLobLobLobRobRibRebRobLebLhbLobRobLebRebLobLobRobLobLh
bRcbLibLobRobRibRibRebLhbRebLobRebLcbRobRgbRebRobRebRobRobLcbRobLebRob
RhbLobLobLcbLcbLcbLhbLobLobLobRgbRcbLebRebRebLobRobRobLebRsbLobRobLebR
obRobLcbLobLobLobRibLgbLibRobLebLebRobLobLcbLcbLobLobRebRcbLsbLebLibLi
bRobRebRsbLebLobRebRgbRobRobLebLcbRebLebRebRsbRobRgbLobRebLcbLobRobLob
LcbLcbRibRobRobLebRcbRebRobLobRgbRobRebLobLobLibRcbLobRebRobLobRgbRsbL
cbLibRobLcbLobLobLhbLibLcbRcbLebRobRobLibLcbRcbLcbRobLebLcbRobRobRebRs
bLobLobLibRgbRebRebRebRgbLgbLebRobLsbRcbRcbRcbLcbLobLobRibRibLobLobLob
RibLcbLobRcbRobRcbRibLgbLibLsbRobLobLebLgbLebRcbLebRebRobRcbRobRebRobR
obRebRcbLgbLcbRebRgbRcbRobLobRsbRcbRebLebLcbRobLebRebRebLebLcbRebLebRo
bLcbLebLobRcbRcbLebRcbLcbRobRobLobRcbRebLcbLebRibRobRebLebRebRebLobLhb
RebLibRibLebLcbRibLibRobLjbLebLobRcbLgbLobRibRobRobRibRebRibLibRobLibL
obRobLobRcbLobRobRibRebRebLibRcbRhbRebLebLcbRobLgbLobRobRobRibRobRsbRh
bLebRsbLebLgbRobRobLgbRcbRobLobRobLobRebRcbRebRebLobRebRebLibLebRebRcb
RcbRibLobLibRobLebLcbRgbRobLebRobLcbLebLobRcbLgbLobLsbLobRobRsbLobLobR
cbLobRebRsbRcbRobRobRebRibLsbRobRobRhbLobLobRobLebRcbLebRebLobRebRhbLc
bLebLobRebRebRobLebRobRcbRgbLebLcbLcbLobRobRobRebLebLibLobRibRebRgbRcb
RobRobRgbRobLobLobLobRcbLgbRebRobLobRgbRcbLgbRobLobLcbLcbLcbRobRsbLcbL
gbRcbRgbRobRobLobLobRobRobRcbRobRebRobRobRobLobLobLjbLcbLebLcbLcbLcbLc
bLobLebRebRebLsbLobLobLebLcbLobRobRebLobLgbRibLcbLcbRibRob

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bLcRsbLgRsbLsbLgbRcbLjbLgbLibLibLhbLgbRsbRibRsbRibRsbRgbLsbLibLibRjbLi
bLgbRjbLgbLibLibRsbRsbLibRgbLgbLgbLgbRsbLsLsmbLgbLsLsmbLgbLgRsbRsLsbLg
bLgRsbLjbLcRsLsbRibLsbRsRhbRcbLsbLsbRsbRgbRibLgbLjbRibRcbLgbRibLcLsmbL
sbLibRcRsmbLjbLibRjbLiLsbLsbLsbLgbLsbLgbRsRsmbLhbLcbLiRsbLhbLibRsRsmbL
ibLgbLhbLibLgbLsLsmbRcRsmbLiRsbRjbRcbLjbLibRjbLibsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bLsbRgbLobLoLsmbLsRsbRsbRgbRobLgbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bLiRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bRoLsbLobLibLobLjLsLsmmbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLibLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bLobRgbRjbLgbRcbLjbRgbRgbRsbRsbLgbRobRgLsbRgbLsLsmbLsbLsbLsbLsLsRsmbLo
bRgbRgLsbLsRsbRsbLobLsbLcLsmbLsLsmbRsRsmbLobRsRsmbRsbRgbRsbsbLgbLgbRjR
smbLjbLjbRobLjbLgbsbRobLibLhbRgbRjRsmbLjbLjbLjbRsLsbLoRsbRibRgbLcbLcbR
sbRsbLgbRoLsbLsbLjbRgbRgbRgbRgLsbRsRsmbLsLsmbLsbLcbLhRsbRsbRsbRsbLsbLi
bRgLsbLgbRsRsmbsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLebLobLobRcbLhbRobRobLebLobRsbLebRibRsbLcbLgbLebLebRobRhbRobRobRobRgb
LhbRcbLobLebLobLebLobRhbLgbRsbLobLibLsbLebRibLobRobLobRebRobRcbLebLobR
cbLobLobRobLobRsbRhbLcbLobLebLcbLebLebRebLhbRhbLibRcbRebLebLebRobLebLc
bRebRjbLebRebRibRebRobLibRebRcbRebLobRcbLebRcbRobRobRcbRobRebLhbRcbRsb
RobLebLebRobRebLobLobRobRgbRjbRebRobLobLsbLcbLobRobRebRobLebLebRcbLcbR
sbRobRebRobRebRobRgbLebRebLobRobRebLobRebLgbRebRcbRsbRsbRcbRebRebLobLo
bRjbRebLcbLobLebRobLobRcbRcbRobLibLobRcbRobLebLcbRebLobLsbRcbLobRebLjb
LibRobLcbLebRebRcbRobLobRgbRgbRobLobRcbRobLebRobLebRebLcbRebLsbLobRebL
cbLobRcbLobRgbRobLobRobLebLebRjbRobRobRibLebLobLhbRobRobRsbRebRobRobLo
bLibRobLgbLobRibLcbRibRobLcbLobRebLebRebLebRibRobLcbRebRibRcbRobLebLob
RibLcbRebLobRobLobLcbRebRgbRobLobRobRobLebRibLibRebRobLobLobLhbLobRcbL
jbRibRobRebLebLibRobLsbRcbLebRobLcbRobRibRobRobLcbLobLjbLobLgbRebLebLo
bLobLobRebLebRebLebRobLobLobLcbRgbRcbRobRebLobRebLobRobRebLibLcbRjbRib
RobRcbLebRebRebLobRibLobLebLobRgbLibLobLibLebRibRcbLebLcbRobRcbLjbRobR
ebRobLjbLgbLcbLobLobRebRobLebRobRobLobLcbLgbLobRsbRibLsbLebRobRcbLcbRe
bRgbLebRsbRobLobLebLcbLsbLobRcbLcbLobRobRibRcbLebLcbLobRgbLibLsbLebLob
RcbLobRebLgbRcbRhbLebLsbRhbRobRcbRcbLsbRgbLobRobRobLobRibLebRebLsbRobR
ebRobLebRcbRobRebLebRcbRebLebLobLsbRsbRebLobRebLobLobRobLcbRobRobLebLo
bRobRobRobRebRebRobRobRobLobLobRobLobLsbLgbLebRebLgbLebLobLobLhbLobReb
RcbRcbLebLobRobRjbRobRebRobRobLobRgbRebRebRobLcbLebRobRgbRgbRebRobRobL
obRobLgbRobRobRcbLebLobRcbRhbLobRebLobRobRobLebLebLobLobLobRobRebRebRo
bRebRgbLobRobRobLjbRebRcbRebLobLcbRcbRobRebRebRsbRebRibRibRibRcbLgbRob
LsbLcbLobRibLebLobLobLgbLebLobLobRobRebLobLobRgbRebRobRcbRibLebLsbRobR
ebLebLobRobRgbLebLobLjbRibLebLobRebLobRcbRebRibRobLebRobLsbLcbRebLobRo
bRsbLobLobRgbLobRjbLibRebLsbLcbRobLibLsbRobRobLebLcbRobRibLcbLebRjbLob
RebLcbRobLebRobLibRobLobRcbRobRebLgbRgbLcbRobLebRibRebLobLsbLebLobRibR
obRsbLebRebRobRobLobLebLobLobRobLobRebLjbRebRgbRcbRebRobLcbLjbLcbLcbRe
bRobLsbLobLcbRebLebRobRibRobRgbRgbRebLsbRgbRebLgbLobLobLobRobRgbLobLob
RebLcbRibLcbLgbRebLebRsbLobRobLobLobRgbLebLobLobRebLibRobLsbRgbRcbRibL
obLobLcbRgbLebRobRobLobRobLebRgbRebLobLsbLobLobRebRobLcbLibRcbLgbRobLh
bRgbLibRobRobRgbRebRcbRebRebLebRobLobRcbLebRebRobRebRcbLcbLebLgbLsbRob
RobLebLebLobRcbRhbLobLcbLcbRcbRibRibLsbRgbRobLobLobLcbLibLebLebRobLgbR
ebRobLebRhbLobLcbRibLcbLobLobRibLobRobLjbRcbRcbRcbRibLcbLibRobLobLebLe
bLebRobLcbRibRebLobRibRobLebLsbRebLebLibLobRobLebRobLobLobRibRobRcbRob
RobRobLibLobLobLobLobRebLebRobLebLobLibRobLebLobLcbRobRhbLcbRgbRobRobL
obRibRcbRibLobRebRobRcbRibRobLjbLsbRebLgbRgbRhbLsbRobRebLobRebRebLcbLc
bLobLobRcbRobLebLebRsbLcbLebRebRobRcbLobRibRibLobRobLgbLcbRcbLebRibReb
RebRgbRibRobLobRjbLobLibRebLobRcbRcbLobRobLibLobRebRibLgbRebLobLibLhbR
obRobRebLobRebLobRebRobRobLcbLgbLobLobRobLebRebRobLobLebRebLobLebRebRc
bRebLobRcbLgbRebRcbRcbLobRobLgbRobLcbRobLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bRsbRsbLebRcRsmbLsLsmbRjbRgRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bLgLsLsmbLsbLsLsmbRsLsLjbRsbLsbLsbLsLsmbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bRsRsmbRsRsmbLsRsbLgbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bRsbLobLcbRsbRsLsbRibLsbRsbRiLsbLsbRibLgLsbLsbLsbRhbLibRsLsbRcbRsbLgbR
sLsbLsbLsbLsLsmbLoLsmbRgbRgbLsbLsbRibRgLsbRibLsLsmbRgbLebLibRjbLibRsbL
gLsbLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bRibRobLebLjbRebLebRebRjbRebLjbRjbReb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 25; Drug: Control Apo 0.5 然
bRcbLcbRhbRobRjbRcbRgbRcbRsbRibLgbLiRsbRsbLgbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 26; Drug: Control Apo 0.5 然
bLcbRcRsmbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 27; Drug: Control Apo 0.5 然
bRcbRobRgRcRgLsbRibRibRibRsbLsbRhRsmbRobsbRobLoLsmbRjbRcbRcLsbRsbLhRsb
LsLgLsbLsbRobLcbRsRsmbRibRobRsbRcbRibRibRsbLsLsmbLsbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 28; Drug: Control Apo 0.5 然
bLobRobLobRobLcbLobLobLebLibRcbRobLcbRsbRcbLobLobRobRebLcbRobLobLgbRcb
RobRobLgbLgbRobRobLebRobRsbLebLobLobLebLobRobLobLobRhbRobRebLcbRcbLebL
obRebRibRsbLobRobLjbLcbLobRebLobLcbRibRsbRebLebRjbLobRebLebLcbRcbRibLo
bRgbRobRebLobRobRcbRobRcbRibRobRobRebRibRebLebLcbRjbLobLebRgbLebRobLob
RobRobLobLobLebLobRobLsbRobLobLcbRobLcbLobRebRcbRobRobLcbRcbRobLebRebR
obRibRobLebLobLibLibLgbLobLobLobRebLcbLibRcbLobRebRgbLebRobRobLobLobRo
bRibRobRebRebLobRcbLobLobRhbRobRobRebRebLibLobRgbRibLobRobLobRhbRjbRib
LhbRobRobRebLibRobLgbRobRjbRgbLobLcbRobRebRcbLgbRgbLobRobRobRobLcbLobL
cbRobLebLobRobRgbRhbLebRobLebRebRebLcbRebRobLobLcbRobRebRsbLobRobLebLi
bRobRcbRcbLobRobRobRcbLobRcbRobLcbRcbRebLobLcbLebLobLobLibRobRobRcbLob
RobLobRcbRibLgbRobRgbLebLsbRobLcbRobLsbLobRcbLcbRcbLobLobLebLobLcbLsbL
obLibRcbRobLebLobLgbRobLebRobLebRobRebLebRobLgbRobLcbRebLibRgbLobLcbLc
bRobLcbRobLibLobLobRcbLobLobLcbRebLobLobRobLebLibLobLebLobRcbRcbRebReb
LebLobRobLobLcbLobRobRobLcbRebLcbRibLebRebLobLobRebRobLobRebRobLobLcbL
obRobLobLibRobRgbRobLobLobLcbRcbLhbRebRobRebLobRgbLcbRobLhbLcbLgbLgbRe
bLibLobLsbRcbRebRobLsbRobRobRobRibLjbLobRgbRibLobLibRgbRcbRebRibLobLcb
LobLsbLcbLcbRcbRibLebLcbRobLobRebRgbRobRobLobRobLgbLgbRobRgbLcbLobRebL
obRibRibLobRobRebRebRgbLobRebRobRgbLebLobRebRobLebRcbRcbRibRobLcbRobRg
bRobLobRcbLcbLcbRcbRebRobRebLobLebLibRibRobRcbLcbLobLibRobRobLibRebRob
LgbRcbLebLcbLobRobRobRobRgbLobRobRcbLcbRobLebRcbRibLobLcbRibRebRebLgbR
obRebRcbRobRobRhbRgbRibRobLobLcbLcbRobRsbRcbRobLobLobRebLebLobRcbRobLo
bRsbLobLibLcbRebRcbRobRsbLobLebRjbLibLobLobLobRcbLcbRebRebLebLobLebLcb
RobRebLobRcbLcbLsbLobRebLebRebRhbLobRobLobLebRebRobLgbRibRebRgbRobRobL
ebRibLgbLcbRebLobLcbRcbRobRobLcbLgbRobRobLcbLobLebRebLcbLobRcbRebLobLo
bRebRobLcbRobRcbRobRebRebRebRebRobRobLobLcbRobLibLebLobRobLobRibRobRob
LobRobLebRcbLcbRibRsbLebLebRcbRobRebLebRebRcbLebRobLcbLobRibLcbLobRobR
gbRobLobLobLcbLebRobRobRobRobLhbLobRcbRobLcbLebRobRobRcbRobLebLobLcbRc
bLhbRsbLobLobRgbLobLebLcbLobLobRobRibRcbRgbRebLobLcbRgbRcbRebLebRobRob
RobRcbLibRobLsbLobRobRebRgbLobRobLcbRhbRebLibRobRobLibLobLgbRcbLobRgbL
ebRsbLebRebRobLibRgbLebRcbRibLcbRcbLebLebLcbRcbLobLcbLebRebLebLebLobLc
bLobLhbRobLobLgbLobLcbRgbRhbRebRsbRebLebRobRibRsbRobLobLcbLobRibLcbRob
LebLobLcbRobRibLobRobLhbLobRcbLibLebLibRebLibRobRebRebLibLobRcbLobLebL
ebRebRobRcbRcbRsbRebRibRobRgbLcbLobLobLsbRcbRebLcbLgbRobLebRobRebLebRo
bLcbLebRebRobLobRobLobRobLobRsbRcbLobLobRobLgbRebRcbLobLebLibRebRobLeb
RobRibRobLobRebLebRebRebRebLcbRcbRebLebRcbRebLobRebRobRebLobLcbLobRcbR
obRebLobRobLebRcbRsbLibLgbRcbRgbRsbRjbLebLobRsbLcbRgbRcbLobRobRobLobLo
bLobLobLebLebRibRobLcbRibRebLebRobRcbRobLcbRsbRsbRjbRcbRibRobLsbRobLob
RobLobRcbLebLcbLcbLobLobLhbLobRsbRobLebLsbLobRobRcbRobLjbRebLcbLcbLibR
obRcbRobLebRebLsbLobLgbRsbLebRobRgbRcbLobRcbRebRobLcbLhbLcbRebLgbRobRo
bRobRobRsbRebLcbLebLgbRjbRebLobRobLgbRsbRobLobLobLibRcbLebLgbRobRobRob
LjbRcbRebRebRibRgbLebRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 29; Drug: Control Apo 0.5 然
bLcbLjbLibLibLsbLcbLgbLibLjLsmbLiLsbLibRcbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 30; Drug: Control Apo 0.5 然
bLsbLsbRsLsbsbsbRgLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bRsbRsRib

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bLibRob

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bRsbRibLjbRsbRsbRsbLgbLsbRcbRebRjbLebLgbRobRgbLjbLsbLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bRibRibRibRgbRsbLsbRobLob

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bRobRiRsmbRjbLibRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLgbRgbLgbLsLsmbRsbLsbLobRsbLsbLsbLsbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLibLib

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLibLjbRsbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bRgbLsbLsbLjLsmbLsbLgLsbLsbRsbRsbLcRsbLsbLsbLsLsmbLsbLsbLgbLsLsmbLsLsm
bsbLsbLsLsmbLibRhbLsbLsbsbRcbRibLsLsmbLsLsmbLsbRjbRgbsbLgbLsbRibLsbsbL
cbLjRsRsmbLsbsbLcRcbRgRsmbLsbRsRsmbsbRsLsbRsbRgRgbLobRgbRjbLibLsbsbLsb
LsbLsbsbRibRgbLgbRiLsbLsbLoRsbLgbLcbRsbRsLsbRgbLgbRsbLibLiLsbLiLsbRsbR
sRsmbRsbRsbLsbRgbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bsbLcRsbRsRsmbLsbLiRsRsmbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bLebRibRobLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bLsbRcLsbLobRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bLsLsmbLibRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bReb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRsRsRsmmbRsLsbRsbRsbRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 182946; End: 183446;
Recording: 10-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bRibRsbLibRobLsbLgbLibLcbLgbRibRcbLgbRoRsmbLgbLcbRjbRsbLsbRobRcbLsLsmb
RcLsbRsbRsbRsbRibLsbLobRjbLgbRebRibLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 1; Drug: Control Apo 0.5 然
bLjLsmbLibRiRsmbLjbRibLcbLgbRjbRcbLcbLgRsbRcbRgbLjbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 2; Drug: Control Apo 0.5 然
bRobLsbLibLgbLibLsbLjbRsRsmbLsbLgbLgbRsbRgLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 3; Drug: Control Apo 0.5 然
bLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 4; Drug: Control Apo 0.5 然
bRhbLgbLgbLjbLjLsmbLibRibLibLgbLgbLsbLsbLibLibLsbLsLsmbLgbRobLsbLgLsbL
gbRcbRibRibRibRibRgbRcbRgbRibRibRgRsmbLgbLgbRhbLgbRibLgbLsbRsbLsbRsLsR
sbRgLsbLgbRsbRibRibRsbLgbRsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 5; Drug: Control Apo 0.5 然
bsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 6; Drug: Control Apo 0.5 然
bLobLobRebRobLebRebRjbLjbLjbLobLjbRjbLebRobLgbLebLebRjbLobRobRgbLjbRob
RsbRsbRebLsbLjbRjbRsbRsbLobRobLjbLcbLsbLjbRebLcbLobRebRobRcbRebRjbRsbR
sbLobLsbRgbLobRebLobRebRjbRsbRebRebRjbLsbLebRobLjbLebRjbLsbLjbLsbRobRs
bLebLsbLjbReb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bLibRiRsmbRsLsLsmbLgbLgbLsLsmbLgbLsbRsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bsbsbLcbRibRcbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
bRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bRjbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bRcLsLsmbLgbRcbLgbRobLsLsmbLgbRcbRibRsbRoLsbLcbLsbLcRsbRobRobRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bLsbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bLibLgbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bLsLsmbRsbRsbLsbRcbRsbRgbLgbLibRsbRgbLcLsRsmbLibsbsbLsbLsLsRsLsLsmmbRs
bLsbLsbRsbLsRsLsLsLsmmbLcLsmbRsbLjbLobRoLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bsbLibLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bsbLsbsbLsbLsbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bsbsbLsbRjbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bLsLsLsmmbLsLsmbLjbRjbRsbLsbRsRsmbRiRsmbLsLsmbRoLsbLibLibLsLsmbLsLsmbR
sbLgLsbLsbLsbLsbLsbLgbLsbLsLsmbLgbLsbsbLsbLsbLsbLgLsbLsbLsLsmbLsbLgbLg
bLjLsmbLibLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bRsbLsbLsbLgbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bLjbRcbLgbLibLibLsbLgbLoLsmbRgbLhbRgbRsbRsbRsRsLsmbLgLsbRjbRhbLgbLgbLi
LsbLgbRjbRhLsbRcbLgbLgbLibRsbLjbRebRibRcbRiLsbRibLsbRibRibLiLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bsbRsRsmbRsbRsRsmbRsRsmbRsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 25; Drug: Control Apo 0.5 然
bLjRiRsRsmmbRsbRibRibRcLsbLsLsmbRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 26; Drug: Control Apo 0.5 然
bLobRiLsLsmbLcRsRsRsRsmmmbLjbRcbLgbLgbRsbRcRsmbLjbRhRsRsmmbLebLgRsLsbs
bRoLsbLjbRjbsbLsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 27; Drug: Control Apo 0.5 然
bRibRgbRhbRsbRgbRjbRcLsbRibRibLiRsbLoLsmbRibRsbsbRsbRiLsbLsbRobRiRsmbR
gRsmbRiRsmbRhbRhbLsbRjbRiLsbRsbLsbRsbRgRsRsmmbRgbRcbRiRsmbRibLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 28; Drug: Control Apo 0.5 然
bRebRobRebLebRobLgbRobRobRebLgbLjbLobLobRebLobRsbRcbRcbRobRobRobLebReb
LcbRobLobRobLebRcbLobRcbRobRobRobLebRobRobRobLsbLebLobRobLebRebLebLebL
obRebRobRebRsbLobRobLobRobLobLebRobRebLibLobLobRobRobLobRgbLgbLobRcbLo
bRebRgbLobLobRibLsbRobLhbLebLobRobRgbLibRobRcbRebLcbLebLebLgbLobLebLgb
RobRibLobLibLebRsbLcbLibLobLcbRebLobLibLcbRcbLcbLsbRebLobRebRhbLcbRcbR
sbRgbRebRobRobRjbRebRebLgbRobRebLibRibLcbRibLobRhbLebRcbLibLobLsbRebRg
bLebLobLebRcbRobRibLebLcbRsbLobRcbLebLebLobRebLgbLobLobLcbRobRobLjbRob
RebLobRebRebRobLobRobLibRobLebRcbLobRcbLsbRobRobLobLobLobLobRcbLcbLebR
ebLobLobRobLgbLebLobRobLcbLobRebLibLobRjbLobLhbLgbLobRebRibRcbRgbLgbRg
bLcbRcbRebLobLobLcbRobRebLobRebLcbRebRobRobLobLhbLobRibRcbLebLobRobRib
RobRibRgbRsbLcbRobRobLgbLebRobRcbRgbLobRcbLgbLebLobRhbRcbRobLebRobRobR
ibLcbLcbLobRhbRobRebRobRobLobRobLobRobRcbLibLobRebLcbLibLcbRcbLobRobLi
bRibRibRobRebLebLebLobLcbLobRhbLcbRgbRobRebLobRcbLobLobLcbLsbRgbRebRsb
RibRobRcbRebLebLobRhbLobRobRobRcbRebLebRebRobLebLebLobRibRobRobLebRebL
cbLibRobLobLebLibLebRcbLobRcbLobLobRgbRcbLebLobLhbLsbLebLibLobLebLobRi
bLebLgbLobLgbRibRsbLebRcbRcbRgbLibRobLebRobLcbLobRobLobLobLebLobRobLob
RgbLcbLobRobLcbRcbRcbRobLobRgbLibLcbLgbRibLebRobLcbLobRobRobRibRebLcbR
cbRebRobRebLobLcbRobRobLebLcbLsbLibLhbRobLgbLobLobLebLsbRebRobRebRebLo
bLebRobLcbLobLcbLobLcbRobLcbLebRsbRcbLibLcbLcbLobRibLobRobLibRobLebLcb
LobLebLibRebLhbLibRgbLebLobLebLobRcbRobLobLobRobLibRebLobRhbLcbLcbLebR
ebRhbLebLebLibRcbLobRcbLobRcbLobRebLobLcbLebRebRebRebLgbLibLobRcbLcbRo
bRebLibLobLobLibRebRebRobRgbLhbRobRobLgbRebLcbRebRobRobRebRebLebLebRob
RcbLebRebLobRcbLcbRobRcbLebRcbLobLcbLebRhbRobLgbLobRebRcbLobLebLebLebL
ebRcbLebLebLebRcbRcbRobLgbRobLcbRebRebLgbLebRhbLebRobRobRobLobLobLhbRo
bLcbLsbRebRcbLobRebRsbRibRibLebRobRsbRebLcbLsbRobLebRibLibRsbRobRebRob
LhbRebRebLobLobRebRhbLobRobLsbRebLebLobLcbLobLebLsbRsbLcbRobRobLebLgbR
ibLobRobLcbLobRobLebRobRibRgbLebRobLsbLobLobLibLobRebRsbRgbRcbLibLobLe
bRebLebRobLhbLcbLcbRsbLcbLcbLobRobRobRibLcbRobLebLobLgbLobRgbLobLobLgb
LcbRobRebRcbRgbRobLebRebRobRebLebRcbRcbRebRebLgbLobLgbRebRcbLsbRgbRobR
gbRcbLobRebRibLobRobRobLobLobRobLsbRhbLobLsbRobLsbLsbRgbLibRobRebLobRe
bRebRobRibLobLobRobLebRibLobLebLebLcbRebLgbRhbLobLebLobRebRobLcbLobLeb
RgbRobRebLobRcbRebRobLebLobLebLobRobRobRcbLobRebLobLcbLobRgbLobLebLhbL
ebLobLgbRsbLcbRgbLobLsbLhbLgbRibRobLcbLebLcbLcbLobLobLobLcbLebLibRcbLe
bRibRgbLcbRobLobLobLibRcbLebLebRebRgbLebRcbLebRgbRebRebLobLibRgbRhbRsb
RebRobRcbLebLobRcbRobLobRcbRobLcbRobLebLebRcbLibLebLebLgbLibRsbLobLsbR
ebRobLobRcbRobRebRhbRibRsbLcbRebRibLebLcbLsbLcbLibRobLibLobLobLobRebRs
bRgbLobLgbRibLebRobRebLebLobLsbRobRebLobRobRobRobRgbLcbLgbRobLebRcbLeb
RibRcbLebLobLebLibRobRsbLgbLebLebRobRobLebLobRcbLobLobRgbRobRobLobRgbL
obRobLgbLobRobRebRebRobRgbLobRobRebLobLobRobLebLobRcbLcbLobRobLobRobRh
bLebRsbLobLgbLobLibRobLobRgbRcbLsbRobLobRcbLcbRobLibRobRebLibLobRobRob
LcbRobLobRobLobRobLobLcbLcbLcbLobLebRcbLhbRobRibRobRobLcbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 29; Drug: Control Apo 0.5 然
bRobLcbLhbLsbLsbLsbLgRsbLsRsbLsbLcbLcbRobLgbRsbLgRsbLgRsbLsbLgLsbLeLsL
smbLsbRoRsmbRibRibRsbRhbRjbLibRiLsbRsLsbLsLsmbLibLsbLibRjbRjbRibRsLsbR
iLsbLsbRcbRgbRsbLsbLsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 30; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bRsLsbLgLsLsmbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bRob

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bLoRsbLobLibLgRsbsbsbsbLsbRjbLcbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLcRsbRsbRibLibRsbLsbRsbRgbLsLcbLobLgbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bRsLsbLebLcbLiRsbLibLgbLiLsbLcbLibLcbLhbLgbLjbLiLsbRibLiLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLgbRsbRcbLjbLsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bRhRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bLgbLsbRobRsbRgbRsRsmbRcbRibRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bLcbRobRsbLsbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bLgbRhRsLombLoLsmbLibLiLsbRsbRobLsLsmbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bsbLsbLsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRgLsbRsbRsLsbRsbRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183448; End: 183948;
Recording: 11-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bLgbRsbRsLsRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 1; Drug: Control Apo 0.5 然
bLibRhbRibLgbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 2; Drug: Control Apo 0.5 然
bRcbsbLiLcbRsLsbLgbLgLsbLgLsbLgbLsbLgbLsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 3; Drug: Control Apo 0.5 然
bLobRibRsbRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 4; Drug: Control Apo 0.5 然
bRsbsbRgbRobRcbRobRsbRgLsbLjLsmbLjbRoLsbRgbLobLiRsbLibRsbLjbRobLgbRsRs
mbRobLgbLhbRhbRiLsbRgbRsbRjbRibRobLsbRsbRsbLgbRgbRibRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 5; Drug: Control Apo 0.5 然
bRcbLiRsbLsbRcbRsbLjbLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 6; Drug: Control Apo 0.5 然
bLiRsbLsbRcbRsbLhbLgbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bRebRsRsmbLobLsbRobRsbRgLsbLsbLsbRiLsbRsRsmbRgbRsbRoRsmbLsbRsRsmbLsbLs
RsRsmbLjLgbRgbLjbLcbRsRsmbRsbsbLsbRgbRsbRsbRsbRcRsmbLcLsmbRebLsbLgbLsb
LsbLsbRcbLsbLsbRoRsmbRsbRsbRibRiRsmbRgbLsbRgbRsRsmbLsRsbRibLsRsbRjRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bRgRsmbLjbLeLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bRsLjbRgbLgbLhbLibRsbRobsbRibLsbLsbLsbLcbLoRsRsRsmmbLhbLsbLibRsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
bsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bLgbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
bLebLobsbsbsbLsRsLsLsRsLsLsRsRsmmmbRsRsmbRgRsmbLobLgbLibRob

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bRgbRsbLibRsbsbsbLsLsmbLsbsbRsLsbRibLsLsmbRsLsbLgbLgbLgbRobLoRsbRibRoL
sbRsbLibLoLgbRobLcbLgbLgbRgbLcbRibLsbLjbLgbRsbLgbLsbsbsbsbRsbLsRsbLsbL
sbRsbLsbLsbRsbsbLsLibLsLsmbLoLsmbRgRsmbRsbLgbRobLgbLgbLjbLibLibRsbLibR
gbLsbRsbLgbLgLsbLgbLgbLsbLgLsbLsbLgbRsRsmbRsRsLsmbLgbLgbRsbLgbLsbLgbRc
bLgbRcbLjbLsbRgbLjbRsbLibLgLsbLgbRsbRibRgbRibRgRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLsbLibLsLsmbRsbRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bRsRsLsmbRsbLcbLsbLobRob

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bLgbRibLsbLsbLsRsbLsbRjbLjbRgLsbLobLsbLcRsbLcLsmbLsbLgbLsbsbLsbLhbLibL
sbLsRsbLsLsLsmmbLsLsmbLsLsmbRsbRgbLsbLgbLgbLsbRsbRsbLsbLgbLsbRhRsmbsbL
oRsbRsbRsRsmbRsbRgbRsLsbLgLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bLgbLsbRcbLobLiLsbLibRsbLsbLiLsbRibLsLsmbLsLsmbLiLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bLoRsbRhbRcLsbLibRhbLgbLsbLsbRsbLoRsbLiLsLsmbLgbRgbLibRsbRsbLsbLgRsbLs
bRsLsbLsbLsRsbRcbRibLsLgbRibRibLsLsmbLsbLgbLgLsbLibRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bRsbsbsbsbsbsbsbLsbsbsbsbLsbsbLsbLsbsbLsbsbRsbsbRsbRsbsbsbsbsbRsbRsbsb
sbsbsbLsbLsbRsbRsbRsbLsbLsbsbLsbRsbRsbsbRsbsbsbsbsbsbLsbsbsbLsbLsbsbsb
LsbLsRsbsbsbsbRsbRsbsbRsLsbLsbsbsbsbLsbLsbsbsbsbLsbLsbsbLcbRcbLjbRcbLi
bRcbLhbRjbRibRgRsmbRobRobRobLsbRsbLhbRcLsbLobsbRebRibLgbRsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 25; Drug: Control Apo 0.5 然
bLhbRibLsbsbLcbRjRsmbRjRsmbLhbRobRsLsRsRsRsRsRsRsmmmmmbRibLhbRsbRjLsbR
obRibRjbRibRgbRibRsbRjRsmbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 26; Drug: Control Apo 0.5 然
bsbLcbRcbRsbRsbRsbRoLsLsmbLhbLibLsbsbLcbRjRsmbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 27; Drug: Control Apo 0.5 然
bLgbLoLsmbRobLgbRsbLoRsbRjbLcLsmbLsbRsRsmbRsbRsbRsbLsbLsbRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 28; Drug: Control Apo 0.5 然
bLobLebLobLcbRgbRcbRcbRebRobRsbLobLobLobLobLobLebRcbRobRgbRobLobLcbRob
RcbRobRcbRobRobRcbRobRobLobLobRebLgbLibLobRsbLobLebRebRobLgbLcbRobRcbL
ebRcbLobLibLobLcbLcbLobLobRobLobRobLobLebLebLgbLobRgbRobLhbRobLobLcbRo
bLcbRcbLobRsbLobRcbRobRobLcbRebLhbRobRebLobLebLobRsbRobRobLsbRebRobLob
LobRcbRobRobLgbLebLcbRobRebRobRobRibRobRobLgbLebLobLobLobRibRebLobRebR
hbLebRobRcbLebRsbLibLobRobLobRobLebLebLobRobLcbRcbLobLobRobRgbRsbLsbLo
bLobLobRobRobLsbLobLebRobRobRsbRobLjbLibLobRobLebRebRsbRsbLhbRcbRjbRob
LgbRebLobRobRibLobRebLcbRsbLsbLibRhbRobLobRcbLgbLobLobLobLobLibRhbLobR
ebLobRcbLhbRebLobRcbLgbRibLsbLibRgbRobRobRobRobLgbRebLebRibRsbRsbRcbLo
bRcbRobLebLobLcbLibRcbRibRobRcbLebRsbRgbRcbLsbLobRobLsbRebRibRibRgbLib
RobLsbRcbLebLobRobRibLobLgbRebRebRebLibLibLsbLibRobRobRcbRobRebLgbLobR
hbRcbLgbRebLebRobRobLhbRobRebRobRibLgbLhbRcbRgbLobRibLobRobLobLobLcbLe
bRcbLcbLobLcbRobRibLobLebLobRcbLobRobLobRobLobRebLobLobRjbRcbLobRebLgb
RobRobRobLebRibLibLobRibRobRcbLobLebRebLobLcbLobLobRobLcbLobRobRobLobR
ebLcbRebLcbLcbLobLebRebLhbLgbRebLcbRgbLobRebRibRobLobRebLsbRebRobLcbLc
bRobRebLebRcbLobRebRobLebRobLebRobRobLobRobRcbLobRcbRebRobRcbLebLobRob
RebRobLobLcbRebLobRjbRobRobLibRobLebLobRobLobLobRobLibRebRcbRhbRsbRibL
obRcbLobRsbRgbRebLebLgbLobLhbLebRobRibRobRcbLobLobRibRibRobLebLibRcbLo
bRcbLcbRobLebRibLgbRsbLebRobRsbLebLobRobRobRobLcbLobLibLobLcbLcbRcbLeb
RobLobRcbRebRobLobLebRobLibLebLebRcbRcbRcbRobRgbRsbLobLebRebLcbRebRsbL
cbRcbRebLobRobLgbLobRobLobLobLcbRibLobRobLcbLobRcbLebLobRcbLobLobLebRi
bRobLebRobRebRobLcbRobRebLobLgbLhbLebRobLgbRobRebLobRebLobLobRebLebLob
LobRcbRobLobLobLobRgbRebLebRobLebLobLobLebRebLebLobLgbRobLgbLgbLebLebL
obRobLcbLcbLhbLobRobRcbRebRgbLibRebRebRebLobRebLobLebRobRebRibRebLobLi
bLobRobRobRobLobRobLcbRcbLgbRcbLobRibRibRebLobRobRcbLcbLobRibLobLcbRob
LgbRobLsbLobLebLobLobRcbLibRjbLobRebRobRobLobRobLcbLebRobRobLobRhbRcbL
cbLobLjbLebRebRobRobLobLibRcbRobLebLebRebRebRebRebRobLsbLobRobLobRobRs
bRobLobLgbRcbRcbLobLobLebLibRebLobLobLobRgbRobLobLgbRobLebLebLebRibReb
RibRobLobRobRobRebRibLobLebRobRobRobRcbRibRhbRobRobLsbLobLhbLebLcbLobR
sbLcbRobLobRobLobRebRobLebLibRebRobRobLibRebLebLcbLcbLjbLsbLobLobLobRo
bLebRobRobRobRgbLobLcbLcbLebRebRobLjbRobLobLcbLobRobLobLobRibLobRobRob
RgbLcbLobRobRcbLcbRobRobRobRebLhbLcbRobLobLobRjbRobLebRcbLebRobLobRebL
obRibRobRobLsbRobLgbRcbLebLebLobRcbRobLjbLebLgbRgbLcbRsbRobRebLebRobRc
bRhbRebRobLebRobLebRobLgbRobLebRcbLibRsbRibRobLebLobLobRebLcbRobLcbLob
LobRobLcbLebRobRobRobLobRebRcbLsbLobLobRibLibLebRobLibRobRgbLebRobLsbR
obRobLcbRebRebLobRobLobRobLobRsbRobRobLobRibRibRebLobLsbLcbLibRobRobLo
bRobLebLobLobRobRebRebLcbLcbLebRsbLibRebRjbLebRebRgbLibLobLgbRobLcbRib
LsbRgbLobRebRebLebRhbLebRobRcbRebRebLgbRebRcbLsbLjbLcbLobLebRibRobLebL
ebRgbRobLobLobRebRebLsbLebLobLobRobLebRobRebLcbRobRjbRebRobRobRcbLobRc
bLobRjbLebLebLibLebRcbRobLcbRebLhbLobLcbLobRibRebRibRobRebLcbRcbRobLeb
RcbRjbRcbRhbRcbRgbRcbRobLobRobRobRobLcbLobRobRobRobRobLobRcbLebLobLcbR
ibRebRobLsbLebLobRsbRebRsbRobLgbRobRobLobLobRcbLebRebLebLobLob

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 29; Drug: Control Apo 0.5 然
bsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 30; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bRgbLoLsmbLobLgbLsbLobLsbLsRsbRoRsmbRsbsbLsbRsbLsbLobLsRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
bRobRsbRibRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bsbLsbRsLsLsmbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bRsbsbsbsbsbRib

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bsbsbsbsbRgLsbLgbsbsbsbsbLsbsbRsbsbLsbLsbsbRsLsLsmbRsRsmbLsRsbsbsbsbRs
bRsbLsbsbRsbsbLsbRsLsbLsbsbsbLsRsbsbsbsbsbRsbsbLsbsbsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLgbRsbRibRobLcbLobLsbsbLgbLsRsbRoLsbRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLhRsbLgbRoLsbLsbLhRsbRsbRgbLoLsLsmmbLjbLobRgLsbRsbLobLsbLgbLibLgbLibL
sbLsLiLsbLgbLgbLiRsbRgbRjbRobLgbLjbRebRcbLsbLcbLcbRcbRibLcbRobLjbRgbLi
bLobRcbLibRibLsbRgbLibRgbRibLhbLgbRibRgbLgbLgbLcb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bRhbLgRsbLcbRebRgbLibRobRgbLibLsbLsbLjbLiRsbLgbRobRoRsmbLebLiLsbRsbLob
RsLsbRgRsmbRsbLiLhbLsRsLsRsbRjbLoLsmbRsbLhbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bLsRsbRiRsRsmmbRoRsmbLsbRibRgbLsbRgbLsbRcbLsRsbRobRgbLsbsbLgbLgLsLsmbR
obLsbRobRsbLibLsLsmbLsLsmbLgLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bLgLsbsbLgbLibRcbLobRsRsmbRsRsRsmmbRsRsmbRsbRobRoLsRsbRgbLsbsbRsbsbLsb
RibRsbRgbLsLsmbRsbLobLibLobLhbRgbRoLsLsLsmmbLsbRcbLgbRobLsbRgbRsbRsbLs
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bRobLcbLsbLebRobRcbRobRobRjbRibLjbRobRobRebLobLebLsbRobLebLjbRjbLobLjb
RebRebRobLebLjbRjbLobRjbLobRcbRsbLobLjbLebLcbLcbRebLebLobLcbLobLjbLjbR
ebRcbRobLsbRebLebLcbRjbRcbRebLobLcbLjbRobLebLobLjbRobRcbRobRobLjbRobRo
bRebRibLjbLebLebLebRobLjbRobLcbLebLjbLjbRebRebRjbRobRobLjbLebLebLcbLsb
LebLcbLcbLebRebLobLobLjbRcbRcbLebLobLobLebLjbRjbRobLebLjbRobRobLobLebR
ebLjbRobRcbLjbLcbLobLebLcbRjbRobRobLobRobRebRcbRjbRjbLebRjbRjbRebLjbRo
bLjbLobLebLobLobRcbLobRobRobLcbLjbRebRsbLobRobLebLobLobLjbRsbLebLobRob
LebRobRcbLobLibRebLobRcbLobRobLjbLjbLcbRobRcbLcbLjbRobRobLebLcbRebLebR
jbLjbLjbLebLobRsbRebRobLcbLobLjbLobRobLebRebLobLcbLcbRobRcbRobLebRobRj
bRcbLjbLobRjbRcbRjbRcbRsbLobLebLobLebLebRjbLobRjbRcbLjbLcbLebRcbLcbRjb
RobRjbRsbRjbLebRjbRjbRsbLobRebRcbRobLobRibLjbRobRcbLobLjbLobLebLobLjbR
obLobLobRobLsbLjbRcbRobLebRjbLcbLebRjbRobRebLcbLsbRebLjbLebRsbLjbRsLsb
RebRgbLobRjbRobRobRobLebRjbRebRobRcbRebRjbRebLebLjbLcbRcbRcbRjbLobLjbL
obRcbRjbLobLebRebRjbRobLobLjbLcbRobRsbRobLobRobLjbLobRobLobLsbLobLcbRs
bRsbRcbLjbLcbRobRobRsbLebLcbRobRobRjbRjbLcbRebRobLjbRebRcbLcbRobRsbRjb
LobLcbRebRcbLebRobRjbLebRjbRobRobLjbLobLebLcbRcbLobRobLjbRebRcbLobLebR
obRebLebLcbLcbLjbRobRjbRobRjbRobRebRobRcbRebRjbLjbLobLobRobLjbLebLobRo
bRobLobLobLjbRobRsbLcbLobLjbLcbLobRobLsbRobLobRobLebLobRcbRobLobRebReb
RcbLobRobLjbLebRcbLcbLebRobRobLobLobRjbLsbRcbLobLjbRobRjbRjbLobRgbRobR
jbRgbLjbRobRobRebRobRcbRcbLebLobLcbLjbLjbLebRebRjbLebRjbLjbRjbRebLobLc
bLobRebRobRobRjbRobRcbLobRcbRobRjbRsbLobRebLjbRcbLsbRjbRjbRobRebRcbRob
RobRobRjbLcbLebLgbRebRsbRobRobLobLebRebLibLobLobLobLebRobRobLebLobLcbL
obLebRebLjbRobLobLobRcbLobRjbLebLsbRsbLsbLsbLsbLobRsLsbLsbRsbLsRgbLsbR
sLsbLsbLsbLsRsbRsbLsbRebLsRsbRsbLsbLsbRsbRjbRsbRsbRebLjbLsbLsbRsbLsbLs
bLsbLsbRsbLsRjbRsbLsbLsbRsbLebRsbRsbLsbLsbRebRsbRebRjbRsbRsbLsbRsbLsbL
sbLsbRsbLsbRsbRsbLsbRsbLsbRsbLsbLsbLsbLjbLobRsbRsRsmbRsbLcbRsLsbLsbLjb
Lob

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bRgRsmbLsbsbRgbRsbRsbLsbRgLsbRibLibLjLsmbRgRsmbLsbRsbLgLsbLgbLsbLsbLsb
LgbLgLsbLcbLsbLsbRsbRobLsbLcbLsbRsbLsbLgbLsbLsbLsLgbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bRgbLsRsRsRsmmb

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRsLsbRob

>ZF Recording 2016-03-15; tW: 300s; Start: 183950; End: 184450;
Recording: 12-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bLsbRsbRsbLsLsmbLsbRsRsmbLsbsbRsbsbsbLsbLsRsbLsbRsbsbsbLsbRsbsbsbRsbsb
sbLsbLebLobRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 1; Drug: Control Apo 0.5 然
bRgLsbRgLsLsmbLsRsRsmbLjbRjbLibRcbLjbRcbLsbLjbLiRsbReRsmbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 2; Drug: Control Apo 0.5 然
bLibLsLsmbLgbLgRsbLgbLibRibRsbLsbLobLobLiLsbLcbRsbRibLibLcbRoRsmbRsbRs
bRsbRsbRgbRibRgbRibRsbLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 3; Drug: Control Apo 0.5 然
bLjbLobLobRobLsbLebLobLjbRebLobRebRobLebRobLebRebLebRjbRcbLobLjbRebLob
RobRsbLobLobLobRobLebRsbRjbRobRobLsbRsbRjbLob

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 4; Drug: Control Apo 0.5 然
bLibLgbLgbRsbRcbLibRoLsLsLsmmbRgbLgbLgbRgbRsbLibRgbLsLsmbLgLsbLsbLibRc
bRobLcbLibLibLsRsLsbLgbLgbRiLsbRsbLsbLgbLjbLobLgbLsbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 5; Drug: Control Apo 0.5 然
bRjbLsbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 6; Drug: Control Apo 0.5 然
bLsLsmbLsbLgbLsbRjLsRibRibRgbRsLsbRsbRsbRgLsbRgbRsbLgbLibRjbRcbLsbRjRs
mbRibRgbRsLsbLsbRgbRgbRgbRsbRsbRsbRsbRsbRgRsmbRsbRsRsRsmmbRsbRcLsLibLi
bsbRjbRjbLcbRjbRobLsbRibRgbRsbRibRgbRsbRsbRsbRgbRgbRsbRgbRgbRgLsbRsbLs
bRgLsbLsRsbRsbLsbRgbRsbRgbRgLsbRgbRgbRsbRsbRsbRgbRsbRibRsbRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 7; Drug: NDMC 1 然 Apo 0.5 然
bRjRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 8; Drug: NDMC 1 然 Apo 0.5 然
bRsRsmbsbsbLsbRsbRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 9; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 10; Drug: NDMC 1 然 Apo 0.5 然
bLsbRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 11; Drug: NDMC 1 然 Apo 0.5 然
bLoLsmbRcbLsbLsLsmbRoRsmbLsbLgbLcLsmbLobRsbRsbLsbLjLsmbLhbLibLgbRhb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 12; Drug: NDMC 1 然 Apo 0.5 然
bLsbRsbLsbLoLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 13; Drug: NDMC 3 然 Apo 0.5 然
bRjLsbsbRsbRsbsbsbsbLsbsbsbsbsbsbsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 14; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 15; Drug: NDMC 3 然 Apo 0.5 然
bLsLsLsLsmmmbLgLsbLsbRhbLsbRgRsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 16; Drug: NDMC 3 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 17; Drug: NDMC 3 然 Apo 0.5 然
bLibLsbLcbRjbRcbLjbRhbLoRsbRgbLsbLgbLibLsbLgbRsRsmbRsbLgRsbLgLsbRcbRgb
LsbRgbRsLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 18; Drug: NDMC 3 然 Apo 0.5 然
bLsbLsLsmbLsbLgbLsLsmbLsLsLsmmbLsbLiRsRsmbRobLgLsbLsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 19; Drug: NDMC 10 然 Apo 0.5 然
bRjb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 20; Drug: NDMC 10 然 Apo 0.5 然
bRcbRgRsmbLhbRhbRiRsmbLibRibLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 21; Drug: NDMC 10 然 Apo 0.5 然
bRgbLsLsmbLsbRgbRjbLjLsmbLsbLibLsbLsLsmbLsbLgRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 22; Drug: NDMC 10 然 Apo 0.5 然
bRsRsmbLobRoLgbLgbRsbRsbLsbLsbRsRsmbRgRsmbRibRgbRgRsmbLgbReRsmbLsbRibR
ibLgbLsbRcbLjbLibRibRgbLsbLib

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 23; Drug: NDMC 10 然 Apo 0.5 然
bLcbLibRsbRgbRsLsbLgbLsbLsLsmbRibLgbRcbRiLsbLsbLjbLibRgbLgLsbLsbLgbRgb
RcbRsbsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 24; Drug: NDMC 10 然 Apo 0.5 然
bRibRebRibLhbLgbLgbLsbLgbRoRsLsmbLjbRibLobLibLiLsbRcRsmbLebLsbsbLsbsbL
gb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 25; Drug: Control Apo 0.5 然
bRibRjbLibLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 26; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 27; Drug: Control Apo 0.5 然
bRgbRcbRibRobLcbLcbRjbRibRobRgbRsbLsbLjb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 28; Drug: Control Apo 0.5 然
bLobRsbLsbRebRsbLebRebLebLgbRebRobRobLjbLobRobLjbLcbRgbRobRobLobRobRgb
RsbRjbLjbLobRcbRobLebLebLsbLcbLobRobRebLgbRebRobRcbLobRcbRgbLebRsbLebR
obLobLcbRebRhbRebLjbRgbLebLcbRebLebLsbLebRobLobLhbLobRcbLibRgbRcbLcbRe
bLobRobRibRebLcbRebRibLcbLcbRobRebRsbRobLebRebLcbLibRobLobRobLebLebRsb
RobRobLcbLobLcbRebRibRobRobRcbLobLebLobRobRebLobRobRobRobLobRobLjbLsbR
gbRebRobLobLgbLebLibRsbRcbLcbRjbLjbLjbRebLobRobRcbLobLjbRebRebRibLcbRs
bLebRobRgbLebRobLcbLebLcbRobRobRebLibRcbLibLebRhbRobRjbLobLcbLibLgbLgb
RobRebLobRibRobRobRobLjbRsbLobRibRcbRobLcbRobRebLgbRobRobRibLsbLobRibR
obRcbRobLobRebLebRebLibLcbRobLobRebLhbRobLibLobRobLcbRcbRobLobRebRebLo
bLobRhbRebLgbRebLcbRobLobLobLobRsbLhbLhbRebLcbRebRobLsbRjbLibRgbLebLgb
RcbRhbLobRgbLobLibLibLsbLobRobLcbLibRebRgbLebLobLjbRcbLjbRobRebLebRcbR
obRobLobRcbLobRcbLibRobRobLgbRobRsbRobLebLebRebLobRcbRobLebRebLobRibLo
bLibRibRobLobRobRebRobLcbRobLebRobRobRobLobRibRebLibRebLobLsbLobRebLob
RobRcbLobLsbRcbLcbLobLobRcbLgbRobLibLobLobRsbRcbRobLobLebRobLebLobLgbL
obRcbLebRibLgbLebLcbRcbLibLobLsbLsbRgbRgbRsbRobRebLcbRsbLobRcbRobRebLs
bLobRebLobLebLobLebLobLcbLgbLebRebLobRebLobLobLcbLobRobLebRobRsbRobRsb
RhbLebRgbLobRobLobRobRebRobRobRobRgbLcbRibRgbLgbLobRgbRgbLobRobLhbLebL
gbLebRebRcbLcbLobLobLobRebRsbLobRobRcbLcbRsbLebRobRcbRcbLobLsbLibRsbLe
bLcbLcbLobRcbLcbRobRebRebLcbLibLobLsbRobLebRsbRebRobLebLibRebLebLobReb
RgbLebRobRobRebLebRobRobLhbLcbRobLobRcbLobRobRibRcbLobLebRobLobLsbRcbR
obLsbRcbRhbRcbRcbLobLebLobRcbRobLebRjbRcbLobLebLobRobLcbRobRebLebLebLc
bRcbRcbRobLsbRgbLcbRcbRsbRobRebLcbRibLobLsbLjbLobLgbLebRebRobRobLebLhb
LebLsbRcbRobLcbLibLebRcbRobLgbLjbLobLebLobRebLobRibRobLobRcbLcbLobLobL
ebLebLcbLobLcbLobLobLobRobRcbLgbLobRobLsbLibLobLhbRsbRcbLcbRobRobLebLs
bLsbRobRebLgbLobLobRebLobLgbRobRibRebRobLebRobRobRgbRebRebLebLobLobLob
LhbRebRobLsbLcbRcbLobRobLcbRibRebLhbRobLcbRcbRebLcbRibRobRibLcbLobRgbL
obRcbLobLebLgbLcbLobLcbLcbRobRsbLobLobRibRobLjbLobRibLibRibRcbRebRebRo
bRjbRcbLobRebRobRobRobRsbLibRobRjbRcbLebRcbLebRobRobRobRobLobRobLebLob
RebLcbLobLebRobRobRebLebRebLhbLobRobLcbLobRobRcbLcbRcbLobRgbRsbRebRibR
gbLcbRobLobLibRobLhbRgbRebRgbLobRobLebRobRhbRobRcbLgbLebRcbRebRobRobRo
bLebRibRhbLebRobLcbLebLhbLobLobLobRobRebRebRobRobLobLebLcbRcbRebLebLgb
RcbRobRebLgbLsbLhbLobLobRcbRobRcbLsbRebLcbRgbRibRebRobRgbLobLebLhbRcbL
gbRgbRebRcbRobLebLobLebLobLhbRobLobRcbRcbRcbLibRebRebLobLcbLobLibLobLo
bRobRobRobLobRebRebLcbRcbRcbLobLobRobRobLebLobRobLobLsbLobRobRgbRebLob
RibRibRebRcbLebRgbLibRhbRobLobLobLobRgbRibLobLsbRebLebRobRobRibRobLsbL
ebRobLobRobLgbRobRobRebRobLobLobLebLebRcb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 29; Drug: Control Apo 0.5 然
bLibRobRibRoRsmbLjbLgbLcRsbLsbRcbLsLsmbLjLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 30; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 31; Drug: NDMC 1 然 Apo 0.5 然
bRjbRcbRsbRgbLcRsbRsbRgbRcbRgbRsbRgbsbLsLsmbRcLsbsbsbRsbRibRsRsmbRsbRc
bRsbRsbRjRsRimbRebRibRsbRsbRgbLsbRibRgbLsbLsRsbRiRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 32; Drug: NDMC 1 然 Apo 0.5 然
b

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 33; Drug: NDMC 1 然 Apo 0.5 然
bRhbLsbLsbLsbRsbLsbRsbRsbRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 34; Drug: NDMC 1 然 Apo 0.5 然
bLebLsbLobRcbLsbLsbRsbRobRsbRebRobRobLobRebLsbRjbLebLsbLjbLsbLjbLsbRjb
RobLsbRjbRebRebLobLsbRjbRsbRobLsbLsbRobRobLobRcbRobLobLobRebLobRsbRcbR
obRobRobRcbLobRsbLobLobRebRebLebRobRebLjbRebLobRobRebLobRobLebLebRobLc
bLobLobRebLcbLobLsbRebLobLobLjbRjbRjbLobLsbLjbLebLobLobLobRobRebLobRjb
RebRebRobLsbLobRjbLjbLobRjbRobRjbLobRsbLebLebRebRobRsbLcbRcbLebRobLjbR
obLebRobRobLjbRsbRobRjbLjbLobLobRebRjbLsbRobLjbLsbRjbLjbRebLebRsbRcbLj
bRobLebLjbLobLobLebRsbLobLsbRsbRsbLobLobRobLobRjbRsbLsbRsbRobRsbLobRjb
LebRsbLobLebLobRjbRsbLsbLebLcbLebLobRebLobRjbLebRebLsbLobLobRebRsbLeb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 35; Drug: NDMC 1 然 Apo 0.5 然
bLoLsmbLsRsbRiLsbRhbRsbLsbRgbRsbRgbRgRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 36; Drug: NDMC 1 然 Apo 0.5 然
bsbLgbsbRsbsbLsbsbsbsbsbsbLsbsbsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 37; Drug: NDMC 3 然 Apo 0.5 然
bLibRgbRgbRsRsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 38; Drug: NDMC 3 然 Apo 0.5 然
bLebRsbLibLsbLgbLibRsbLsbLhbLibRgbRsbLsbRsbRcbRibLsbRsbRiLsbRsbRsbRsLs
bRsbRiLsbRsbLsbRibRsbRsRsmbLsbRiLsbRsbRsRgLsbRsRgbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 39; Drug: NDMC 3 然 Apo 0.5 然
bLibLibRsRsmbLsLsmbLsRsbLsbsbRsRsmbsbLsbRsbsbsbsbsbsbsbLsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbLsbsbsbLsbRsbLsbsbLsbsbLsLsmbLsbsbsbsbs
bsbsbsbsbLsbsbsbsbsbsbsbLsbLsbRsRsmbsbLsbsbLsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 40; Drug: NDMC 3 然 Apo 0.5 然
bLobRobRoLsbLiLsRsbLsRsRsmbRcbLsbRsbRobRibLsbLsbRgRsmbRjbRibRhbRsRsmbL
sbRsbRibLsbLsRibRiLsbLsLsmbLgbRiRsmbRoLsRsLsRsbsbRsbRsbLsbLobRoRsmbLsL
smbRsbRibLgLsbRibRibLsbRiLsbLgbRcbLgbRsbRgbRsRibLgbRibLjbLgbRgbRgbLibL
sbLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 41; Drug: NDMC 3 然 Apo 0.5 然
bRsRsmbLgbRsbLsbRiLsbLgbRibRsbLsLsmbRhbLsbRcRsmbLsbLsbLsbLsbRgbRibRsLs
bRsbRsbLsbLsLgb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 42; Drug: NDMC 3 然 Apo 0.5 然
bRgbLsbLsbRcbLsbLgbLibRsbLsLsmbLsbLgRsbRsLsbLgbLsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 43; Drug: NDMC 10 然 Apo 0.5 然
bRgbRjbRobRgbRcbRgLsRsbRgRsmbRobLobRgbLsbLsbRobRhbRebRgLsbRsbRgbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 44; Drug: NDMC 10 然 Apo 0.5 然
bRsbLhbLibLibLgbLsbLgbLsbLoRsbLsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 45; Drug: NDMC 10 然 Apo 0.5 然
bLsLsmb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 46; Drug: NDMC 10 然 Apo 0.5 然
bRsLsbRsRsmbRsRsRsmmbRsbRsRsmbRsbRgb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 47; Drug: NDMC 10 然 Apo 0.5 然
bRsbLsbRjbLobLobLsbRsbLsbLjbRsbLsbLsbRjbRsbRsb

>ZF Recording 2016-03-15; tW: 300s; Start: 184452; End: 184952;
Recording: 13-1; Individual: 48; Drug: NDMC 10 然 Apo 0.5 然
bLobLsRsbLibRhbRhRsmbRiLsbRcbRgbLgbRhbLgbLjbLibLibRsbRib

